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Abreviations and units used in this thesis:
Abbreviation Units
Ca02, CVO2 Arterial and mixed venous ml/100 ml
oxygen contents
Cl Cardiac index litres/min/m^
COD Coefficient of oxygen delivery
EF Ejection fraction
FEV1.0 Forced expiratory volume litres
in 1 second
FVC Forced expiratory volume litres
HR Heart rate beats/minute
H+ Hydrogen ion concentration nmol/litre
LV Left ventricle
LVEF Left ventricular ejection
fraction
MBP Mean systemic blood pressure mmHg
MPAP Mean pulmonary arterial mmHg
pressure
PaC02 Arterial carbon dioxide tension kilopascals
Pa02 Arterial oxygen tension kilopascals
PCW Pulmonary capillary wedge mmHg
pressure
P/V Pressure volume ratio
RAP Right atrial pressure mmHg
KV Right ventricle
KVgpyj Right ventricular end-diastolic ml/m^
volume index
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RV,EDP
RVEF
RVESVT
RVSP
W 9rtl
Sa02 
SDO2 
SVI 
SVR
TPVR, PVR
Right ventricular end-diastolic 
pressure
Right ventricular ejection 
fraction 
Right ventricular end-systolic 
volume index 
Right ventricular peak systolic 
pressure 
Right ventricular stroke work 
index
Arterial oxygen saturation 
Systemic oxygen delivery 
Stroke volume index 
Systemic vascular resistance 
Total pulmonary vascular 
resistance
mmHg
ml/m2
mmHg
g.n/m2
%
ml/min/m2
ml/m2
_c
dynes.s.cm J 
dynes.s.arT5
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A reproducible method of measuring right ventricular ejection 
fraction was devised using the technique of equilibrium radionuclide 
ventriculography. In an assessment of ventricular function, in a 
population of 100 patients with chronic bronchitis and emphysema, the 
right ventricular ejection fraction was, on average, lower than in 
normal subjects, but was still relatively well preserved in most, as 
was the left ventricular ejection fraction. However, the range of 
values of ejection fractions in patients with chronic bronchitis and 
emphysema was wide, and low values occurred mainly in patients with 
oedema, indicative of decompensated pulmonary heart disease. The 
right ventricular ejection fraction was lower in those patients with 
lower arterial oxygen and higher carbon dioxide tensions, but was not 
related to the level of simultaneous measurements of pulmonary 
arterial pressure. Right ventricular ejection fraction was, 
however, related to right ventricular afterload as measured by the 
pulmonary vascular resistance.
Occult right ventricular dysfunction could be demonstrated during 
exercise in patients with chronic bronchitis and emphysema. The 
change in right ventricular ejection fraction was related to the fall 
in oxygen saturation which occurred in such patients during exercise.
In 20 patients with chronic bronchitis and emphysema and pulmonary 
hypertension, the right ventricular end-systolic pressure/volume 
relation was calculated from combined measurements of right 
ventricular pressure, ejection fraction and cardiac output, in order 
to assess right ventricular contractility. Analysis of the
pressure/volume relation indicated normal or enhanced right
v c iiL -J .x ^ ujlcij.  i , u i i u x c i ^ u x x x u y  x i i  l x ic o c : ^ a u L a i u o ;  u c o j ^ x i x r  t_ u c  j^ /l c o c i i u ;  u x
pulmonary hypertension. The right ventricular end-systolic 
pressure/volume ratio was unchanged when right ventricular systolic 
pressure was reduced by an infusion of sodium nitroprusside.
Oxygen (3 litres/minutef nasal prongs) both when given acutely and 
over a period of 6 months (15 hours/24 hour day) to patients with 
chronic respiratory failure reduced pulmonary arterial pressure, but 
did not result in any change in right ventricular ejection fraction, 
nor in right ventricular contractility as assessed by the 
pressure/volume relation. From these results there was little to 
suggest that the effect of domiciliary oxygen in improving survival 
in patients with respiratory failure was mediated through a direct 
effect on the right ventricle. However, oxygen did improve right 
ventricular function during exercise in such patients although the 
mechanism remains obscure.
The beta-agonist Pirbuterol produced pulmonary vasodilatation in 
patients with hypoxic chronic bronchitis and emphysema. Moreover, 
the right ventricular end-systolic pressure/volume ratio increased, 
suggesting that this drug had an additional inotropic effect.
In order to determine if patients with acutely decompensated 
pulmonary heart disease truly had 'heart failure1, haemodynamic 
measurements were made in 6 patients with respiratory failure and 
pulmonary hypertension, who presented acutely with oedema. 
Measurements of right ventricular ejection fraction and analysis of 
the right ventricular end-systolic pressure/volume relation, 
suggested that right ventricular contractility was depressed. 
However, right ventricular function, as measured by the cardiac index
10
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mechanism involving large increases in right ventricular end- 
diastolic volume, as predicted by Starling's Law. In those patients 
who presented with oedema, these haemodynamic changes did not seem to 
result from an increase in pulmonary arterial pressure. Moreover, 
the relief of hypoxaemia by breathing oxygen had no consistent effect 
on right ventricular performance, despite a small reduction in 
pulmonary arterial pressure.
The measurement of right ventricular ejection fraction in patients 
with chronic bronchitis and emphysema when measured in isolation, may 
give little information as to the cause of right ventricular 
dysfunction in such patients, but when combined with haemodynamic 
measurements obtained during right heart catheterisation, allows 
assessment of the right ventricular pressure/volume relation. This 
measurement is useful in assessing the mechanism of right ventricular 
dysfunction and in measuring the effects of therapeutic interventions 
in patients with pulmonary heart disease.
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Chronic bronchitis and emphysema is a common disease, A survey of 
18,000 male civil servants in London revealed that 10% had symptoms 
suggestive of chronic bronchitis, although few had a reduction in 
their ventilatory capacity (270), In the UK this condition is 
estimated to account for 10% of all days lost from work due to 
sickness, more than any other single disease entity (254), and in 
Scotland results in 46.5 deaths/100,000 of the population (269),
In some patients the condition will progress leading to chronic 
hypoxaemia, with or without hypercapnia. Once chronic hypoxaemia 
has developed such patients are at risk of developing 'cor pulmonale1 
or 'pulmonary heart disease1, The classical view of the development 
of cor pulmonale is that hypoxia results in pulmonary 
vasoconstriction, leading to pulmonary hypertension (113). It is 
proposed that the consequence of this increased pressure load is the 
development of right ventricular hypertrophy or cor pulmonale (361) 
with eventually clinical signs of right ventricular failure, often 
occurring during an exacerbation of chronic bronchitis and emphysema. 
However, whether the clinical syndrome of oedema in association with 
cor pulmonale is due to true right ventricular failure remains 
controversial (276). Whatever the events are which lead to cor 
pulmonale, its presence results in a high mortality, only 45% of such 
patients surviving for 2 years, compared with a 69% survival at 2 
years in those patients without cor pulmonale (271). Similarly, the 
presence of pulmonary hypertension in patients with chronic 
bronchitis and emphysema also worsens the survival (351).
Clearly a greater understanding of the effects of pulmonary
12
Figure 1  Traced outline of contrast angiographic studies in 6 
normal subjects without evidence of cardiovascular 
disease. The right ventricle is shaded (after Arcilla R 
A et al [10]).
bronchitis and emphysema, particularly in determining whether true 
ventricular failure occurs in the syndrome of cor pulmonale, would 
lead to more rational treatment of this condition, which might reduce 
the mortality.
The assessment of right ventricular function, particularly 
measurement of its volume by contrast angiography (126) has 
previously been difficult, principally because of the variable and 
irregular shape of the right ventricle (figure 1). The introduction 
of radionuclide ventriculography (317) allows the measurement of 
ventricular ejection fractions, independent of the ventricular 
geometry. More detailed measurements of right ventricular mechanics 
can be made by combining simultaneous measurements of right 
ventricular ejection fraction and conventional pulmonary 
haemodynamics, measured during right heart catheterisation. These 
measurements allow a detailed analysis of the pressure/ volume 
relationships within the right ventricle.
The purpose of this dissertation is to assess in detail, the function 
of -the right ventricle in patients with chronic bronchitis and 
emphysema. The initial studies were made to develop a reproducible 
method of measuring right ventricular ejection fraction (R7EF), using 
the technique of radionuclide ventriculography. Having established 
a reliable and reproducible method of measuring RVEF, it could be 
applied to assess right ventricular function in a population of 
patients with chronic bronchitis and emphysema, comparing the results 
with those in normal subjects. The measurements of both right and 
left ventricular ejection fractions (LVEF) could then be correlated 
with the clinical parameters of the disease in such patients.
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Simultaneous measurements of right ventricular haemodynamics, 
measured during right heart catheterisation, and radionuclide right 
ventricular ejection fractions allow, as will be seen later, right 
ventricular volume to be derived and thus the right ventricular 
pressure/volume relationship can be measured. In this way the 
effects of pulmonary hypertension on right ventricular mechanics and 
contractility can be studied in patients with chronic bronchitis and 
emphysema. In addition, the effects on right ventricular function 
of therapeutic interventions which might reduce the pulmonary 
arterial pressure, such as vasodilators or oxygen, can also be 
studied in patients with cor pulmonale with and without the clinical 
signs of 'right ventricular failure*.
Ls'i.S
From these studies I hope the answer the following questions:
1. Is right or left ventricular function impaired in patients with 
chronic bronchitis and emphysema?
2. How does right ventricular function relate to the clinical 
parameters of disease in such patients?
3. How does the presence of pulmonary hypertension affect right 
ventricular function in patients with chronic bronchitis and 
emphysema?
4. What are the effects of reducing pulmonary arterial pressure on 
right ventricular function in patients with pulmonary 
hypertension?
14
pulmonary hypertension and clinical signs of right ventricular 
failure?
/
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INTRODUCTION
Historical review
Each of the organs of the human body is supplied by a specialised 
circulation. However, the blood supply to the lungs is unique, 
since it is in series with the systemic circulation, and therefore 
receives all of the cardiac output. The large pulmonary arteries 
were known to Herophilus of Alexandria in the fourth century BC 
(179). Several centuries later Galen (138-201 AD) proposed that the 
function of the pulmonary circulation was to supply nutrients to the 
lungs. According to Galen blood was manufactured in the liver, 
passed to the right ventricle and hence to the lungs. The blood 
then entered the left ventricle through interventricular pores and 
was distributed from there, throughout the body, to be consumed in 
the tissues (179). It was presumed that the lungs delivered air via 
the pulmonary veins to the left ventricle, where it became the 'vital 
spirit*. The left ventricle then acted as a furnace to supply heat 
to the rest of the body. Hie exhaust fumes from this furnace being 
conducted away, through the mitral valve, by way of the pulmonary 
veins to the lungs to be exhaled.
Blood was originally thought to ebb and flow, and it was not until 
the Renaissance that the concept of the circulation of blood was 
perceived. William Harvey (1578-1667), who was a medical student in 
Padua, realised that the circulation was not simply a generator of 
'vital spirits* (69). He estimated that the cardiac output was too 
great to simply allow a one way flow. In his classic work De Motu 
Cordis (146) he states "It is manifest that more blood is continually
16
can furnish, or is possible to be contained in the veins". Harvey 
first introduced the idea of the pulmonary circulation as a bridge 
between the two ventricles (145). However, it was not until a few 
years after Harvey*s death that Malpighi provided proof of the 
continuity between the circulations, by visualising, in a frog lung, 
the passage of blood from the pulmonary artery to the pulmonary veins 
through what he called 'porosities* (211).
Following the discovery of oxygen, by Priestley (1733-1804), it was 
Lavoisier (1747-1794) (68) who proved that oxygen was the essential 
constituent of air which was necessary to support life, thus 
introducing the concept of the lungs as an organ of gas exchange.
Hie first quantitative measurements of blood pressure were made by 
Stephen Hales (1677-1761) (65). Moreover, by pouring wax into the 
ventricles of dogs and measuring the volume of water displaced by the 
subsequent ventricular cast, Hales was able to estimate the stroke 
volume. By calculating the product of the stroke volume and the 
heart rate, he made the first measurements of cardiac output. In 
addition, although he was not. able to measure the pulmonary arterial 
pressure, he deduced that the pulmonary vascular resistance was lower 
than the systemic vascular resistance, because the walls of the right 
ventricle were thinner than that of the left ventricle (65).
It was in Carl Ludwig's laboratory in the 1850s that practical 
methods of measuring pulmonary vascular blood flow and pressure were 
developed (32). Adolph Fick (1829-1901), a student of Ludwig's, 
derived the theoretical basis, in dogs, for the measurement of 
cardiac output: the total oxygen uptake per minute divided by the
17
through the lungs (138), Direct measurements of pulmonary arterial 
pressure are attributed to August Chauveau (1827-1917) and Etienne 
Jules Morey (1830-1904) who passed a double lumen catheter by way of 
the jugular vein to the pulmonary artery of a conscious horse. Both 
right ventricular and pulmonary arterial pressures could then be 
measured using an air filled manometer and recorded on a polygraph, 
which was also invented by Morey (138). Later Forsman (1929) 
demonstrated on himself, that a catheter could be passed to the right 
heart from a peripheral vein (119). The systematic investigation of 
pulmonary haemodynamics in man, however, began in 1941 with the 
catheterisation of the right atrium by Cournand (67) and five years 
later with the catheterisation of the pulmonary artery in normal man 
and in patients with chronic lung diseases (35).
au&liMk!IRE AND FUNCTION OF THE HUMAN PULMONARY CIRCULATION
The normal pulmonary circulation (110, 131, 140)
Ohe pulmonary circulation and lungs form part of a complex system to 
enable external respiration to occur. As such the pulmonary 
circulation exists to perfuse , rather than nourish the lungs. In 
contrast with the systemic circulation, where the arterioles have a 
coat of circular smooth muscle, and are the vessels which contribute 
most to the systemic vascular resistance, the low pressure pulmonary 
circulation does not have an anatomical counterpart of the systemic 
arteriole. The absence of precapillary muscularised arterioles in 
the pulmonary circulation, means that other small vessels contribute 
appreciably to the driving pressure, which is represented by the 
difference in pressure between the pulmonary arteries and veins. 
Moreover, the small pulmonary vessels can respond passively to
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as a reservoir for blood.
The pulmonary arteries themselves subdivide into terminal branches 
which have a wider bore and thinner wall than the corresponding 
systemic arteries. The structure of the wall of the large pulmonary 
arteries, which consists of smooth muscle inserting into short 
elastic fibres, appears to be designed to allow distensibility of the 
vessel, rather than active constriction or dilatation (148). 
However, the early animal work of Von Euler (96, 97) demonstrated 
that the potential exists for large pulmonary arteries to constrict 
and increase the pulmonary vascular resistance. Vessels which can 
actively change calibre need to have smooth muscle in their walls. 
Thus the small muscular pulmonary arteries appear to be the major 
site of changes in resistance in response to changes in pulmonary 
vasomotor tone. The presence of medial thickening in these small 
arteries would potentiate any active constriction and lessen the 
ability of the vessels to undergo passive distension. Thus, under 
these conditions, the vessels would contribute more to the resistance 
to blood flow (58).
The pulmonary capillary network appears to have neither contractile 
cells nor smooth muscle in its walls. It is therefore unlikely that 
the capillaries contract actively, but they may be more apt to be 
reduced in size passively as a result of extrinsic forces, such as 
swelling of the endothelial cells, perivascular transudates (85), 
raised alveolar pressures (280), or by changes in intrathoracic 
pressure (329). The pulmonary capillaries are suspended in the 
walls of the alveoli allowing the entire right ventricular output to 
take part in gas exchange. It is estimated that the pulmonary
19
of 50-70m^ and increases further , to 90m^, at 75% of the total lung 
capacity (345), The enormous expanse of the alveolar capillary 
surface in the normal subject can increase further during activity, 
without changing the balance between alveolar ventilation and 
pulmonary capillary perfusion, even during strenuous exercise (17).
Since the pulmonary circulation must accommodate the total cardiac 
output, a perfusion pressure of only 10 mmHg is required to 
distribute the cardiac output within the lungs at rest. The 
pulmonary circulation is therefore a low resistance system, with a 
low basal tone, since vasodilators which reduce systemic vascular 
pressures have little or no effect on the normal resting pulmonary 
arterial pressure (185, 236, 258, 335, 346). The normal pulmonary 
vascular bed therefore offers less than one-tenth of the resistance 
to flow of the systemic circulation. Thus , although factors such 
as gravity, lung inflation, neural stimulation, and local vasoactive 
substances affect the pulmonary circulation, they appear to have 
less of a physiological role in modifying pulmonary vascular 
resistance, which is affected much more by the local alveolar oxygen 
tension (109).
Thus the vascular resistance in the pulmonary circulation is 
dependent on the cross-sectional area of the small muscular arteries 
and the arterioles. However, it is also dependent on a number of 
other variables, such as the blood viscosity, the total mass of lung 
tissue (ie, resistance is higher in infants than in adults) and the 
extra-mural compression of vessels (eg, perivascular oedema). ttie 
distensibility of the normal pulmonary vascular bed means that the 
cross-sectional area of the bed varies directly with both the
20
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resistance decreases passively, with increases in flow (57). 
Consideration of the Poiseuille equation:
R = P/Q = 8Hl/TTr4
(R = resistance? P = pressure drop? Q = flow? M = viscosity of 
fluid? 1 = length of the vessel? r = radius of the vessel)
shows that small changes in the vessel radius can have a large effect 
on resistance. A change in calibre may, of course, not only arise 
from a change in the diameter of the vessels, but also from a change 
in the number of parallel paths which are being perfused, ie, 
recruitment of previously under-perfused vessels (194). As an 
illustration of this, acute changes in flow, such as occur during 
balloon occlusion of a single pulmonary artery are associated, in the 
supine position, with an increase in pulmonary arterial pressure so 
that the pulmonary vascular resistance remains unchanged (299). 
However, in the upright position, the blood vessels are usually in a 
partial or completely collapsed state, and these vessels may expand 
in response to an increased flow resulting in a reduction in vascular 
resistance (142). Thus changes in pulmonary vascular resistance do 
not necessarily accurately reflect active changes in vascular 
calibre, unless all of the other passive mechanisms affecting vessel 
calibre are taken into account. This has led to the use of 
pulmonary arterial flow curves and pulmonary vascular flow resistance 
curves to detect active changes in pulmonary vascular calibre (109).
During supine exercise in normal man (292) the pulmonary arterial 
pressure increases by 3-5 mmHg. The increase in systolic pressure
21
the exerciser pulmonary arterial pressure often falls below the 
control resting values (81 f 305), The pulmonary vascular resistance 
either remains unchanged (46) or falls during moderate supine 
exercise (277, 137)f most probably by passive dilatation of the 
vessels. With severe exercise, where the cardiac output is tripled, 
the pulmonary vascular resistance becomes constant (192).
As discussed above it is difficult, in a normal subject, to increase 
pressures in the pulmonary circulation more than a few mmHg. 
Although a large number of both humoral and neural factors can be 
shown to affect pulmonary vasomotor activity (74), at present there 
is little evidence to indicate that, under normal circumstances, 
these factors are critical in maintaining normal pulmonary vascular 
function. However, in disease states, the pulmonary vascular bed 
can undergo profound changes in vasomotor tone. It might be 
supposed, in the development of pulmonary hypertension, that 
reduction in the extent of the pulmonary vascular bed would be more 
important than humoral or neural pressor mechanisms. This is of 
course of practical importance, since diseases such as emphysema may 
destroy large areas of the pulmonary capillary bed. However, it is 
generally believed that the physical loss of vessels contributes 
significantly to the development of pulmonary hypertension only when 
the reduction in vessels is extreme, such as in multiple pulmonary 
emboli, aplasia, or extensive excision of lung tissue (3, 130, 202). 
Support for this view comes from experiments in dogs, where more than 
two-thirds of the pulmonary vasculature has to be ablated before 
pulmonary hypertension develops (192). In addition, inpatients 
with pulmonary emphysema where alveolar vessels are widely destroyed, 
resting pulmonary arterial hypertension occurs only late in the
22
In the early 1940s the mechanism of the development of pulmonary 
hypertension, in what was then called 'chronic emphysema*, was stated 
to be from lung destruction, and was thought to be irreversible
(102), However, in 1946 Von Euler and Liljestrant1 (96) first
/
proposed, from experiments in the cat, that acute hypoxia produced 
pulmonary vasoconstriction. Morley et al (1947) (238) were the 
first to describe hypoxic vasoconstriction in normal subjects. 
There followed several other studies showing that, in normal 
subjects, when the inspired oxygen concentration falls below 15%, 
pulmonary arterial pressure rises, with no change, or a slight 
increase in the cardiac output and the pulmonary capillary wedge 
pressure so that pulmonary vascular resistance rises under these 
conditions (84, 107, 108, 112, 354). The mechanism of this rise in 
pulmonary arterial pressure in response to hypoxia remains unclear 
(112, 202). However, it seems likely that the site of the hypoxic 
vasoconstriction is in the small pulmonary arterioles, that it does 
not depend upon innervation of the lungs, and may act through the 
release of an as yet unspecified mediator, or as a result of the 
direct action of hypoxia on the pulmonary vessels (112, 127, 174). 
When normal subjects, who are resident at sea level, breathe oxygen 
heart rates falls, cardiac output changes little, and there is a 
trivial fall in pulmonary arterial pressure (18, 119).
The pulmonary circulation In .chronic b ronchitis .and emphysema 
Early studies of pulmonary haemodynamics in patients with 'chronic 
emphysema* indicated that pulmonary arterial pressure may be normal 
or slightly elevated when measured at rest (37, 143, 162, 243) and 
may rise to an abnormally high level during exercise (153, 277),
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pulmonary arterial pressure - the increase being greater in subjects 
over the age of 50 years (81, 91f 153, 277). This greater rise in 
pulmonary arterial pressure during exercise in patients with chronic 
lung diseases was considered to be due to the inability of the 
reduced pulmonary vascular bed, in such patients, to expand to 
accommodate the increased cardiac output, as can occur in the normal 
pulmonary circulation (79). However, it is now known that in the 
development of pulmonary arterial hypertension, several factors must 
be considered (table 1).
FACTORS CXPTOIPTOWQ TO THE DEVEliOPMENT OF FPLMONARY HYPERTENSION 
Destruction ££ pulmonary vascular bed
As discussed above, decrease in the anatomical extent of the 
pulmonary vascular bed does not appear to have a major role in the 
development of pulmonary hypertension. Since the quantification of 
pulmonary emphysema in life is difficult (331) studies where a 
comparison has been made between the 'emphysematous* and the 
'bronchitic* patients are open to question. However, these studies 
seem to indicate that pulmonary arterial pressure is raised in the 
'bronchitic* and normal in the 'emphysematous* patients (243, 347), 
when measured at rest, despite the fact that emphysema produces a 
greater destruction of the vascular bed. In addition, it appears 
from post mortem studies that there is no correlation between right 
ventricular hypertrophy and the total alveolar surface area, which is 
reduced in emphysema (140).
24
The evidence that breathing gases of low inspired oxygen 
concentrations produces an increase in pulmonary arterial pressure in 
normal man has been discussed previously (112). The rise in 
pulmonary arterial pressure is proportional to the fall in Sa02 
(122). In patients with chronic bronchitis and emphysema the 
correlation between pulmonary arterial pressure and SaC^ was first 
reported by Harvey et al (143), and has been subsequently confirmed 
by many other authors (37, 88, 93, 103, 120, 122, 159, 229, 243, 355, 
356, 365). Most recently data from a large European multicentre 
study of almost 1,000 patients suffering from common chronic lung 
diseases (595 of whom had chronic bronchitis and emphysema), showed a 
highly significant correlation in such patients between pulmonary 
arterial pressure and SaC^ or Pa02 (34). This relationship does not 
constitute proof that chronic hypoxia is the only cause of pulmonary 
hypertension in patients with chronic bronchitis and emphysema. 
However, as has been stated earlier, acute hypoxia produces pulmonary 
vasoconstriction in normal subjects and in patients with chronic 
bronchitis and emphysema (52, 84, 108).
A positive correlation also exists between the arterial P002 and the 
pulmonary arterial pressure (2, 143, 159, 299). However, in studies 
where increasing concentrations of inspired carbon dioxide were given 
to patients with chronic bronchitis and emphysema, although the 
pulmonary arterial pressure rose, carbon dioxide may not have 
produced vasoconstriction directly, since cardiac output also 
increased (108, 183, 281). Moreover, in only one of these studies 
did pulmonary vascular resistance increase significantly in response 
to breathing hypercapnic gas mixtures (183). Thus the pulmonary 
vasoconstrictor effect of carbon dioxide in patients with chronic
25
has been suggested that part of the effect of the PaCC^ on pulmonary 
arterial pressure may be as a result of changes in lung mechanics 
produced by the hyperventilation induced by the rise in PaC02 (141). 
There is also some data which suggests that an increase in the 
alveolar PCO2 potentiates hypoxic vasoconstriction (87).
The influence of arterial hydrogen ion concentration on the pulmonary 
circulation
Although a positive correlation has been shown between the arterial 
hydrogen ion concentration and the pulmonary arterial pressure, the 
induction of changes in arterial hydrogen ion concentration in 
patients with chronic bronchitis and emphysema has been shown to have 
equivocal effects on pulmonary arterial pressure (2, 94, 144, 160). 
In normal subjects intravenous infusion of sodium bicarbonate, so as 
to increase the pH to 7.5, had no effect on the pulmonary arterial 
pressure or cardiac output (28), whereas in patients with chronic 
bronchitis and emphysema, intravenous infusion of sodium bicarbonate 
or TRIS buffer produced no significant change in pulmonary arterial 
pressure but did produce a substantial increase in cardiac output, 
suggesting that pulmonary vasodilatation had occurred (94).
However, in view of the curvilinear relationship between pressure and 
flow in the pulmonary circulation in patients with chronic bronchitis 
and emphysema changes in pressure and flow should be interpreted with 
caution. Similar inconsistent effects on the pulmonary circulation 
have been reported when attempts were made to increase the hydrogen 
ion concentration in patients with chronic bronchitis and emphysema, 
by the intravenous infusion of hydrochloric acid (144, 160). Indeed 
when the arterial pH was decreased over a period of 5-7 days by
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and emphyseraaf no consistent change in the pulmonary arterial 
resistance occurred. However, there does appear to be some 
synergism between hypoxia and acidaemia in their pulmonary 
vasoconstrictor effect in patients with chronic bronchitis and 
emphysema, such that for a given Sa02 mean pulmonary arterial 
pressure is higher at higher levels of arterial hydrogen ion 
concentration (94). Thus when there is marked desaturation the 
pulmonary arterial pressure is more sensitive to changes in hydrogen 
ion concentration than at lesser degrees of desaturation. These 
studies take no account however of the extent to which changes in 
extra-cellular pH affect the intra-cellular pH of the smooth muscle 
of the pulmonary vessels,
Alterations in pulmonary mechanics
Changes in airway resistance have an important effect on gas exchange 
in patients with chronic bronchitis and emphysema. Since 
correlations have been shown between the PaC^r PaOC^r hydrogen ion 
concentration and the pulmonary arterial pressure, it is not 
surprising that a correlation has also been shown between pulmonary 
arterial pressure and FEV^ in such patients (141). Changes in 
airway resistance may augment pulmonary vascular resistance in 
patients with chronic bronchitis and emphysema by an effect on 
alveolar pressure. Harris et al (141) showed in normal man, that 
the relationship between pressure and flow in the pulmonary 
circulation, when alveolar pressure is normal, is rectilinear. 
However, when the alveolar pressure is increased (by increasing the 
gas pressure at the mouth) the pressure flow relationship in the 
pulmonary circulation initially becomes steeper and the relationship 
is now a curved one, the pressure no longer increasing in proportion
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increased alveolar pressure causing compression of the resistance 
vessels of the lungs. Thus if alveolar pressure is increased in 
normal subjects the relationship between pressure and flow in the 
pulmonary circulation resembles the relationship which exists between 
pressure and flow in bronchitic patients during normal tidal 
breathing (141).
The influence of the airways resistance on the pulmonary arterial 
pressure may be important in patients with chronic bronchitis and 
emphysema during episodes of hyperventilation. In contrast to 
normal subjectsf where hyperventilation produces no effect on the 
pulmonary circulation, hyperventilation in patients with severe 
chronic bronchitis and emphysema causes an increase in both pulmonary 
arterial pressure and wedge pressures, without changing cardiac 
output, so that the resulting increase in pulmonary vascular 
resistance can be interpreted to be as a result of a reduction in 
calibre of the vessels (141). Conflicting results have been 
reported in less severely disabled patients with chronic bronchitis 
and emphysema, where hyperventilation did not change the pulmonary 
vascular resistance (198). It has also been shown that the 
amplitude of the respiratory swing of the pulmonary arterial 
pressure, when patients with chronic bronchitis and emphysema perform 
exercise (which is related to changes in intrathoracic pressures), 
correlates with the pulmonary arterial pressure (348).
Increased cardiac output
The increase in cardiac output which occurs during exercise, for 
example, can be accommodated in the normal pulmonary circulation 
because of its distensibility, without producing large changes in
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increase by a factor of 2.5 to produce any significant increase in 
the pulmonary arterial pressure in the normal vascular bed (140). 
In contrast, in patients with chronic bronchitis and emphysema, where 
the vascular bed may be restricted, small increases in flow, even 
those occurring during mild exercise, may produce significant 
increases in pulmonary arterial pressure (278).
The effect of blood volume
Abraham et al (5) studied the effects of expansion of the blood 
volume on the pulmonary arterial pressure, in patients with chronic 
bronchitis and emphysema. Hypoxia resulted in a rise in the 
pulmonary arterial pressure and only a small increase in the cardiac 
index and thus an increase in the pulmonary vascular resistance, in 
these patients. Albumen infusion increased both the pulmonary 
arterial pressure with a greater increase in the cardiac index, 
producing a fall in the pulmonary vascular resistance. Breathing 
hypoxic gas mixtures, after the infusion of albumen, blunted the 
hypoxic vasoconstrictor effect, perhaps because the infusion of 
albumen increased pulmonary arterial transmural pressure, thus 
diminishing the vasoconstrictor effect of hypoxia (5).
The results of this study (5) do not support the hypothesis that an 
increase in blood volume is a major factor in the development of 
pulmonary hypertension. Moreover, during the recovery phase in 
patients with acute respiratory failure, the pulmonary arterial 
pressure starts to fall without any corresponding changes in the 
plasma volume and there is no significant correlation between the 
pulmonary arterial pressure and the plasma or total blood volume in 
such patients (6).
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The effect of blood viscosity
Patients with chronic bronchitis and emphysema who become hypoxic, 
develop secondary polycythaemia (32) which increases the viscosity of 
the blood. In theory since viscosity is a factor in the Poiseuille 
equation, then viscosity may have a role in the development of 
pulmonary arterial hypertension. The effects of reducing packed 
cell or blood volume and thus the plasma viscosity in patients with 
chronic bronchitis and emphysema have been studied by Segal and 
Bishop (305). Reducing the blood volume produced a small fall in 
pulmonary arterial pressure without change in cardiac output. Thus 
pulmonary vascular resistance fell slightly. This study suggests 
that blood viscosity at least contributes to the development of 
pulmonary arterial hypertension.
The effect q f pulmonary .venous pressure.
Although a raised pulmonary venous pressure produces an equal rise in 
pulmonary arterial pressure in patients with mitral valve disease or 
chronic left ventricular failure, it does not appear to have a role 
in the development of pulmonary arterial hypertension in patients 
with chronic bronchitis and emphysema, unless these other conditions 
are present concomitantly.
In the preceding section I have discussed the various factors which 
have an influence on the development of pulmonary arterial 
hypertension in patients with chronic bronchitis and emphysema. 
Hypoxia, either directly, or indirectly via a mediator, appears to be 
the most important factor (109, 110, 112, 131, 140, 222), I will 
now consider the consequences of pulmonary arterial hypertension in 
patients with chronic bronchitis and emphysema, how it progresses,
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THE EFFECTS OF PULMONARY HYPERTENSION IN CHRONIC BRONCHITIS AND
EMPHYSEMA
In this dissertation I have used the terras chronic bronchitis and 
emphysema synonymously, as both conditions usually co-exist 
pathologically (330). Most patients, however, lie in clinical, 
physiological and pathological terms in the middle of a spectrum of 
disease. Those with predominant chronic bronchitis or predominant 
emphysema are in the minority and lie at either end of the spectrum 
(54, 56, 232). A simplistic distinction of chronic bronchitis from 
emphysema was first attributed to Dornhorst (82) who coined the 
phrases 'pink puffer' and 'blue bloater'. The 'pink puffer' is 
thought to have predominant emphysema, with relatively normal 
arterial blood gas tensions. The development of pulmonary 
hypertension or right heart failure occurs late in the course of the 
disease. In contrast, the 'blue bloater* is considered to have 
predominantly chronic bronchitis, have hypoxia and hypercapnia and 
develops pulmonary hypertension early in the course of the disease, 
resulting in repeated episodes of 'right heart failure', often during 
acute episodes of respiratory failure. Thus not all patients with 
chronic bronchitis and emphysema inexorably pursue the road to 'right 
heart failure'. In those who develop hypoxia, pulmonary arterial 
pressure increases (106). Hypoxaemia tends to occur earlier in the 
'blue bloater' and the prognosis in these patients seems to be worse 
(41). Burrows et al (57) in evaluating the pulmonary haemodynamics 
in 50 patients with stable 'chronic airways obstruction*, found that 
those with elevated pulmonary vascular resistance had two patterns of 
cardiovascular dysfunction. Some had relatively normal arterial
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pulmonary arterial pressure. These patients were considered to have 
predominantly the 'emphysematous type of lung disease1. Those with 
more severe blood gas abnormalities had a more 'bronchitic type* of 
disease, and had normal or elevated cardiac outputs and more severe 
pulmonary hypertension. However, as with all such studies, the 
division of patients into 'emphysematous* or 'bronchitic* groups is 
imprecise, since the diagnosis of emphysema is a pathological one, 
and is difficult in life (330, 331).
What is the natural history of pulmonary hypertension in patients 
with chronic bronchitis and emphysema? Numerous studies have shown 
that when patients with chronic bronchitis and emphysema develop an 
elevated pulmonary arterial pressure, this pulmonary hypertension 
progresses slowly (41, 117, 288, 297, 349, 350). Weitzenblum et al 
(350) studied the changes in pulmonary arterial pressure in a group 
of patients with chronic obstructive pulmonary diseases, (mainly 
chronic bronchitis), over an average of 5 years, and found that 
pulmonary arterial pressure increased by an average of only 3 
mmHg/year. The mean increase in pulmonary arterial pressure was 
greater than 5 mmHg in only 33% of these patients over this period. 
Those whose pulmonary arterial pressure worsened tended to have lower 
PaC^ and higher PaCC^ eventually than those patients without 
worsening haemodynamics. Similarly Boushy and North (41) reported a 
mean increase in pulmonary arterial pressure of only 7% in 136 1
patients with chronic obstructive pulmonary diseases , studied before 
and after an average interval of 25 months. This change in 
pulmonary arterial pressure was associated with an increase in 
cardiac output of 6%. In contrast, Schrijen et al (297) found no 
significant deterioration in pulmonary haemodynamics in a group of
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period of 3 years, even in those with elevated pulmonary arterial 
pressure when first measured. However, in this study (297) 30% of 
patients had a fall in systemic arterial pressure with time. 
Schrijen suggested that this was as a result of the peripheral 
vasodilatory effects of hrypercapnia.
Despite the slow progression of pulmonary arterial hypertension in 
patients with chronic bronchitis and emphysema, its presence results 
in a poor prognosis. Weitzenblum et al (351) showed that patients 
with a normal pulmonary arterial pressure «  20 mmHg) had a 4 year 
survival of 72% compared with a 49% 4 year survival in those whose 
pulmonary arterial pressure was elevated (3). The prognostic value 
of pulmonary arterial pressure has been confirmed by others (217). 
Burrows et al (57), in a longitudinal 7 year study of 50 patients 
with chronic airways obstruction, showed that the level of pulmonary 
vascular resistance correlated best with survival, with none of the 
patients whose pulmonary vascular resistance exceeded 550 
dynes.sec.cm“^ surviving for more than 3 years. However, in one 
study of patients whose pulmonary arterial pressure was only 
minimally raised (mean PAP 20-29 mmHg at rest), although there was a 
25% mortality within 3 years, a similar percentage were alive after 
10 years (257). This conflicting data may relate to the duration of 
the pulmonary hypertension in an individual patient. However, it is 
clear that some patients tolerate increases in pulmonary arterial 
pressure remarkably well.
The presence of pulmonary arterial hypertension in patients with 
chronic bronchitis and emphysema usually attracts clinical attention 
when it causes the clinical syndrome of 'cor pulmonale'or pulmonary
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radiological and electrocardiographic evidence of right ventricular 
hypertrophy, often in association with peripheral oedema and raised 
jugular venous pressure (103, 104, 113). The current wisdom (figure 
2) suggests that in patients with chronic bronchitis and emphysema, 
hypoxia, in association with the other factors discussed previously 
results in pulmonary hypertension, which in turn leads to increased 
right ventricular work and cor pulmonale (103, 104, 113, 202, 328). 
However, no standard definition of cor pulmonale or pulmonary heart 
disease has been universally accepted. To some it indicates merely 
the presence of pulmonary hypertension, to others associated oedema 
and to yet others the presence of right ventricular hypertrophy. 
The difficulties of definition were highlighted by the WHO who 
defined chronic cor pulmonale as 'right ventricular hypertrophy 
resulting fran disorders that affect either the structure or function 
of the lungs' (361)* Thus accurate diagnosis of cor pulmonale 
requires pathological confirmation, since right ventricular 
enlargement may be difficult to diagnose in life either clinically or 
radiologically (155, 202, 278).
Pathological changes of pulmonary hypertension
As a result of pulmonary hypertension, longitudinal muscle may 
develop in the intima of the muscular pulmonary arteries, and in 
pulmonary arterioles (140). This change in the intima may also 
result from repeated stretching of the arteries particularly around 
emphysematous bullae, as it does occur in some cases of bullous 
disease without pulmonary hypertension (154). In addition the 
pulmonary arterioles may become muscularised (147), in contrast to 
the muscular pulmonary arteries which do not undergo arty significant 
medial hypertrophy (154). These findings in patients with chronic
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pulmonary vascular disease produced by primary pulmonary hypertension 
or left atrial hypertension which produces marked medial hyper trophy 
(59). The muscularisation of the pulmonary arterioles relates 
closely to the development of right ventricular hypertrophy in 
bronchitic patients (86).
Measurements of right ventricular thickness can be inaccurate and 
misleading in determining the size of the right ventricle (233). It 
appears to be more accurate to weigh the right ventricle by the 
standard method of Fulton et al (124). In this method the right 
ventricle is dissected free and the septum and left ventricle are 
weighed together. Measurements can then be made of the right 
ventricular weight or the ratio of the right ventricular weight to 
that of the left ventricle plus the interventricular septum. It has 
also been suggested that measurements of the myocardial fibre 
diameter is a better indicator of right ventricular hypertrophy 
(166).
Although initial studies suggested a relationship between'chronic 
emphysema* and right ventricular hypertrophy and failure (298), later 
studies have all shown no relationship between the anatomical extent 
of the emphysema and the weight of the right ventricle (70, 86, 229, 
233). In fact, severe emphysema involving 80% of the lung can be 
present with a normal right ventricular weight, but 45% emphysema 
with evidence of associated chronic bronchitis can result in right 
ventricular hypertrophy (86). In one study when the ECG showed 
right ventricular hypertrophy 25% of cases did not show hypertrophy 
of the right ventricle at post mortem (340). Thus factors other 
than an increase in right ventricular mass can produce right
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contrast, have shown that ECG changes of right ventricular 
hypertrophy in life do correlate with the pathological estimation of 
right ventricular hypertrophy at autopsy (71f 233).
It appears important/ therefore, to be able to distinguish those 
patients with chronic bronchitis and emphysema who have pulmonary 
hypertension alone, from those with 'cor pulmonale* as defined by the 
WHO (361), as an enlargement of the right ventricle in response to 
the increase in pulmonary arterial pressure. A distinction should 
also be made between those with 'cor pulmonale*, and those with, in 
addition, evidence of right ventricular failure, which is seen as the 
eventual consequence of cor pulmonale (322). These distinctions can 
be difficult to define clinically, since pulmonary hypertension and 
right ventricular enlargement often do not present with classical 
clinical, radiographic or electrocardiographic signs (222, 252). In 
addition, the presence of peripheral oedema in patients with cor 
pulmonale may not represent clinical evidence of true right 
ventricular muscle failure (276). In future discussions in this 
thesis I will use the term cor pulmonale as being right ventricular 
enlargement consequent on pulmonary hypertension and acute cor 
pulmonale as being an acute increase in pulmonary arterial pressure 
resulting in acute right heart strain or overload, usually as a 
result of a massive pulmonary embolism (165). The terms cor 
pulmonale with right heart failure or decompensated pulmonary heart 
disease will be used when there is clinical evidence of peripheral 
oedema for which no cause, other than cor pulmonale, can be found. 
Such patients may or may not have engorged jugular veins which are 
often difficult to detect clinically in patients with airflow 
limitation.
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Incidence .of s o l  pulmonale 12c pulmonary heart disease 
Cor pulmonale is considered to be a relatively common type of heart 
disease (113, 361) and is commonly associated in the UK, and the USA, 
with chronic bronchitis and emphysema (272). Recent figures 
indicating the incidence and prevalence of this condition are 
lacking, perhaps because of the difficulty in defining the condition 
clinically. In the UK at autopsy, 40% of patients with chronic 
bronchitis and emphysema show pathological evidence of cor pulmonale 
(149) and cor pulmonale accounts for 30-40% of cases in the UK (319,
355), and 10-30% of cases in the USA (165), admitted to hospital with 
a diagnosis of congestive cardiac failure.
Eight ventricular function In _chr.QDis b ronchitis .and emphysema 
Since hypoxia produces pulmonary vasoconstriction (112), and since 
the degree of hypoxia in patients with chronic bronchitis and 
emphysema has been shown to correlate with the level of the pulmonary 
arterial pressure in such patients (34), it seems reasonable to 
compare the effects on the right ventricle of chronic elevations in 
pulmonary arterial pressure, with the effects of systemic 
hypertension on the left ventricle (202). A further increase in 
pulmonary arterial pressure, which occurs during periods of acute
A
exacerbations of bronchitis (often precipitated by a respiratory 
infection) (6), should then lead to right ventricular overload and 
the features of right heart failure (143, 319).
Before birth both right and left ventricles appear to have the same 
pumping action. The differences which exist between the two 
ventricles in adulthood have been attributed to the different flow- 
resistance conditions in the two circulations (45, 191). Hie right
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Figure 2. The effects of increasing afterload (A) and pre-load (B) 
on the right and left ventricles in the dog. Stroke 
volume decreases rapidly when afterload is increased in 
the right ventricle, in contrast to the left ventricle, 
which maintains stroke volume reasonably well against an 
augmented afterload (A).
In contrast, the stroke work of the left ventricle 
increases dramatically when pre-load is increased, which 
is not the case with the right ventricle (B) (after 
McFadden E R and Braunwald) [202].
series with the low pressure pulmonary circulation. This is in 
contrast to the concentric contraction of the left ventricle, which 
works in a high pressure system. The normal thin walled right 
ventricle is therefore more compliant, and is capable of distending. 
Its geometric configuration is thought to be most suited to ejecting 
large volumes of blood with minimal myocardial shortening. It can 
therefore cope with considerable variations in the systemic venous 
return, without producing large changes in filling pressures (115, 
191). However, it is thought that the right ventricle is less able to 
adapt to the development of high intra-cavity pressures (1, 294). 
In contrast the left ventricle, has the ability to cope with 
increases in pressure load. Hie response of the right ventricle to 
progressive increases in afterload has been sparsely studied and most 
of the evidence for the difference in the response of the ventricles 
to changes in pressure and volume have come from animal data (1, 191, 
294). Figure 3 illustrates changes in stroke volume plotted as a 
function of various increases in ventricular afterload, produced by 
actively constricting the main pulmonary artery or aorta in dogs. 
For the right ventricle, even small increases in pulmonary arterial 
pressure result in a rapid decrease in stroke volume, whereas the 
left ventricle maintains its stroke volume relatively well despite 
increases in systemic arterial pressure. However, increasing 
ventricular pre-load or filling pressure fourfold (from 5 to 20 mmHg) 
(figure 3) by volume infusions into the atria - again in dogs, 
produced an increase in left ventricular work five times that of the 
right ventricle.
Thus a chronic increase in pressure load should lead to changes in 
the configuration, mass and function of the right ventricle. The
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found in patients with chronic bronchitis and emphysema produce these 
changes, is unknown. It is known, however, that acute constriction 
of the pulmonary artery in dogs produces no change in right 
ventricular pressure or cardiac output until the lumen of the 
pulmonary artery is constricted by more than 50% (324). Animal 
studies suggest that the ability of the right ventricle to compensate 
as the pulmonary artery is constricted is determined by (1) the 
increase force of contraction as the right ventricle distends; (2) 
the adequacy of the coronary circulation; (3) the circulatory 
neurohumoral reflexes, which increase the force of contraction; (4) 
the blood volume which can augment right ventricular end-diastolic 
pressure (134).
In patients with pulmonary hypertension as a result of mitral valve 
disease, right ventricular dilatation and failure occurs when the 
right ventricular systolic pressure reaches 60-80 mmHg. The level 
of right ventricular outflow tract obstruction which produces these 
changes can be increased or reduced by increasing or decreasing right 
coronary artery blood flow (50). Although banding of the pulmonary 
arteries in the cat produces a 2-3 fold increase in right ventricular 
weight, it is very unlikely that such rapid changes occur in man. 
Furthermore, the levels of pulmonary hypertension in bronchitic 
patients seldom reach the systemic levels needed to produce the acute 
changes which may occur in patients with multiple pulmonary emboli or 
primary pulmonary hypertension (339).
Thus in summary patients with relatively mild obstructive airways 
disease, without severe hypoxaemia or hypercapnia, have normal or low 
cardiac output, the latter occurring late in the course of the
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Figure A  Right ventricular stroke work index is highest in those 
patients with cor pulmonale both at rest and during 
exercise. When stroke index (right) is related to the 
right ventricular end-diastolic pressure, patients with 
cor pulmonale do not have a normal increase in stroke 
index during exercise, suggesting depressed right 
ventricular function. However, right ventricular stroke 
work index increases during exercise in all 3 groups 
(left), those with COPD and cor pulmonale operating on an 
extension of the normal right ventricular function curve, 
at the expense of an increase in right ventricular end- 
diastolic pressure (after Khaja et al [181]).
303, 338, 355, 356, 365). Right atrial pressures and right 
ventricular end-diastolic pressures are normal. Pulmonary arterial 
pressure is only slightly elevated but is inappropriately high for 
the level of cardiac output. Pulmonary vascular resistance is 
normal or only slightly elevated when at rest. When exercising 
pulmonary arterial pressure rises to abnormal levels (54, 252). 
However, as in normal subjects, the increase in cardiac output during 
exercise is normal relative to the increase in oxygen consumption 
(49, 181, 356). Right ventricular end-diastolic pressure also rises 
to abnormal levels on exercise (181). Right ventricular stroke work 
is normal at rest in these patients and rises on exercise (181). 
The increase in heart rate and stroke volume on exercise is similar 
to the changes which occur in normal subjects. However, the right 
ventricular stroke work index (which relates the stroke index to the 
pressure difference between right ventricular end diastolic-pressure 
and pulmonary arterial pressure) (figure 4) is higher in these 
patients due to an increase in pressure work against a higher 
pulmonary arterial pressure. However, if the right ventricular 
stroke work index is plotted against the right ventricular end- 
diastolic pressure, it appears that these patients operate on an 
extension of the normal right ventricular function curve (181). 
These findings are in keeping with the Starling mechanism such that 
the small increases in right ventricular end-diastolic pressure which 
occur on exercise, produce a large increase in right ventricular 
stroke work index. These changes in right ventricular haemodynamics 
may not be associated with clinical or electrocardiographic evidence 
of right ventricular hypertrophy in such patients (57).
As the airflow limitation and arterial blood gas abnormalities in
at the stage when chronic hypoxaemia develops, often but by no means 
always, in association with chronic hypercapnia, pulmonary 
hypertension is present at rest and worsens with exercise (49, 170, 
181, 338, 356). However, at rest right ventricular end-diastolic 
pressure is normal (181) even in those patients with past episodes of 
right heart failure or clinical evidence of right ventricular 
enlargement. Right ventricular end diastolic-pressure is, however, 
elevated in the majority of such patients during exercise. The 
presence of normal right ventricular end-diastolic pressures in these 
patients, at rest, is at least presumptive evidence of normal right 
ventricular end-diastolic volume (49).
Right ventricular function in patients with decompensated pulmonary 
heart disease
Relatively few haemodynamic studies have been made in patients with 
chronic bronchitis and emphysema who have had episodes of 'right 
heart failure' either at the time of study or in the past (37, 57, 
184, 243, 356). Such patients have a lower arterial oxygen 
saturation or tension, and a higher pulmonary arterial pressure and 
pulmonary vascular resistance, when at rest than those without 
previous evidence of cardiac failure (356). Some, but not all of 
these patients desaturate during exercise when breathing air, and 
exercise also produces an increase in pulmonary arterial pressure 
resulting in an increase in pulmonary vascular resistance (57, 181,
356). In the few studies where right ventricular function has been 
measured (27, 170, 181), right ventricular end-diastolic and right 
atrial pressures are often elevated,. However right ventricular 
stroke work index is well maintained. Moreover, in those patients
failure, right ventricular stroke work index responds normally to the 
increase in pressure work which occurs on exercise (figure 4). 
However, the right ventricular stroke index does not change 
significantly during exercise in those patients with right 
ventricular failure despite similar increases in heart rate (181). 
These changes produce a further increase in filling pressures.
There does not seem to be strong evidence, from the few studies 
available, that the right ventricle truly fails in cor pulmonale even 
when there is right ventricular enlargement or oedema (49, 113, 276). 
From the few studies of patients with cor pulmonale who have oedema, 
there is circumstantial evidence from right ventricular pressure 
measurements and cardiac output, that the right ventricle, with its 
smaller muscle mass, adapts to a high pulmonary vascular resistance 
by increasing its fibre length (increased diastolic volume) at the 
expense of a rise in end-diastolic pressure as would be predicted 
from Starling 's law of the heart (175). Clearly it is important to 
differentiate the failure of the ventricle to perform as a pump, from 
the failure of the heart muscle to perform as contractile tissue. 
It is possible that the right heart, faced with an excessive volume 
load or pressure load in 'cor pulmonale1 may be failing in a clinical 
sense, yet the contractility of right ventricular muscle is well 
maintained, however, its efforts are wasted by the excessive tension 
requirements of the ventricle as a whole. Thus a clearer 
understanding of right ventricular performance in patients with cor 
pulmonale would be important in determining rational treatment for 
this condition. The major purpose of this thesis is therefore to 
explore in more detail the right ventricular performance in patients 
with chronic bronchitis and emphysema.
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RADIONUCLIDE ASSESSMENT OF VENTRICULAR FUNCTION
INTRODUCTION
Until recently ventricular performance could only be accurately 
assessed by cardiac catheterisation and contrast ventriculography. 
Although right heart catheterisation probably involves less risk of 
complications than the arterial puncture required for left heart 
catheterisation, complications occur overall , in one quarter of 
cases, but are serious in only 4% (42). The injection of hypertonic 
contrast media is also not without risk and, because of the marked 
variability of the normal right ventricular shape and configuration 
(83), quantitative measurements of right ventricular volumes and of 
right ventricular ejection fractions using contrast ventriculography, 
are extremely difficult to obtain. This invasive technique is 
therefore less suitable when repeated measurements are required to 
study the effects of therapeutic interventions, or to study 
ventricular function in large populations. Many other methods have 
been used to assess right ventricular performance, in particular to 
detect right ventricular enlargement, which is a prerequisite for the 
diagnosis of cor pulmonale. These include EOG/vectorcardiography 
(237), echocardiography (7) and thallium myocardial scintigraphy 
(182). No one method has been shown to predict right ventricular 
hypertrophy reliably. Measurements of right ventricular function, 
from M-mode or two dimensional echocardiography are also limited, due 
to the difficulty in obtaining satisfactory images, particularly in 
patients with chronic bronchitis and emphysema (352).
Radionuclide ventriculography has proved to be an accurate,
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global, and regional function (318), However, its use in assessing 
right ventricular function, particularly in patients with chronic 
bronchitis and emphysema, has not been fully defined.
flisfcprisal fcagkgravmd
Following the discovery of radioactive isotopes by Becquerel, in 
1896, radioactive materials were first used in assessing 
cardiovascular performance by Blumgart and Weiss (1927) (36). They 
used radium 226 to generate radon gas and subsequently its decay 
product radium C, which they injected intravenously , as an aqueous 
solution. Using a cloud chamber to detect activity, they were able 
to measure trans-pulmonary transit time as a measure of pulmonary 
blood volume. Twenty years later, using an artificial isotope 
(sodium 24) and more sophisticated radio-sensitive detectors, in the 
form of a Geiger counter, Prinzmetal was able to record right and 
left ventricular volume curves during the first transit of a 
radioactive isotope through the right and left ventricles - the so 
called first pass technique (265). The generation of time activity 
curves from the ventricles using this first pass technique was then 
used in the late 1950's to estimate cardiac output and pulmonary 
transit time (205) derived from the principle of radiodilution based 
on the Stewart-Hamilton equation (136, 315). Using rectilinear 
scanners static images of the heart could be obtained, but with the 
later development of the modern scintillation gamma camera and the 
development of tracers labelled with radionuclides, dynamic images of 
the heart were possible.
Three elements are required for radionuclide ventriculography: (1) a 
radioactive tracer, (2) a gamma camera, (3) a system for handling and
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Radioactive tracers
The availability of radioactive substances for use as tracers was 
initially restricted to radium and its products, Blumgart and Weiss 
(36) initially used the ionic form of radium C or bismuth 214 which, 
although it has a short half life of 20 minutes, emits alpha, beta 
and gamma rays which result in a substantial radiation burden to the 
patient. Modern radionuclides, in contrast, emit only gamma photons 
or x-rays of sufficient energy to pass through the overlying tissues 
and thus be detected, without themselves producing substantial 
accompanying radiation, which is produced as a result of deposition 
of some of the photon energy in the tissues through which it 
traverses. Moreover, the half life of a radionuclide should be 
sufficiently long to allow measurements to be repeated over a period 
of hours but not long enough to produce an excessive radiation burden 
to the patient. In radionuclide ventriculography the radionuclide 
should be distributed and equilibrate in the blood pool, and must 
therefore be bound to a vector which determines its bio-distribution 
- the radionuclide and the vector together constituting a 
radiotracer.
The radioisotope which has the most suitable physical properties for 
use in nuclear cardiology is technetium^111. It was originally made 
in 1937 by bombarding its parent element Molybdenum with neutrons in 
a cyclotron (260) and was, in fact, the first artifically produced 
element. Later, in the 1960's, a practical generator system became 
available to separate technetium^111 from Molybdenum^111 (275). 
Technetium^111 has a half life of 6 hours. During its decay it emits 
a single photon of 140 KeV. Where repeated studies are required it
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vitro) or, more easily, to albumin, using a kit preparation (139), 
The tracer Tdr^m labelled human serum albumin (HSA) can therefore be 
injected as a bolus intravenously and data can be acquired during the 
'first pass* of radioactivity through the cardiac chambers, stopping 
the acquisition of data before the radioactivity reaches the lung 
fields. Alternatively, after a suitable time the 
radiopharamaceutical (radiotracer) mixes evenly within the blood pool 
(equilibration) and thereafter the acquisition of data can be 
commenced, and repeated if required, with adequate radioactive counts 
obtainable over approximately 3 hours. The radiation dose delivered 
to a subject, after an injection of Tch9^m HSA has been estimated to 
be 16 mRADS/mCi injected (lmCi = 37 MBq), If on average for a 
radionuclide ventriculogram one injects 20-30 mCi then the radiation 
dose is 320-480 mRADs (30),
The gamma camera
In order to measure cardiac function the radiotracer must be 
distributed in the heart in proportion to the function under 
investigation. Thereafter the nucleus of the radionuclide must 
rearrange itself to a more stable state by emitting a photon with 
sufficient energy to traverse the chest wall. The path of this 
photon must allow it to pass through a hole in the collimator, 
attached to the face of the camera and finally the photon must 
interact in a radiation detector to produce a signal, which permits 
localisation of this interaction.
The scintillation camera is the standard device in nuclear medicine 
for imaging the heart. This instrument is equally sensitive to 
radiation across its field of view, and is capable of localising the
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crystal of the detector. Two common scintillation devices are in 
use:
Tbs single crystal .camera (figure 5)
The interaction of a gamma photon on a sodium iodide crystal produces 
a flash of light (scintillation). The scintillation is brightest at 
the site of the interaction but light is also propagated throughout 
the crystal. A number of photo multiplier tubes are used to view 
the crystal and each detects a fraction of the light output from the 
scintillation. The gamma interaction can be localised by comparing 
the intensity of light observed by each tube (9).
The multicrystal camera
This device uses an array of discrete sodium iodide crystals which 
are viewed by a number of photomultiplier tubes. This arrangement 
allows a higher speed of processing and a higher count rate than the 
single crystal camera. However, the single crystal camera has a 
higher resolution than the multicrystal camera.
The addition of a lead collimator (figure 5) in front of the camera 
assembly results in gamma photons, other than those which are emitted 
parallel to the axis of the collimator holes, to be screened out, 
thus producing a one to one correspondence between the point of 
emission from the patient and the image. The X and Y position of 
light flashes detected by the camera crystal are indicated by the 
output X and Y (figure 6) and are used to control the horizontal and 
vertical deflection amplifiers of a cathode ray oscilliscope. When 
a light flash falls within the appropriate energy range, the signal Z 
is generated. The outputs from the camera are then fed into an
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figure 2  Creation of a digital image (B) from the scintillations 
produced as gamma photons strike the crystal (A).
system. When the signal Z is detected, the outputs of the X and Y 
signals are sampled, held at a constant voltage, and converted to a 
digital representation. Thus events which are within the desired 
energy window can be converted by the ADC's to digital form and can 
be processed by the computer.
The coordinates of the gamma photon scintillation on the camera 
crystal are processed according to the mode of acquisition, either 
frame mode or list mode. Frame mode is the more common form of 
acquisition and is simply a process of creation of a digital image as 
the counts strike the face of the crystal. This process can be 
illustrated by considering the face of the camera as if partitioned 
by a wire mesh (figure 7). The number of scintillations produced as 
gamma photons strike the crystal (A), within each square, will have 
the corresponding digital value (B). In practice, the camera field 
is divided into finer partitions using larger matrix sizes and thus 
the net effect is to produce a small light dot on the cathode ray 
tube for each gamma ray detected, in the same relative position as it 
occurred within the subject.
In contrast, list mode acquisition results in transfer of the X and Y 
coordinates of the scintillation directly on to the computer memory 
without initially producing an image. The data can thereafter be 
converted into a digital matrix after the acquisition has been 
completed. The advantage of frame mode acquisition is that the 
images are available immediately after acquisition and therefore less 
computer time and storage space are required (15).
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TIME (SECS)
Figure £  Time activity curve from a region of interest around the 
left ventricle during the first passage of a radionuclide 
bolus through the left ventricle. The systolic troughs 
and diastolic peaks of radioactivity are shown.
Th£ fixat pass method
In cardiovascular nuclear imaging several heart beats will be needed 
before sufficient photons have been accumulated in the camera and 
computer to accurately assess cardiac function. The measurement of 
ejection fraction by radionuclide techniques originates from the work 
of Kriss et al in 1966 (190), who first used a gamma camera connected 
to a digital computer to visualise the initial passage or 'first 
pass* of radionuclide labelled-tracers through the central 
circulation and were able to photograph the events. Later Van Dyke 
and colleagues were the first to quantify left ventricular function 
using the first pass technique (338). Accurate measurements of left 
ventricular ejection fraction, during the first passage of a 
peripheral intravenous injection of a radionuclide bolus, were made 
by frequent sampling of the fluctuations in activity during several 
cardiac cycles. Time activity curves, with high temporal 
resolution, can thus be generated from the left ventricle made up of 
a series of oscillations, the peaks and troughs of activity 
corresponding to the end-systolic (ES) and end-diastolic (ED) 
activity respectively (figure 8). Hie difference between the ED and 
ES activity corresponds to the stroke volume. Measurement of left 
ventricular ejection fraction from an analysis of these time activity 
curves, generated from the first pass technique, have been shown to 
correlate well with measurements made by biplane contrast angiography 
(295).
Background activity
In the analysis of left ventricular ejection fraction by the first 
pass technique, an appropriate correction must be made for background
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In order to correct for the background contributions to the 
ventricular time activity curve, two regions of interest (EDI) should 
be drawn? the first around the left ventricle and the second to 
account for the background counts. The best area for background 
correction has been found empirically to be a horseshoe area around 
the lateral and inferior borders of the left ventricular EDI, Thus 
two simultaneous time activity curves can be generated from these two 
regions. Hie activity curve from the background region can then be 
digitally smoothed to minimise statistical noise. Thereafter the 
contribution of background radioactive counts to the left ventricular 
EDI can be calculated by multiplying the background radioactivity by 
the ratio of the ventricular to background areas to 'normalise* to an 
area equal to that of the ventricular area. Since the radioactivity 
from each selected area is proportional to the ventricular volume, 
the average systolic and diastolic volumes for the three beats at the 
peak of the radioactive dilution curve (figure 8) (if there is 
adequate mixing) can be used to calculate the ejection fraction (EF):
"7 EF = End-systolic counts - end-systolic counts
End-diastolic counts - background counts
An accurate assessment of background activity is therefore essential 
to avoid under-estimation of the ejection fraction (245).
The first pass method has several advantages. It allows both 
temporal and special separation between the right and left ventricles 
(267). Hiis is particularly important in accurately determining the
50
acquisition time is required (20-30 seconds). When studying the 
right ventricle in isolation the acquisition of data can be stopped 
before the bolus of radiotracer enters the lungs, thus reducing the 
background counts.
However, there are certain disadvantages of the first pass technique. 
Only a single measurement of ejection fraction can be made following 
each injection of radiotracer. Repeated injections must therefore 
be limited to two or three in the same day because of the cumulative 
radiation burden. Thus haemodynamic changes following therapeutic 
interventions are difficult to study using this technique. Before 
the injection of the radionuclide bolus the camera must be in a good 
position to record the events during the first passage of 
radioactivity, since it is impossible to readjust the position of the 
gamma camera during the course of the examination. It is also 
important to obtain a good bolus of radiotracer, in order to achieve 
acceptable radioactive counts and this may be difficult in, for 
example, severe pulmonary hypertension or severe tricuspid 
regurgitation. The assumption that radioactive counts are 
proportional to volume demands that there is adequate mixing of the 
radiotracer in the blood within the cardiac chamber (88). Even with 
an adequate bolus injection, count rate limitations make the first 
pass technique less suited to conventional gamma cameras and a 
multicrystal scintillation camera with high count rate capabilities 
is often required to obtain statistically reliable data (23).
Despite these limitations, quantitative first pass radionuclide 
ventriculography has become a useful technique for non-invasive 
assessment of left ventricular performance in man (245). Until
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assessment of right ventricular performance using radionuclides. 
Several authors have now also published results of measurement of 
right ventricular ejection fraction using the first pass technique in 
patients with chronic bronchitis and emphysema (23, 24, 307, 309, 
364), Angiographic determinations of right ventricular volumes are 
difficult, and may be unreliable (126), However, correlation 
between right ventricular ejection fraction measured by first pass 
radionuclide and contrast angiography has been made in one previous 
study of patients with ischaemic heart disease (312).
Gated .cardias .studies
Strauss et al (317) first described a technique which allowed serial 
evaluation of left ventricular performance. This technique uses 
electrocardiographic gating mechanisms to trigger repeated 
acquisition of data at end-systole and end-diastole after the 
injection of a radiotracer has completely equilibrated in the blood 
pool. Radioactive counts from 200-500 heart beats can be summated 
permitting ejection fraction to be measured. Thus following a bolus 
injection of radiotracer, measurements of ejection fraction can be 
made during the first passage of radioactivity, and thereafter the 
radiotracer can be allowed to equilibrate for a gated equilibrium 
blood pool study. The electrocardiogram lead with the most 
prominent R and T waves is usually most suitable for gating. The 
technique of gating involves an electronic switch which determines 
the interval during which the events are recorded by the 
scintillation camera. The onset of the recording period is fixed by 
a delay control which regulates the time between the triggering 
signal (R wave) and the opening of the electronic 'gate*. The time 
thereafter during which an image is recorded is determined by a
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Figure £  Diagramatic representation of the electrocardiographic 
gating system of the gamma camera. The R wave of the 
electrocardiogram triggers the gating circuit, which is 
followed by a delay interval. After this interval the 
gate is opened and the gamma camera accepts data during 
the record interval. Data is thus acquired and 
accumulated during a record* interval at end-diastole and 
end-systole (after Strauss et al 1971 [317]).
viz the last 40 milliseconds after the R wave and during the 60 
milliseconds before the next R wave, counts can be accumulated over 
200-500 beats and an image of the mean appearance of the heart at 
both end-systole and end-diastole can be achieved (figure 9) (317). 
The data can then be stored on magnetic disc or tape for subsequent 
analysis of end-diastolic and end-systolic left ventricular volumes 
calculated from long axis and area measurements with subsequent 
calculation of left ventricular ejection fraction.
Multiple .gated .acquisition
By gating picture frame images from short time intervals distributed 
throughout the cardiac cycle (multiple gated acquisition) f images can 
be summated from 500 sequential heart beats and viewed in a movie 
format (245). The gated image is created by recording the X and Y 
coordinates of all the gamma photon scintillations occurring in each 
20 millisecond interval after the R wave marker. All the 
scintillation data from 500 heart beats are then sorted and 
accumulated into the appropriate 20 millisecond frames, resulting in 
a ventricular curve with its temporal relationship to the 
electrocardiogram (figure 10). The first 20 millisecond 
accumulation of data, triggered by the upstroke of the R wave, thus 
produces the first frame which represents end-diastole. Since 
radioactive counts are proportional to volume (if complete mixing of 
the radiotracer has occurred in the blood pool), the ejection 
fraction can be calculated, after suitable correction for non-cardiac 
background activity. Empirically, for the left ventricle when the 
gamma camera is placed in the normal 30° left anterior oblique 
position for imaging, a background area is chosen from the 
inferolateral wall of the left ventricular outline (figure 10) the
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Figure 10 Cumulative time activity curves from the left ventricular 
(A) and background regions of interest (ROI). Since 
radioactive counts are proportional to volume, the 
ejection fraction is the difference between the end- 
diastolic (EDC) and end-systolic counts (ESC) divided by 
the EDC minus the normalised background counts.
technique, normalised to an area equal to that of the left ventricle 
(245).
This technique has several advantages:
1. Most gamma cameras single or multiple crystal can be used for 
this method with minimal additional instrumentation.
2. Repeated studies can be performed with ease and with no further
radiation burden. Hie camera can be adjusted between periods
of data acquisition and thus the effects of therapeutic 
interventions can be easily studied.
3. Multiple scans can be recorded over 3 hours without loss of
7 tracer into the intra-vascular space, provided a high quality
i
electrolytically labelled human serum albumin is used.
4. Since data is acquired over numerous beats the radioactive 
count statistics are more reliable than with the first pass 
technique.
5. A bolus injection is unnecessary.
The disadvantages are:
1. The routine position for imaging - the left anterior oblique 
position - may not produce adequate separation between the 
right and left ventricles.
2. This technique produces best results where the cardiac rhythm
is regular, although it is possible to utilise computer
programmes to eliminate data collected from ectopic beats.
3. Hie relatively lengthy acquisition time may result in problems
of haemodynamic stability, particularly in obtaining adequate
data during maximal exercise.
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Left ventricular performance
The measurement of left ventricular ejection fraction from either 
first pass or gated equilibrium radionuclide ventriculography, is now 
standard in all nuclear medicine departments. As discussed 
previously, several studies have confirmed a good correlation between 
left ventricular ejection fraction (LVEF), measured by contrast or 
radionuclide ventriculography and this has been confirmed in our own 
laboratory (245). There is also a good correlation between the 
first pass and equilibrium techniques both at rest and on exercise 
and both techniques have a variability of only 4% when measured on 
separate occasions (216).
Right ventricular performance
As discussed previously the use of contrast angiography to visualise 
the right ventricle and measure its volume is difficult and tedious 
because of the wide variability of the right ventricular geometry 
(10, 126, 268). Radionuclide ventriculography to some extent avoids 
this problem, particularly when the first pass technique is used 
since measurement of right ventricular ejection fraction (WEF) can 
be made from the time activity curve, and therefore variations in the 
geometric configuration of the ventricle become less important. 
Most previous studies of right ventricular performance have used the 
first pass, rather than the gated equilibrium technique, which 
appeared more suitable for studying right ventricular function. 
Both techniques have advantages and disadvantages. The principal 
disadvantage of the first pass technique, namely the difficulty in 
performing repeated measurements and the short acquisition time, 
results in low counts and statistical uncertainty in the calculation
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attractive. As discussed in the preceding section, the equilibrium 
technique is the standard method of measurement of left ventricular 
ejection fraction, but until recently it has not been used to measure 
right ventricular performance because of a number of problems.
The first pass technique uses a right anterior oblique projection to 
separate the right atrium from the right ventricle (23) and counts 
from the overlapping left ventricle can be prevented by detecting the 
bolus of radiotracer only as it passes through the right side of the 
heart, stopping the acquisition before it reaches the left ventricle. 
Whereas, to separate the right and left ventricles with the 
equilibrium method, a left anterior oblique projection must be used. 
Until recently it was thought that this projection could not be used 
for the determination of KVEF because of the contribution of the 
right atrium. Recently, Maddahi and colleagues (209) suggested that 
this difficulty could be overcome by assigning separate regions of 
interest to the right ventricle at end-diastole and end-systole. 
However, in this study of normal subjects and patients with ischaemic 
heart disease, in whom the majority had normal RVEF, the authors 
admitted that in its present form the technique was subjective, and 
required a considerable experience for accurate assignment of a right 
ventricular region of interest. However, for the purpose of this 
thesis the equilibrium technique was deemed to be more suitable 
because of the ability to repeat measurements in intervention 
studies. To achieve an accurate and reproducible method of 
measuring W E F  by the gated equilibrium technique, particularly in 
patients with chronic bronchitis and emphysema, there appeared to be 
several major problems:
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varies from patient to patientr making the assignment of an 
accurate right ventricular region of interest more difficult.
2. The contribution from the right atrium to the counts in the 
right ventricular region of interest will vary depending on the 
atrial size.
3. A deformed or poorly contracting right ventricle may worsen the 
separation between the right and left ventricles.
7  (£S The contribution from background counts is higher with the
equilibrium than with the first pass technique, and comes from 
all of the structures around the right ventricle. The most 
suitable site for a background correction remained uncertain.
A standardised and reproducible technique for assessing right 
ventricular performance, both in normal subjects and in patients had 
therefore to be developed before applying this technique to 
populations of patients or using it in intervention studies.
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-RIGHT ventricular peitormance assessed by first pass and equilibrium
RADIONUCLIDE VENTRICULOGRAPHY 
Patients
A comparison of measurements of right ventricular ejection fraction 
(F57EF) by both first pass and gated equilibrium methods was made in 
43 patients (364), Eleven of these patients had atypical chest pain 
and had a normal left ventricular ejection fraction both at rest and 
on exercise. Their subsequent follow up suggested that their chest 
pain was musculoskeletal in origin and because of this they were, 
for the purpose of this study, deemed to be normal subjects. 
Fifteen patients had ischaemic heart disease documented by history 
and/or electrocardiographic findings. Seven of these patients had 
evidence of previous myocardial infarction. The remaining 17 
patients had chronic bronchitis and emphysema with severe airflow 
limitation (FEVj 0.70 t SD 0.32 1, FVC 2.35 t 0.70 1). These 
different groups of patients were chosen so that a wide range of 
values of both ER7EF and LVEF could be measured.
J&dionugXide methods
The patients lay supine beneath a Searle LEM gamma camera equipped 
with a high sensitivity parallel-hole collimator (figure 11). An 
intravenous infusion of 5% dextrose was given via a large peripheral 
vein. Through the IV line a bolus injection of 740 MBq (20 mCi) of 
technetium^™ labelled human serum albumin (HSA) was given rapidly, 
followed by a bolus of 5% dextrose squeezed from the reservoir of the 
IV giving set. This technique was used to obtain an adequate bolus 
injection. ttie gamma camera was positioned in a 10° right anterior
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Figure 11 Patient lying supine beneath the gamma camera positioned 
in the 30° left anterior oblique position.
images were gated from the R wave of the patient's electrocardiogram, 
and collected in frame mode on a Cromemco (System 3) microcomputer. 
For the first pass technique data acquisition was started immediately 
after the bolus was injected and terminated once the activity, viewed 
on the gamma camera's persistence monitor, was seen to be in the 
lungs. Thus the first pass technique was modified to include a 
gated system and in this way approximately 10 cardiac cycles were 
recorded (205).
For a period of 5 minutes following the bolus injection, the 
radiotracer was allowed to equilibrate in the blood pool. The 
position of the gamma camera was then changed to a 20 - 30° left 
anterior oblique projection with a 20° caudal tilt for the 
equilibrium study (figure 11). Gated images were then acquired from 
500 sequential heart beats, as previously described, for the 
assessment of left and ventricular function (216, 245). Images from 
the composite cardiac cycle were then displayed from both first pass 
and equilibrium studies in 'movie* format on a IV monitor.
Analysis of right ventricular ejection fraction 
First pass, study
From the movie image and the time activity curves from the right 
ventricular region of interest (ROI), the end-diastolic and end- 
systolic images were identified (figure 12). Using a light pen 
regions of interest were drawn around both of these images and the 
radioactive counts within these regions could be obtained. These 
end-diastolic and end-systolic counts were corrected for background 
counts by drawing separate background ROl's along the inferior margin 
of the right ventricular ROI at the appropriate phases of the cardiac
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Figure 12 The end-systolic frame of a first pass radionuclide 
ventriculogram. Data acquired in the right anterior 
oblique position.
RA = right atrium, RV = right ventricle, SVC = superior 
vena cava, PA = pulmonary artery.
cycle, and scaling the counts obtained within these background ROl's 
to an area equal to that of the corresponding right ventricular 
region (205), EVEF was calculated from the equation:
KVEF = EDC ESC 
EDC
where EDC and ESC are background corrected counts at end-diastole and 
end-systole respectively.
Equilibrium -Study
Minor adjustments of the position of the gamma camera were required 
in each individual patient to obtain good separation between the 
right and left ventricles and this could be done by assessing the 
image produced on the persistence monitor of the gamma camera. With 
experience less than 2% of all studies could not be analysed 
satisfactorily because of the overlap of the cardiac chambers, which 
persisted despite repeated adjustments of the projection of the gamma 
camera. In the vast majority of cases therefore, inspection of the 
movie image demonstrated good separation between the right and left 
ventricles (figure 13). However, during ventricular systole the 
right atrium enroached on the right ventricular end-diastolic ROI. 
Thus the use of a fixed ROI, as previously described in the analysis 
of LVEF would be inappropriate since a contribution from the right 
atrium, which would be variable depending on its size, would result 
in a significant underestimation of the RVEF. It will be apreciated 
that accurate edge detection is essential in obtaining an accurate 
ventricular ROI. In radio-isotope studies the presence of isotope 
in cardiac and non-cardiac structures, which may overlap the 
ventricular ROI may interfere with edge detection, particularly 
during the equilibrium technique where, in contrast to the first pass 
technique, there is no temporal separation of the isotope in the left
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Figure 13 The end-diastolic (A) and end-systolic (B) frames of a 
gated equilibrium radionuclide ventriculogram. Data 
acquired in the 30° left anterior oblique position. The 
right and left ventricles are separated by the 
interventricular septum. The right atrium is also shown 
in the end-systolic frame (B).
and right ventricles. A form of threshold analysis is used in our 
laboratory to help to detect the ventricular edges, which places the 
ventricular edge where a specified change in counts occurs. In 
addition to careful positioning of the gamma camera, so as to achieve 
separation between the cardiac chambers, and inspection of the movie 
image, three specific computer programmes were used to assist in 
identifying the right ventricular end-diastolic and end-systolic 
images.
1. A movie sequence could be used which subtracted counts in frame 
n from frame n - 1 and so on throughout the cardiac cycle. 
This resulted in a movie image with maximum contrast between 
the ventricles and atria by identifying the different phases of 
emptying and filling of these chambers (78).
2. A further computer programme was used based on a Fourier 
transformation of the ventriculogram (83). This technique is 
particularly useful for delineating the right ventricular 
outflow tract, which was difficult to identify by any other 
method (figure 14).
3. A third programme was based on the logarithm of variance 
between each pixel and the surrounding pixels. This technique 
allowed identification of a count gradient for each image and 
is a form of edge detection analysis which enabled delineation 
of the ventricular outline at end-systole and end-diastole.
In order to identify the right ventricular outline, it was often 
necessary to use a combination of these computer methods in addition 
to observation of the movie image.
Figure 14 Phase image of a radionuclide ventriculogram. Regions 
of the image which are out of phase in the cardiac cycle 
are shown as opposing colours on the 'colour clock1. 
Thus a contrast is achieved between the right atrium (RA) 
and the right ventricle (RV). A dyskinetic area (D) is 
also shown at the apex of the left ventricle (LV). This 
technique also allows delineation of the right 
ventricular outflow tract (0).
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Figure 15 Comparison of the stroke counts for both ventricles when 
the background for the right ventricle was taken along 
the inferior paraventricular border of the right 
ventricle at end-diastole and end-systole. The line of 
identity is shown. The mean difference between the 
stroke counts from the two ventricles was 4,9%.
Background correction
The correction for background counts for the left ventricle has been 
derived empirically, but has been shown to produce calculated left 
ventricular ejection fractions which correlate with those measured by 
contrast angiography (242). Various areas around the right 
ventricular outline were chosen to identify a suitable region for 
background correction for the right ventricular counts. The stroke 
counts (EDC - ESC) should be the same for each ventricle. Thus, 
using the left ventricular stroke counts as a standard, the right 
ventricular stroke counts were calculated, corrected for the 
background counts obtained from various background areas. The best 
area for right ventricular background correction should produce equal 
stroke counts from both ventricles.
RESULTS
Background correction
Four possible background regions were compared in 20 patients: 
superior and inferior right and left paraventricular regions. The 
most consistent results were obtained when using a right 
paraventricular region along the inferior border of the right 
ventricular outline. By assigning separate background regions at 
end-diastole and end-systole in this area, then 'normalising1 the 
counts to the corresponding ventricular area, a background correction 
for the end-diastolic and end-systolic right ventricular counts could 
be obtained and could be substracted from the two different 
ventricular regions of interest. Thus the background corrected 
right ventricular stroke counts could be calculated and a comparison 
could be made with the corresponding left ventricular background 
corrected stroke counts. Using this inferior right paraventricular
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Figure 16 Comparison of the right ventricular ejection fraction 
(RVEF) by the first pass and equilibrium methods. The 
line of identity is shown. The mean difference in RVEF 
by the two methods was 0.04 (n = 43, r = 0.91, p < 
0.001).
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Figure 17 Repeat analysis of RVEF by the same observer in 40 
equilibrium studies. The line of identity is shown. 
The mean intra-observer variation was 0.03.
area for background correction, the stroke counts from both 
ventricles were closely correlated (figure 15), The mean difference 
between the counts for the two ventricles in the 20 patients who were 
studied was only 4.9%.
Reproducibility
The values of RVEF measured by the first pass and equilibrium 
techniques were compared in 43 patients. An excellent correlation 
was achieved between the two methods (r = 0.91, p < 0.001) (figure 
16). The mean difference in RVEF between the two methods was only 
0.04.
To assess intra-observer variability 40 equilibrium studies were 
analysed on two separate occasions by the same observer. Intra­
observer variation was only 0.03 (figure 17). Inter-observer 
variation was assessed by two observers who independently analysed 15 
studies using the equilibrium technique. The inter-observer variation 
in RVEF was 0.04.
In 7 patients RVEF was measured using the equilibrium technique on 
two separate occasions 30 minutes apart, during which time the 
patient rested in a supine position. There was no significant 
difference in the mean between the two measurements (figure 18), the 
mean difference being only 0.02. The reproducibility of FVEF over a 
period of time was also assessed in one patient who lay at rest. 
RVEF remained unchanged when measured at 30 minute intervals over a 
period of two hours (figure 19).
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FIRST S E C O N D
Figure 18 Repeat measurements of RVEF in 7 patients on two separate 
occasions 30 minutes apart. Mean values and standard 
errors are also shown. The mean difference between 
successive measurements was 0.02.
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Figure 19 Repeat measurements of RVEF and LVEF in one subject at 
rest at 30 minute intervals over a period of two hours.
DISCUSSION
There are inherent difficulties in studying right ventricular 
function which must be considered.
The. contraction ot ±he right .ventaicle
Not only is the configuration of the right ventricle variable (287) 
but its contraction is complex and consists of three independent 
movements (287). Firstly, the trabeculae and papillary muscles 
displace the tricuspid valve downwards, towards the apex, which 
shortens the longitudinal axis of the chamber, but does not produce 
much effective ejection of blood. Secondly, the right ventricular 
free wall opposes the convex surface of the septum, producing the 
majority of the right ventricular ejection fraction. Thirdly, the 
circular fibres of the left ventricle contract and increase the 
curvature of the inter-ventricular septum. The mode of contraction 
of the right ventricle has been likened to a bellows. This complex 
action contrasts with the isometric, concentric contraction of the 
left ventricle. Oius although contrast angiographic studies have 
been performed in order to measure right ventricular volumes, the 
great variability in right ventricular shape and configuration has 
meant that no technique has found general acceptance (10, 100, 126, 
268).
In all of these techniques, certain assumptions, to account for the 
three dimensional shape of the right ventricle, have to be made when 
measuring right ventricular volume. Although such measurements have 
been shown to correlate relatively well with the data derived from 
post mortem casts of the right ventricle, the reported normal ranges
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of right ventricular volumes vary widely, and there have been no 
correlative studies in patients with cardiac or respiratory diseases 
(25). Radionuclide ventriculography has the advantage that since 
radioactive counts are proportional to volume, the right ventricular 
ejection fraction measured by this technique is independent of the 
right ventricular geometry. However, an appreciation of right 
ventricular contraction, as discussed above, • must be considered when 
determining the limits of the right ventricular outline. Moreover, 
the variability in shape and more complex right ventricular 
contraction, make overlap of the cardiac chambers more likely, making 
the measurement of right ventricular ejection fraction by the 
equilibrium radionuclide technique more difficult.
PK.Q jgetiOD
In most patients, separation between the left and right ventricles 
can be achieved using a 20-30° left anterior view. However, 
variable degrees of obliquity must be used in individual patients to 
obtain maximal separation of the ventricles (248). Failure to 
achieve separation between the ventricles makes accurate measurement 
of right ventricular ejection fraction impossible. With experience, 
however, this occurs infrequently.
The overlap between the right atrium and right ventricle presents a 
further problem in measuring right ventricular ejection fraction. 
As discussed previously, this can be solved by drawing two regions of 
interest around the right ventricle, the first at end-systole and the 
second at end-diastole. in addition, in a previous study (364), in 
order to check the effect of various projections on the degree of 
overlap between the ventricles and between the right atrium and right 
ventricle, a fixed human heart was filled with particles of an ion
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exchange resin labelled with T c " m. The gamma camera was then 
placed in the right anterior, anterior? and 10°, 20°, 30° and 40° 
left anterior oblique projections. In each projection images were 
also obtained with the camera in a 10°, 20° and 30° caudal tilt. 
The atrium was then filled with the T c ^ m labelled resin and the 
contribution of the right atrium to right ventricular counts was 
determined in the various projections. In this way the projection 
which produced the best separation between the ventricles was found 
to be a 20° left anterior oblique projection with a 20° caudal tilt. 
However, even in this projection the right atrial contribution to the 
right ventricular counts was around 30% and this may increase further 
in diseased hearts with right atrial enlargement. These results 
stress the importance of using two regions of interest in the 
calculation of right ventricular ejection fraction so as to eliminate 
the right atrial counts which encroach on the right ventricular region 
of interest during systole. As previously discussed, the use of 
phase image and edge detection techniques may be useful to obtain a 
more accurate estimation of the right ventricular outline, 
particularly the free right ventricular wall. The phase image is 
particularly useful in delineating the right ventricular outflow 
tract (figure 14) which has largely been ignored by other authors 
(156, 209, 239, 306). Thus a combination of techniques is necessary 
to obtain a reproducible right ventricular outline.
Background
As with the left ventricle, the area for background correction in the 
measurement of right ventricular ejection fraction has been chosen 
empirically. However, the validity of the chosen area for 
background correction was verified by the fact that the ratio between 
background corrected left and right ventricular stroke counts
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approached unity.
I have not corroborated the values of RVEF measured by the 
equilibrium technique with measurements using contrast angiography 
because no standardised technique is available for the measurement of 
FS7EF by contrast angiography. Quoted normal values for RVEF using 
contrast angiography have varied in the literature (10f 100, 126, 
268). Gentzler et al (126) found a mean RVEF, using angiographic 
techniques, of 0.50 1 0.16 in 8 normal subjects, whereas Ferlinz et 
al (100) quotes a mean RVEF of 0.66 t 0.12 in 9 normal subjects. 
Only one study has correlated radionuclide scintigraphic measurements 
of FVEF with those obtained by contrast angiography (312). In this 
study the mean RVEF for 14 normal subjects was 0.57 1 0.06, similar 
to the range of values obtained in this study. A good correlation 
was obtained between RVEF measured by contrast angiography and first 
pass radionuclide ventriculography (r = 0.80). No similar data has 
been published in patients with chronic bronchitis and emphysema.
Thus since there is no standard method of measuring right ventricular 
volumes by contrast angiography the results of measurements of right 
ventricular ejection fraction by the equilibrium radionuclide 
technique have been compared with those measured by the first pass 
technique and a good correlation between the two was achieved. 
Previous studies (156, 209, 239, 306, 360) have also shown good 
correlations between measurements of right ventricular ejection 
fraction made by first pass and equilibrium techniques.
Great variability exists in the literature concerning the methods 
used in calculating right ventricular ejection fraction by gated 
equilibrium radionuclide ventriculography (95, 151, 156, 187, 189,
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193, 209, 239, 306, 310, 360). Most studies, including the 
technique described in this thesis, use a modification of the method 
described by Maddahi (209) where two regions of interest at end- 
diastole and end-systole are used in the analysis to avoid the 
overlap between the right atrium and right ventricle (193, 239, 310). 
Other authors make an attempt to correct the right atrial 
contribution within the right ventricular region of interest (151). 
In yet other studies a single region of interest around the right 
ventricle is used (306). In addition, however, images can be 
generated which register the changes in counts between end-diastole 
and end-systole in both the ventricle and the atrium. These stroke 
count images (stroke counts being proportional to stroke volume) from 
the right ventricle and right atrium can be superimposed resulting in 
a functional image which allows delineation of the ventricular and 
atrial borders (95, 156, 188, 189). Only a few studies have used 
phase analysis to delineate the right ventricular outflow tract (193, 
364).
Conclusion
The measurement of right ventricular ejection fraction is by no means 
easy. However, the inaccuracies inherent in this measurement can be 
reduced. Accurate delineation of the right ventricular outline can 
only be achieved by the use of a combination of techniques as 
described above and may be technically impossible in a small 
proportion of patients. For the measurement of right ventricular 
ejection fraction the background correction, although derived 
emp^ally, can be checked by correlating right and left ventricular 
stroke counts.
In order to validate the measurement of right ventricular ejection
68
fraction there should be good correlation between ejection fraction 
measured by both first pass and equilibrium techniques. The 
reproducibility of the technique of measuring right ventricular 
ejection fraction should be confirmed by a low intra and inter­
observer variability. Before embarking on studies of measurement of 
right ventricular ejection fraction in patients, the normal values 
for this measurement should be determined.
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RIGHT AND LEFT VENTRICULAR PERFORMANCE IN CHRONIC BRONCHITIS AND 
EMPHYSEMA ASSESSED BY RADIONUCLIDE VENTRICULOGRAPHY
PRODUCTION
Pie last chapter dealt with the method used in measuring ventricular 
function by radionuclide ventriculography and its reproducibility 
when applied to normal subjects, patients with myocardial ischaemia 
and those with chronic bronchitis and emphysema. In this chapter I 
will present the results of measurements of right and left 
ventricular ejection fractions (ER7EF, LVEF) in normal subjects and in 
a population of patients with chronic bronchitis and emphysema.
I have shown, in chapter 3, that gated equilibrium blood pool 
radionuclide ventriculography is an accurate and reproducible 
technique of measuring RVEF when compared with the first pass method. 
This technique can, in addition, be used to measure both RVEF and 
LVEF over a period of several hours following a single peripheral 
intravenous injection of a radiotracer, and is therefore a convenient 
method to study the effects on ventricular performance of 
physiological and therapeutic interventions (364). For these 
reasons, henceforth, all measurements of ventricular ejection 
fractions have been made by gated equilibrium ventriculography.
Ventricular function in normal subjects
Thirty subjects had measurements of W E F  and LVEF made by equilibrium 
radionuclide ventriculography (table 2), (26M: 4F, age 21-63; mean 
age 39.4 1 (s d ) 12.5 years). These subjects were either normal
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atypical chest pain (n = 18). None of the normal volunteers had any 
history or clinical evidence of pulmonary or cardiac diseases. All 
of the subjects had a normal chest radiograph and were studied only 
if their electrocardiograms and radionuclide LVEF were normal, both 
at rest and on exercise (reference values from previous studies for 
LVEF in our laboratory at rest = 0.57, SD 0.07; LVEF increases 
by 0.05 during supine exercise (77, 78). None of these control 
subjects were receiving respiratory or cardiovascular drugs at the 
time of study. Subsequent follow up of those subjects who presented 
with atypical chest pain, indicated that none had ischaemic heart 
disease or chronic bronchitis. Each subject had left and right 
ventricular ejection fractions measured when supine, at rest. In 10 
subjects measurements were also made while the patients exercised 
supine,, on a modified bicycle ergometer, at a fixed work load of 75 
watts.
Right ventricular ejection fraction in normal subjects (table 2)
The mean RVEF in these 30 control subjects was 0.58 1 SD 0.09 (range 
0.47 - 0.83) when at rest. From these results the lower limit of 
normal for FVEF (2 standard deviations below the mean) was 0.40 when 
measured at rest.
The mean RVEF in the subjects who exercised was 0.54 * 0*06 (when 
measured at rest) not significantly different from the resting EVEF 
for the group as a whole. Mean RVEF in these subjects increased to 
0.62 t 0.06 (p < 0.001). Each subject increased their RVEF by at 
least 7% or an absolute increase of at least 0.04. Since the intra­
observer variation in measuring RVEF by the equilibrium technique is 
0.03, an absolute increase of } 0.04 has been chosen as the normal
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Figure 20 Relationship between right and left ventricular ejection 
fractions in 30 normal subjects.
Left .ventricular £jgg_tion fraction in normal subjects 
ftie resting LVEF in these 30 control subjects was 0.61 1 0.08 (range 
0.50 - 0.84). it is important to point out that these subjects had 
been selected because they had a normal LVEF when at rest. The mean 
LVEF when at rest in those patients who exercised was 0.58 1 0.07, 
not significantly different from the mean value for the group as a 
whole, and increased to 0.69 t 0.08 (p < 0.001) during exercise. 
Each patient had an increase in LVEF of at least 7% or an absolute 
increase of 0.05. From these and previous results (ref) the lower 
limit of the normal resting LVEF was taken as 0.45. In response to 
supine exercise the LVEF should increase by at least 0.05. There 
was no significant difference between the mean RVEF or LVEF for these 
30 control subjects. In addition there was a significant 
correlation between the right and left ventricular ejection fractions 
in these 30 control subjects (figure 20).
VENTRICULAR F UNCTION IN PATIENTS WITH CHRONIC BRONCHITIS MD. 
EMEHXSEMft
Method? .and patients
Right and left ventricular ejection fractions were measured at rest 
by gated equilibrium radionuclide ventriculography in 100 patients 
with chronic bronchitis and emphysema. Sixty two males and 38 
females were studied with a mean age of 62 years (range 41-80 years) 
(table 3). Ventilatory capacity and arterial blood gas values were 
measured while the patient breathed room air within 30 minutes of the 
radionuclide study. Only those patients who had largely 
irreversible airflow limitation were included in the study (ie
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Fjgure 2L Individual values (•) of right ventricular ejection 
fractions (RVEF) in 30 normal subjects and 100 patients 
with chronic bronchitis and emphysema (CB&E), Although 
there is a wide range of values of RVEF in the patients 
with CB&E, the mean (-o-) RVEF is significantly lower 
than in normal subjects (* p < 0,001).
by a pressurised inhaler, measured within the preceding 6 months). 
None of the patients had a history, clinical or electrocardiographic 
findings to suggest ischaemic or valvular heart disease or systemic 
hypertension. In all patients current drug therapy was continued 
during the study but inhaled bronchodilators were discontinued four 
hours before measurement of FEV^ and EVC, Patients were excluded if 
they were receiving domiciliary oxygen therapy (> 12 hours/day 
oxygen). Electrocardiograms were obtained, where possible, within 
24 hours of the radionuclide study.
The patients were subdivided into three groups dependent on a history 
of peripheral oedema, documented by a doctor, for which no cause 
other than 'right sided cardiac failure* could be found (tables 4a, 
b, c). On this basis 34 patients had no history or clinical 
evidence of oedema, 38 had episodes of oedema in the past and 28 had 
oedema present at the time of study.
In 50 of these patients (table 6) a Swan Ganz flow directed, balloon 
tipped catheter was placed in the pulmonary artery via a vein in the 
antecubital fossa or the femoral vein and simultaneous measurorients 
of pulmonary arterial pressure (PAP) and RVEF were made. In a 
further subgroup of 20 of these patients cardiac output was measured 
by the thermodilution technique (Edwards laboratory) and total 
pulmonary vascular resistance could be calculated from the formula:
Total pulmonary vascular resistance 
(dynes.s.am"^) =
mean PAP (mnHg) x_ ffO
cardiac output (1/min)
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Figure 22 Relationship between right ventricular ejection fraction 
and arterial oxygen tension (measured when breathing air) 
in 100 patients with chronic bronchitis and emphysema.
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Figure 23 Relationship between simultaneous measurements of right 
and left ventricular ejection fractions in 100 patients 
with chronic bronchitis and emphysema*
In 25 patients RVEF and LVEF were measured at rest and during supine 
exercise at a workload of 50% of their maximum voluntary exercise 
tolerance (table 5a and b). In these patients ear oxygen saturation 
was measured continuously using a Hewlett Packard (47201A) ear 
oximeter.
RESULTS
The mean FEV^ q of the 100 patients with chronic bronchitis and 
emphysema was 0.75 1 0.38 lf FVC 1.98 t 0.8 1 (table 3). These 
patients had a wide range of values of PaC^ and Pa(D2, although most 
were hypoxic (mean Pa02 7.3 kPa; range 4.7 - 11.3 kPa) and 
hypercapnic (mean Pa002 6.4 kPa; range 4.2 - 10.8 kPa), with a mean 
arterial hydrogen ion activity of 43 1 5 nmol/1 (range 34 - 51 
nmol/1).
Right ventricular .ejection -fraction
The mean RVEF measured at rest in these patients was 0.44 t 0.10 
which was significantly lower than the mean RVEF of the 30 control 
subjects (RVEF 0.58 * 0.09; p < 0.001) (figure 21). However, there 
was a wide range of values of RVEF in these patients from 0.17 - 
0.64. Thirty five of the 100 patients had a low RVEF (< 0.40) 
(figure 21, table 3).
There was a positive correlation between RVEF and Pa02 (r = 0.41, p < 
0.001) (figure 22) and a negative correlation between FVEF and PaC02 
(r = -0.34, p < 0.001). Although both correlations were significant 
they did not indicate a close relationship between these variables. 
There were no significant correlations between RVEF and FEV^ q (r =
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Figure 24 Right ventricular ejection fractions in patients with 
chronic bronchitis and emphysema with (1) no history of 
oedema,- (2) past history of oedema, or (3) oedema when 
studied. Individual results (•) and mean values (-o-) 
are shown:
statistical analysis
(1) vs (2) p < 0.05; (1) vs (3) p < 0.001? (2) vs (3) p < 0.01.
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Figure 25. Right (•, RVEF) and left (of LVEF) ventricular ejection 
fractions at rest and during supine exercise when 
breathing air in 25 patients with chronic bronchitis and 
emphysema. Mean values of RVEF and LVEF (-o-) did not 
change during exercise although the response to exercise 
was very variable.
correlation was also found between EVEF and LVEF in these patients (r 
= 0.56, p < OcO01) (figure 23),
When these 100 patients with chronic bronchitis and emphysema were 
subdivided into those with (table 4c) or without clinical evidence of 
oedema, either at the time of study (table 4a) or in the past (table 
4b), those with oedema present at the time of study had a lower PaC^ 
(p < 0.001), a higher PaC02 (p < 0.01), and a lower FEV1#0 (P < 
and FVC (p < 0.01) than those with no previous clinical evidence of 
oedema (table 4). The FEV^, FVC, and PaC02 were similar but the 
Pa02 was higher in those with oedema in the past, compared with those 
with oedema at the time of study. The mean RVEF in those patients 
who had oedema present at the time of study was 0.34 t 0.06, which 
was significantly lower than either the mean RVEF for those with past 
evidence of oedema (mean E57EF 0.45 1 0.08 p < 0.01), or those with no 
previous history of oedema (WEF 0.49 * 0.09, p < 0.001). There was 
a small but significant reduction in RVEF in those patients with a 
past history of oedema when compared to those with no previous oedema 
(p < 0.05) (figure 24). Only 4 of these 34 patients without 
previous history of oedema had a low EVEF compared with 24 of the 28 
patients who had oedema present at the time of study.
The mean EK7EF at rest in the 25 patients who exercised (table 5a) was 
0.45 t 0.07 (table 5b). This value did not change significantly 
during supine exercise (^EFexercise i 0.10). However, the 
change in FMEF in response to exercise was very variable (figure 25). 
Seven of the 25 patients had a normal response to exercise, ie an 
absolute increase in RVEF of >/ 0.04. None of the patients with a 
low R/EF had a normal increase in RVEF during exercise, but 12 of the
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Figure 26A Arterial oxgyen saturation (Sa02) and right ventricular 
ejection fractions (RVEF) at rest and during supine 
exercise, while breathing air, in 7 patients whose RVEF 
increased normally during exercise.
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Figure 2£B Arterial oxygen saturation (Sa02) and right ventricular 
ejection fractions (RVEF) at rest and during supine 
exercise, while breathing air, in 18 patients whose RVEF 
did not increase normally during exercise, where the 
fall in SaC>2 was greater than in Figure 26A.
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Figure 2Z Relationship between the change in right ventricular 
ejection fraction (A RVEF), and the change in arterial 
oxygen saturation (ASa0 2 ) from rest to exercise while 
breathing air, in 25 patients with chronic bronchitis and 
emphysema.
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Figure 28 Individual values (•) of left ventricular ejection 
fractions (LVEF) in 30 normal subjects and 100 patients 
with chronic bronchitis and emphysema (CB&E). Although 
there is a wide range of values of LVEF in patients with 
CB&E, the mean (-o-) LVEF is significantly lower than in 
normal subjects (* p < 0.001).
increase in RVEF when exercising, and in 4 of these patients RVEF 
fell to an abnormally low value during exercise (table 5b).
During exercise all of these patients desaturated (table 5b). 
However, the change in oxygen saturation, as measured by the ear 
oximeter (Sa0 2) was very variable and did not correlate with the 
initial oxygen saturation measured when at rest (r = 0.30, NS). The 
fall in Sa02 was less in those patients who had an increase in RVEF 
of 0.04 during exercise, a normal response (figure 26A) compared with 
those whose RVEF did not increase by this amount or fell when 
exercising (figure 26B). A significant correlation was also found 
between the fall in saturation which occurred during exercise in 
these 25 patients and the corresponding change in right ventricular 
ejection fraction when exercising (r = -0.5, p < 0.02) (figure 27).
Left; .ventricular ejection fraction
The mean LVEF of the 100 patients with chronic bronchitis and 
emphysema, when measured at rest was 0.52 t 0.11, which was 
significantly lower than the LVEF for the 30 normal subjects (0.61 1 
0.08, p < 0.001) (figure 28). However, the mean LVEF for these 
patients was still within the normal range. As with RVEF, the range 
of values of LVEF in these patients was wide from 0.29 to 0.79 
(figure 28, table 3). Twenty three of the 100 patients had a low 
LVEF «  0.45).
There were significant but weak correlations between LVEF and Pa02 (r 
= 0.40, p < 0.001) and LVEF and PaCC>2 (r = -0.26, p < 0.01) but no 
significant correlations were found between LVEF and FEV^ (r = 0.05, 
NS) or between LVEF and FVC (r = -0.03 NS). LVEF was significantly
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Figure 29 Left ventricular ejection fractions in patients with 
chronic bronchitis and emphysema with (1) no history of 
oedema, (2) past history of oedema, (3) oedema when 
studied. Individual results (•) and mean values (-o-) 
are shown.
Statistical analysis
(1) vs (2) NS? (1) vs (3) p < 0.001; (2) vs (3) p < 
0.001.
(LVEF 0.41 Z 0.08) compared with those who had oedema in the past 
(LVEF 0.54 1 0.09, p < 0.001) or those who had never had oedema (LVEF 
0.59 t 0.08, p < 0.001) (figure 29). Twenty of the 28 patients 
(71%) with oedema present at the time of study, had an ahnormal LVEF, 
whereas none of the 34 patients who had never had oedema had a low 
LVEF, and only 3 of the 38 patients (8%) with past evidence of oedema 
had a low LVEF (table 4). Of the 23 patients who had a low LVEF 
only 5 had a normal WEF, and in each of these patients the values of 
EVEF and LVEF were borderline for normality. The reverse, however, 
was not true, since 17 of the 35 patients who had a low RVEF had a 
normal LVEF.
The mean LVEF at rest in those 25 patients who exercised was 0.57 t  
0.09 which was not significantly different from the mean LVEF of the 
total population of 100 patients. LVEF did not change significantly 
in these patients when exercising (LVEFe x e rc ^se 0.58 Z 0.09, NS). 
LVEF increased normally in only 6 of the 25 patients when exercising 
(figure 25) (table 5b). There was no correlation between the change 
in RVEF and LVEF in response to exercise. In contrast to the right 
ventricle, the degree of desaturation while exercising did not 
correlate significantly with the change in LVEF during exercise in 
these patients.
Relationship between PAE RVEF (table 6)
There was no significant correlation between EVEF and either systolic 
or mean PAP (figure 30) (r = -0.15, NS) in the 50 patients with 
chronic bronchitis and emphysema where simultaneous measurements PAP 
and RVEF were made. However, in 20 of these patients, where 
pulmonary vascular resistance was calculated, there was a significant
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Figure 30A Relationship between systolic pulmonary arterial 
pressure (PAP) and simultaneous measurements of right 
ventricular ejection fractions in 50 patients with 
chronic bronchitis and emphysema (CB&E).
The dotted lines indicate the upper and lower limits of 
normal of PAP and RVEF respectively.
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30B Relationship between mean pulmonary arterial pressure 
(PAP) and simultaneous measurements of right ventricular 
ejection fractions in 50 patients with chronic 
bronchitis and emphysema (CB&E).
The dotted lines indicate the upper and lower limits of 
normal of PAP and RVEF respectively.
To
tal
 p
ulm
on
ary
 
va
sc
ula
r 
res
ist
an
ce
 
ind
ex
 
(D
yn
es
.s.
 c
m~
5m
2)
800-
n = 20 
r= -0 -45  
p <  0 05
010 0-20 0-30 0-40 0-50 0-60 0-70 0-80
Right ventricular ejection fraction
Figure 21. Relationship between right ventricular ejection fraction 
and total pulmonary vascular resistance in 20 patients 
with chronic bronchitis and emphysema*
resistance (r = -0.45, p < 0*05) (figure 31).
Relationship between RVEF. .and JSQG
In 45 patients the relationship between RVEF and the EGG findings was 
studied. There was no significant difference in the mean RVEF in 
those patients who had a normal electrocardiograph when compared with 
those who had EGG findings usually associated with cor pulmonale (40, 
259) ie right axis deviation, p pulmonale and right ventricular 
hypertrophy (figure 32).
PISCUSSION
The normal values for right ventricular ejection fraction measured by 
the gated equilibrium radionuclide technique vary in the literature 
from a mean of 0.43 * 0.06 to a mean of 0.62 1 0.09 (table 7). A 
similar degree of variability has been reported for absolute values 
of RVEF measured by the first pass technique (table 7). This 
variability in the reported normal values of RVEF, as discussed in 
chapter 3, results from the lack of a standardised technique for 
measuring RVEF. This has two consequences. Firstly, in 
interpreting data from any laboratory, reference values from a normal 
population should be available. Secondly, unless a technique, which 
has been adequately validated, as described in this thesis, has been 
used in measuring FVEF, comparisons of absolute values of RVEF cannot 
be made between different studies. The mean and range values of 
RVEF in the normal subjects in this study are, however, similar to 
those previously quoted in the literature. In this, as in all other 
published studies, EVEF increases during exercise in normal subjects 
by between 7 and 37%, the largest increases occurring during maximum
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Figure 32 Comparison of the electrocardiographic findings and the 
right ventricular ejection fraction (RVEF) in 45 patients 
with chronic bronchitis and emphysema. The points are 
individual values (•) with the mean RVEF for each 
electrocardiographic group (o 1 SD).
chosen a submaximal exercise protocol since exercise tolerance in 
bronchitic patients is often limited by dyspnoea consequent upon 
their ventilatory capacity which may prevent the completion of the 5 
minute exercise protocol necessary for data acquisition in the 
measurement of RVEF. Thus the exercise protocol for the patients 
with chronic bronchitis and emphysema was fixed at 50% of the 
patients maximum voluntary exercise capacity which was assessed 
prior to each study. This protocol was chosen so as to produce 
comparable levels of exercise in individual patients. The fixed 
workload of 75 watts, used in the normal subjects, was not suitable 
for the majority of bronchitic patients who were unable to sustain 
this level of exercise for the length of time necessary for data 
acquisition.
The correlation which I have found between the right and left 
ventricular ejection fractions, in normal subjects,, has not been 
previously reported. However, although this correlation was 
statistically significant, it was not sufficiently strong to allow 
prediction of FVEF from the value of LVEF. This correlation between 
RVEF and LVEF could result from an interaction between the 
ventricles. Indeed such myocardial interaction between the 
ventricles has been proposed in several studies (199, 293, 325, 344). 
However, the contractile mechanics of either ventricle are more 
likely to be influenced by the other ventricle in diseased states 
rather than in normal subjects. Another explanation could be that 
the method used in measuring R7EF is greatly influenced by the left 
ventricular counts, as a result of overlapping of the chambers. 
This is unlikely firstly because separation of both ventricles, as 
seen on the movie image, was considered to be a prerequisite in the
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separation in the response of the right and left ventricular ejection 
fractions to inotropic therapy in patients with good right but poor 
left ventricular function* In this case the RVEF increased after 
the inotrope was given without any significant change in LVEF (364)*
Right ventricular .ejection frac.tion In s hEanic. bronchitis M  
ei^hys.eroa
To date, this study represents the largest population of patients 
with chronic bronchitis and emphysema in whom ejection fractions have 
been measured by radionuclide ventriculography. The results confirm 
our earlier findings in a smaller number of patients (206). Moreover, 
this population of patients had a wide range of disability, as
measured by their ventilatory capacity and arterial blood gas values.
v
In addition, since patients with historical, clinical or 
electrocardiographic evidence of co-existing cardiac disease (other 
than pulmonary heart disease) were excluded from this population 
(although occult disease has not been excluded), the data accurately 
represent the effects of chronic bronchitis and emphysema on 
ventricular performance. Also excluded from this population were 
those patients who had received domiciliary oxygen (> 12 hours 
oxygen/24 hours), since there is evidence that this treatment alters 
the course of the disease (225, 251), and may have influenced the 
measurement of EVEF.
Although the mean RVEF at rest in these 100 patients with chronic 
bronchitis and emphysema was significantly lower than that of normal 
subjects, there was a wide range of values of RVEF in these patients. 
This wide range of values of RVEF in bronchitic patients as has been 
confirmed by others (table 8). The mean value of RVEF in the
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values quoted in the literature measured mainly by first pass 
radionuclide ventriculography (table 8). Seventy five per cent of 
the patients in this study had a normal RVEF (> 0.40) • Few of these 
patients had low values of RVEF such as have previously been reported 
in acute right ventricular infarcts (267, 333). How can we explain 
the wide range of values of FK7EF in patients with chronic bronchitis 
and emphysema?
The RVEF in chronic bronchitis and emphysema seems to be related to 
the severity of the disease. Although there was no significant 
correlation between RVEF and the indices of ventilatory capacity in 
these patients, there were significant correlations between FS7EF and 
Pa02 and PaCX^. Berger et al (24), in a study of 36 patients with 
chronic bronchitis and emphysema found that those with severe 
impairment of pulmonary function, arbitrarily defined as an FEV^ of < 
1 litre, had a lower mean RVEF than those whose pulmonary function 
was less impaired. Correlation coefficients are not quoted in this 
study but a personal analysis of the data showed no significant 
correlations between RVEF and PaC>2, PaO^, FEVj or FVC. Slutksy et 
al (307) have also shown that RVEF is lower in those patients with 
more severe abnormalities of pulmonary function. However, in these 
studies pulmonary function data could not completely separate 
patients with a normal or an abnormal EVEF.
As I have discussed previously, the definition of cor pulmonale is a 
pathological one (361). However, the results of this study indicate 
that the presence of oedema (for which no cause other than 'cor 
pulmonale* can be found) in patients with chronic bronchitis and 
emphysema is associated with a reduction in RVEF in 86% of cases.
values of RVEF were only just above the lower limit of normal (0,42,
0.41, 0.43, 0.40). Interestingly, however, only 5 of the 28 
patients (18%) with oedema when studied, had an RVEF of < 0.30, which 
is the level of LVEF which would be normally considered to be 
associated with severe left ventricular dysfunction (77, 78). Thus 
even with clinical findings of decompensated 'cor pulmonale', RVEF is 
relatively well preserved in the majority of patients with chronic 
bronchitis and emphysema. Further evidence of the relationship of 
K7EF to clinical evidence of oedema in these patients comes from the 
fact that those patients with a previous history of oedema but no 
oedema when studied, also had a lower mean RVEF than those with no 
previous evidence of oedema. Only 4 of the 34 patients (12%) who 
had no present or past history of oedema had a low RVEF. Three of 
these patients developed peripheral oedema within a year of being 
studied. Thus a low RVEF, in a patient with chronic bronchitis and 
emphysema and no previous oedema, may be an early indicator of right 
ventricular dysfunction and may herald the development of peripheral 
oedema. A normal RVEF, however, can occur in a patient who has been 
treated for past episodes of peripheral oedema.
Berger et al (24) also found that in a group of 36 patients with 
chronic bronchitis and emphysema with 'cor pulmonale', RVEF was low 
but, as in the present study, only 1 of these patients had an RVEF of 
< 0.30. In this study 'cor pulmonale' was defined as 
electrocardiographic evidence of right ventricular hypertrophy (214). 
However, the electrocardiographic findings in the patients in this 
present study did not relate closely to the right ventricular 
function, at least as measured by the ejection fraction. Although 
several studies have shown a correlation b e t w e e n  the
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emphysema and the presence of right ventricular hypertrophy at post 
mortem (39, 171, 282), hyperinflation of the lungs in such patients 
may result in the heart adopting a more vertical position which may 
obscure both clinical, radiographic and electrocardiographic evidence 
of right ventricular enlargement (113, 259). I have been able to 
relate the functional data obtained from the measurorients of RVEF to 
pathological evidence of right ventricular enlargement in only a few 
patients. Preliminary data, however, seems to indicate that a 
normal RVEF can occur in patients with pathologically confirmed right 
ventricular hypertrophy (unpublished observations).
Right ventricular ejection fraction during exercise 
A submaximal exercise protocol was chosen for this study which 
differed from that used routinely in assessing patients with coronary 
or valvular heart disease. Uiis protocol was used for two reasons. 
Firstly, because exercise in patients with chronic bronchitis and 
emphysema is usually limited by ventilatory impairment rather than 
myocardial ischaemia (343). In addition, I felt that a submaximal 
exercise protocol, at a workload of 50% of the patients maximum 
voluntary exercise capacity should ensure that these patients 
exercised below their anaerobic threshold (342).
Twenty-eight per cent of the 25 patients who took part in the 
exercise study had a normal increase in RVEF when exercising and none 
of the patients whose RVEF was low when at rest had a normal response 
to exercise. However, exercise uncovered occult right ventricular 
dysfunction in 63% of the patients whose RVEF was normal at rest. 
In this and other studies (220, 255, 309), although the majority of 
patients with chronic bronchitis and emphysema have a relatively
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FR7EF when exercising,
It has been assumed that failure of RVEF to rise during exercise in 
patients with chronic bronchitis and emphysema has been as a result 
of an augmented right ventricular afterload. Several factors have 
been implicated to account for the increase in pulmonary arterial 
pressure which is known to occur in response to mild supine exercise 
(170). These include changes in airways resistance and hence 
alveolar pressure (141), and concomitant changes in arterial oxygen 
tensions during exercise (170). There is certainly a variability in 
the degree of oxygen desaturation which occurs in patients with 
chronic bronchitis and emphysema and this has been related to the 
pathophysiological type of chronic bronchitis and emphysema in 
individual patients (172f 213). The results of this non-invasive 
study do not indicate the cause of the impaired right ventricular 
function which occurs during exercise in the majority of patients 
with chronic bronchitis and emphysema, but this study does suggest 
that the presence of a normal or abnormal right ventricular response 
when exercising relates to the degree of desaturation which 
occurred during exercise, the fall in Sa0 2 being much more 
significant in those patients whose KVEF did not increase normally 
when exercising, compared with those whose RVEF did increase 
normally. Thus, there was a correlation between the change in RVEF 
and the degree of desaturation which occurred during exercise.
Although the change in RVEF during exercise in patients with chronic 
bronchitis and emphysema has been shown, in several studies, to be 
very variable (24, 220, 221, 255, 309), it has not previously been 
related to the degree of desaturation which occurred during exercise.
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appear to have significant desaturation during exerciser unlike the 
patients in this study. It is interesting that most of these 
previous•studies were performed in North America where desaturation 
during exercise in patients with chronic bronchitis and emphysema 
appears less common than in patients from the UK (54, 55, 56, 343),
These findings together with the correlation between PaCD2 EVEF 
might indicate that there is a relationship between right ventricular 
response to exercise and the cl ini co-pa thological type of chronic 
bronchitis and emphysema in any individual patient. In this study 
all of the patients who had a normal right ventricular response when 
exercising appeared to be clinically of the 'pink and puffing* type 
with a normal PaCC>2 but with variable degrees of hypoxaemia (PaC>2 
range 7.5 - 11.3 kPa) At least some of those whose RVEF did not 
increase normally when exercising were of the 'blue and bloated* type 
with carbon dioxide retention. However, until a reliable method of 
diagnosing and quantifying emphysema in life becomes available, the 
relationship between the RVEF and the underlying lung pathology 
remains speculative.
Left ventricular ejection fraction
Left ventricular performance in patients with chronic bronchitis and 
emphysema has been the subject of much debate (16, 89, 111, 113, 125, 
173, 242). However, it is clear that a degree of left ventricular 
dysfunction does occur in some patients. What is unclear is whether 
the left ventricular dysfunction occurs as a result of primary 
pathology affecting the right ventricle, or as a result of 
coincidental disease affecting the left ventricle (202).
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with chronic bronchitis and emphysema, without other overt evidence 
of ischaemic hypertensive or valvular heart disease, is significantly 
lower than the mean LVEF of normal subjects. However, when measured 
at rest, the mean LVEF for these 100 patients was still within the 
normal range. Moreover, only 23% of these patients had a low LVEF 
and only one patient had an LVEF of < 0.30, indicating severe left 
ventricular dysfunction. As with the right ventricle, a low LVEF in 
a patient with chronic bronchitis and emphysema was related to the 
presence of oedema. Similarly, there were significant (but 
unimpressive) cor relations between the LVEF and the arterial oxygen 
and carbon dioxide tensions, and in addition there was a significant 
correlation between the RVEF and LVEF. Similar correlations have 
not previously been reported in studies of left ventricular function 
in chronic bronchitis and emphysema (23, 184, 218, 219, 221, 255, 
307, 308, 311, 312) (table 9). Berger et al (23), in one of the few 
studies to examine such relationships, found no correlation between 
LVEF and RVEF or indeed between LVEF and arterial oxygen or carbon 
dioxide tensions. In Berger's study (23), arterial blood gas 
samples were not withdrawn immediately before the radionuclide 
ventriculograms as in this present study but were measured within 48 
hours of the ventriculogram. Since some of the patients were not 
in a stable condition, arterial blood gas values could have altered 
over this period and have resulted in the lack of correlation with 
RVEF or LVEF.
In all previous radionuclide studies in patients with chronic 
bronchitis and emphysema, the mean LVEF has been within the normal 
range (table 9), as is the case in the present study. However, 
Slutsky et al (308) reported that in patients with severe 'chronic
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considered to be a more sensitive index of left ventricular function, 
was depressed in 40%, In addition Slutsky (308) found that this 
index had a significant positive correlation with the EVEF (r = 0,73,
p < 0.01).
Of the patients studied during exercise, only one of the 25 patients 
had a low LVEF when at rest and LVEF fell during exercise in this 
patient. However, occult left ventricular dysfunction was 
encountered in a further 15 of the 25 patients, since in these 
patients' LVEF did not increase normally during exercise, and indeed 
fell in 9. These results imply that occult left ventricular 
dysfunction is present in the majority of patients with chronic 
bronchitis and emphysema.
It might be argued that since the filling of one ventricle has an 
important effect on the distensibility and thus the function of the 
other chamber (16, 293, 325), then any left ventricular dysfunction 
is secondary to impairment of right ventricular function. However, 
this is not supported by the independence of the right and left 
ventricle responses in this study during exercise. Previous studies 
have described conflicting results of the effect of exercise on left 
ventricular performance (table 9). Some have reported a normal
increase in LVEF during exercise in the majority of patients with 
chronic bronchitis and emphysema (221, 255), whereas others, as in 
this study, have shown that most patients have an abnormal left 
ventricular response during exercise (51, 217). However, in the two 
previous studies which showed a normal left ventricular response to 
exercise (221, 255), the patients studied differed fundamentally from 
those in this present study, since they did not significantly
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ventricular response to exercise was abnormal in most patients (51f 
217) do not quote the changes in arterial ojqrgen saturation during 
exercise.
Further evidence in support of the presence of left ventricular 
dysfunction in patients with chronic bronchitis and emphysema stems 
from the finding of left ventricular hypertrophy at post mortem in 
such patients (228, 246). In addition, increased left ventricular 
filling pressures have been observed in patients with chronic 
bronchitis and emphysema and have been cited as indicative of left 
ventricular dysfunction (20). Jezek and Schrijen (169) studied the 
effects of augmenting left ventricular afterload, by increasing 
systemic arterial pressures with an infusion of angiotensin, in 
patients with chronic bronchitis and emphysema. Hiis augmentation 
of the left ventricular afterload produced abnormalities of left 
ventricular performance in those patients who had had evidence of 
'cor pulmonale* but not in those with no evidence of 'cor pulmonale*. 
Similar results have also been reported by Baum et al (20). This 
data supports the findings of this present study of a low LVEF 
occurring almost exclusively in those patients with a history of 
oedema. The results of Jezek (169) and Baum (20) have, however, 
been challenged in two further studies (219, 357) where the pressor 
agent methoxamine was given to patients with chronic bronchitis and 
emphysema and it did not affect LVEF, stroke volume index or 
pulmonary capillary wedge pressure.
Moreover, Khaja and Parker (181) found normal left ventricular 
pressures both at rest and during exercise in patients with chronic 
obstructive pulmonary disease.
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From a review of the literature it would appear that left ventricular 
function is normal when at rest except in those patients with 
decompensated 'cor pulmonale'. During exercise, at least some 
indices of left ventricular function, including the left ventricular 
ejection fraction are abnormal revealing occult evidence of left 
ventricular dysfunction. Furthermore, it has been suggested that 
the left ventricular dysfunction which occurs in decompensated 'cor 
pulmonale' is largely related to concomitant coronary artery disease 
or hypertension (311). The results of this present study do not 
support this, although the presence of occult coronary artery disease 
in the patients in this present study cannot be excluded.
Several factors have been proposed to account for the left 
ventricular dysfunction in patients with chronic bronchitis and 
emphysema, including hypoxaemia, acidosis, bulging of the 
interventricular septum into the left ventricular cavity and 
alterations in intra-thoracic pressures (16, 20, 52, 169, 173). The 
correlation between LVEF and Pa02 in this study suggests that 
arterial hypoxaemia might have some role in producing left 
ventricular impairment. In addition, the marked negative swings in 
pleural pressure which occur during inspiration in patients with 
chronic bronchitis and emphysema, particularly on exercise, may 
contribute to an increased pulmonary arterial pressure, hence an 
increased venous return to the right heart. The resultant right 
ventricular dysfunction may cause the left ventricle to be 
effectively stiffer, and thus produce an increase in left ventricular 
end-diastolic pressure, which would decrease pulmonary venous return, 
and hence reduce left ventricular stroke volume (279). Moreover, 
left ventricular afterload may also increase as a result of the fall
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increase in left ventricular end-diastolic volume. The consequence 
of this fall in pleural pressure, therefore, may be to increase left 
ventricular end-diastolic volume and hence decrease LVEF (52, 360). 
The correlation between RVEF and LVEF seems to indicate an inter­
dependence of the ventricles suggesting the reduction in LVEF is as a 
result of left ventricular dysfunction. Data from studies later in 
this thesis support this hypothesis.
Lack .of norr.elatiQn between EM. .and.«
In this study there was no significant correlation between 
simultaneous measurements of PVEF and PAP in 50 patients with chronic 
bronchitis and emphysema, who had a wide range of values of both PAP 
and RVEF. Previous data in the literature has shown wide variations 
in the correlation between PAP and RVEF (table 10). Several factors 
may account for this variability. Firstly, there is a variation in 
the type of patient studied. Only three of these studies were 
exclusively in patients with chronic bronchitis and emphysema (46, 
92, 210). The other studies were of normal subjects (240) or 
included patients with valvular or ischaemic heart disease (53, 72, 
123, 189, 241, 360). In contrast to the present study, measurements 
of PAP and RVEF were not made simultaneously in the majority. A 
lapse of 2-6 days occurred in some instances between measurements 
(92, 123, 189, 241, 360).Conflicting results are quoted of the 
correlation between RVEF and PAP in each group of patients studied 
(table 10). Whereas Korr et al (189) and Morrison et al (241) 
found a significant correlation between PAP and RVEF in normal 
subjects and in patients with ischaemic or valvular heart disease. 
Winzelberg et al (360) found the opposite result in a similar group 
of patients. In a study by Ellis et al (92) of patients with
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PAP and KVEF could be found, whereas Brent et al (46) has published 
the opposite finding. However, these latter authors, in a similar 
group of patients, have also published results showing no significant 
correlation between PAP and KVEF (210). However, there may be more 
fundamental reasons why a good correlation between PAP and KVEF 
should not be expected.
Ventricular systolic function is influenced by numerous factors 
(table 11). In broad terms these can be classified as afterload, 
contractility and preload. Which is the most important determinant 
of KVEF is still debated (63). Studies which have shown a highly 
significant correlation between PAP and KVEF have suggested that EVEF 
is very dependent on afterload (46). Right ventricular afterload 
is, by definition, the stress or tension acting on the fibres of the 
ventricular wall immediately after the onset of shortening (62), and 
is paramount in determining the quantity of blood ejected by the 
ventricle. Thus, right ventricular afterload can be measured as 
the force per unit cross-sectional area acting on the right 
ventricular wall (43, 44). Assessment of right ventricular wall 
stress requires measurements of both right ventricular volume and 
wall thickness. Because of the complex and variable geometric 
configuration of the right ventricle, these measurements have not 
been possible. Thus estimates of right ventricular afterload have 
been made from the pulmonary arterial pressure, which represents only 
a fraction of the true right ventricular afterload, and assumes that 
intra-cavity pressure closely approximates to transmural pressure 
(263). This assumption may not be valid in patients with air flow 
limitation. Pulmonary vascular resistance may be a slightly more 
accurate reflection of the true right ventricular afterload but it is
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Figure 33 In patients with aortic stenosis there was no significant 
correlation between left ventricular ejection fraction 
(LVEF) and the peak left ventricular systolic pressure 
(left). However, in the same patients LVEF did 
correlate with the mean mid wall circumferential wall 
stress (right), which accurately reflects the true left 
ventricular afterload.
It may be useful to examine similar relationships in the left 
ventricle, where measurements of afterload are easier to obtain. In 
a study by Gunther and Grossman (132) in patients with aortic 
stenosis, a situation of pressure overload hypertrophy somewhat 
analogous to patients with pulmonary hypertension, there was no 
significant correlation between peak left ventricular systolic 
pressure (analogous to right ventricular systolic pressure or 
pulmonary arterial pressure in the right ventricle) and the LVEF 
(figure 33) • Gunther and Grossman argued that although the LVEF was 
dependent on ventricular afterload, together with preload and 
contractility, the peak left ventricular systolic pressure 
represented only a fraction of the true left ventricular afterload 
resulting in a lack of significant correlation with the LVEF. 
However, in these patients, when mean left ventricular mid wall 
circumferential wall stress was measured, which represents the true 
left ventricular afterload, there was a highly significant 
correlation between this and the LVEF (figure 33). It may be that 
if measurements of right ventricular wall stress could be made they 
would correlate significantly with the KVEF.
Some support for this argument comes from this present study, where 
although there was no significant correlation between PAP and KVEF, 
the ejection fraction did correlate significantly with simultaneous 
measurements of total pulmonary vascular resistance, which may 
reflect right ventricular afterload more accurately than does PAP 
(figure 31). In addition, the assessment of ventricular wall stress 
includes a measurement of the ventricular wall thickness which would 
become a more important determinant of afterload in patients with
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have right ventricular hypertrophy.
Two other factors from table 11 may have lead to the lack of 
correlation between PAP and KVEF. Firstly, the presence of occult 
tricuspid incompetence which may have been present in some of our 
patients since the clinical criteria for the diagnosis of tricuspid 
incompetence is extremely insensitive (196). Tricuspid incompetence 
would result in a falsely high KVEF. Secondly, the presence of 
right coronary artery stenosis, which may not have been apparent 
clinically could have affected the E57EF (100).
Conclusions
1. Right ventricular ejection fraction, although lower than in 
normal subjects, is well preserved in the majority of patients 
with chronic bronchitis and emphysema.
2. In these patients the presence of oedema at the time of study, 
isassociated with a lower right ventricularejection fraction 
compared to those without oedema.
3. Right ventricular ejection fraction in patients with chronic 
bronchitis and emphysema is significantly correlated with 
arterial oxygen and carbondioxide tensions and with the left 
ventricular ejection fraction.
4. Occult right ventricular dysfunction can be demonstrated during 
exercise in most patients. The change in right ventricular 
ejection fraction during exercise is related to the change in 
arterial oxygen saturation.
5. Left ventricular ejection fraction is normal in the majority of 
patients with chronic bronchitis and emphysema but is low when 
these patients have oedema.
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arterial oxygen and carbon dioxide tensions,
7. The change in left ventricular ejection fraction is not related 
to the change in right ventricular ejection fraction during 
exercise, but there is a correlation between these variables 
when measured at rest.
8, Right ventricular ejection fraction cannot be used in patients 
with chronic bronchitis and emphysema to predict pulmonary 
arterial pressure but is related to afterload as measured by 
the total pulmonary vascular resistance.
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MS H T  S m i f f l M R  SYSTOLIC FUNCTION IN PATIENTS WITH CHRONIC
BRONCHITIS AND EMPHYSEMA AND PULMONARY ARTERIAL HYPERTENSION
As described in chapter 4, right ventricular performance, as assessed 
by the right ventricular ejection fraction, is well preserved in the 
majority of patients with chronic bronchitis and emphysema. 
Although dependent on right ventricular afterload, the ejection 
fraction does not appear to be related to the pulmonary arterial 
pressure, at least in the patients studied in this dissertation. 
However, the right ventricular ejection fraction is influenced by the 
loading conditions of the ventricle, independent of changes in muscle 
function, and thus may not be an accurate assessment of muscle or 
'pump* function of the ventricle in patients with an increased 
afterload (43). To determine the 'contractility1 or inotropic state 
of the right ventricle, as distinct from its performance, as assessed 
by the ERTEF, we must assess a function of the right ventricle which 
is independent of changes in preload or afterload.
In recent years, new indices have been developed to assess left 
ventricular function. These indices, reviewed in detail by Sagawa 
(291) depend on the relationship between the pressure and volume of 
the ventricle at end-systole. The concept of the end-systolic 
pressure/volume relation was first developed in isolated heart 
preparations (290), but more recently, has also been shown to be 
applicable in intact man (129, 226). The changes in the 
relationship between left ventricular pressure and volume in isolated 
heart preparations, can be plotted as a continuous pressure-volume 
loop, which is useful in understanding the ventricular response to
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25. In the presence of heart failure the left ventricular 
(LV) end-systolic pressure/volume relationship remains 
linear, but is displaced downwards and to the right. 
Thus, in heart failure, the stroke volume will be 
diminished (contraction 2) unless the end-diastolic 
volume increases further. In conditions of increased 
contractility, the end-systolic pressure/volume 
relationship is displaced upwards and to the left. The 
normal pressure volume loop (contraction 1) is show nfor 
comparison.
volume, has been shown to be independent of the initial ventricular 
volume, and is thus independent of the preload (321). Moreover, 
the relationship between end-systolic force, or afterload, and end- 
systolic length is also linear (figure 34) (344). Thus, for a given 
contractile state when afterload increases there is less complete 
emptying of the ventricle, and the end-systolic volume is greater. 
However, the end-systolic pressure/volume ratio remains constant, 
indicating that this relationship is also independent of changes in 
afterload. The linear relationship between end-systolic pressure 
and volume in the left ventricle, shifts downwards and to the right 
in states of decreased contractility such as heart failure, and 
upwards and to the left, increasing its slope, during infusion of a 
positive inotrope (figure 35) (43, 44). Thus, this relationship is 
particularly important since it defines the inotropic state of the 
ventricle, independent of the end-diastolic volume (preload) or the 
outflow tract pressure (as an estimate of afterload) (291). The 
end-systolic pressure/volume ratio is therefore sensitive to acute 
changes in the contractility of the ventricle.
In this chapter I will describe a study where measurements of KVEF 
were combined with simultaneous, but independent, measurements of the 
stroke volume, by thermodilution to quantify right ventricular 
volume, a parameter which has been difficult to estimate in the right 
ventricle before the introduction of radionuclide techniques. 
Simultaneous recording of right ventricular pressure thus enabled 
measurements of the end-systolic pressure/volume relationship to be 
calculated in patients with chronic bronchitis and emphysema, and in 
this way to assess right ventricular muscle function or contractility 
in these patients.
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Patients and method
Twenty patients with severe chronic bronchitis and emphysema were 
studied (table 12). All of these patients had severe airflow 
limitation, were hypoxic with variable degrees of hypercapnia, and 
all had pulmonary arterial hypertension at the time of study (table 
13), Eleven of these patients had a past history of peripheral 
oedema, when a diagnosis of 'cor pulmonale* was made. At the time 
of study, however, all of the patients were in a stable condition 
since they were being assessed for long term domiciliary oxygen. 
Their recent clinical condition was unchanged, with no episodes of 
oedema or infective exacerbations of their bronchitis within three 
weeks of the study date. In addition their body weight, arterial 
blood gas values and ventilatory capacity were stable over this 
period. None of these patients manifested clinical evidence of 
hypertensive, ischaemic or valvular heart disease and, in particular, 
none had clinical evidence of tricuspid incompetence. Drug therapy 
in these patients consisted of inhaled beta-sympathomimetics in all 
patients, together with inhaled ipratropium bromide in nine of the 
twenty who were studied. None of the patients were receiving 
domiciliary oxygen, theophyllines or digoxin at the time of study. 
Of the eleven patients who had previous episodes of peripheral 
oedema, eight continued to receive diuretics in the form of 80-120 mg 
of frusemide with potassium supplements. in each case the patient's 
medication was given on the evening before the study, but not on the 
morning of the study, so as to ensure haemodynamic stability 
throughout. Patients were studied in the post prandial state, in 
the afternoon, without premedication.
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Right and left ventricular ejection fractions were measured by gated 
equilibrium radionuclide ventriculography, as described in detail in 
chapter 3,
Haemodynamic techniques
These patients were studied while resting semi-supine breathing room 
air, A fine arterial line (Vigon Ltd 18F) was inserted into the 
non-dominant brachial artery, under local anaesthetic to allow 
sampling of arterial blood, A Swan ganz balloon tipped 
thermodilution pulmonary arterial catheter (No 7F) was passed from 
either an antecubital vein or from the femoral vein to the pulmonary 
artery. Heart rate and rhythm were monitored continuously from the 
electrocardiogram. Intra-vascular pressures were zero referenced to 
a point 5 cm below the angle of Lewis. All intra-cardiac pressures 
were measured by averaging over at least three respiratory cycles. 
Mean pressures were calculated fcy electronic integration. Cardiac 
output was measured by the thermodilution technique (thermodilution 
computer Edwards laboratories) the average of three measurements 
with a variability of less than 10% was used in the analysis.
At least 15 minutes were allowed after the insertion of the arterial 
and pulmonary catheters before any haemodynamic parameters were 
recorded. All measurements, including the radionuclide ejection 
fractions, were made simultaneously, and where this was not possible 
sequentially (eg PAP and right ventricular systolic pressure 
measurements). From the haemodynamic and ejection fraction 
measurorients the following variables were derived:
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Body surface area
Stroke volume index (SVI) (ml. m”2) = taEfliafeJlnt o JK ,100,0.
Heart rate
Total pulmonary vascular resistance
(PVR) (dynes, s. cm” )^ = 80 x mean PAP
cardiac output
Systemic vascular resistance (SVR)
(dynes. s.cnf5) = 80 x mean arterial pressure
cardiac output
Right ventricular end-diastolic volume 
index (RVEDVI) (ml.nT2) = SVI
RVEF
Right ventricular end-systolic volume
index (RVESVI) (ml.nf2) = WHJJI - SVI
Right ventricular stroke work index
(BVSWI) (g.m.m”2) = systolic RV pressure - diastolic RV pressure
x SVI x 0.0136
In ten of these patients, who did not have significantly different 
arterial blood gas values, ventilatory capacity or PAP from the group 
as a whole, control measurements were made and thereafter 
haemodynamic, radionuclide and arterial blood gas measurements were 
repeated during intravenous infusion with sodium nitroprusside, at an
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at least 5 mmHg. Thus right ventricular performance, as assessed by 
the relationship between end-systolic pressure and volume could be 
assessed at a reduced afterload, and compared with the control 
measurements*
Normal values of cardiac index, and right sided cardiac pressures 
published by Gurtner et al (133) were combined with measurements of 
RVEF in normal subjects (from this thesis) to estimate the normal 
right ventricular volumes.
EESIMS
All of the 20 study patients had severe airflow limitation; mean FEV^ 
0.7 1 (range 0.4 - 1.31), mean FVC 1.81 (range 0.8 - 3.31) (table 
12). All were hypoxaemic (PaC>2 7.1 kPa, range 4.5 - 8.8 kPa) when 
breathing air, and the majority had carbon dioxide retention (PaCX^ 
6.6 kPa, range 4.4 - 8.6 kPa). The hydrogen ion concentrations in 
arterial blood were normal in the majority of patients although a few 
patients had a minimal elevation of the hydrogen ion concentration 
when breathing room air (mean H+ ion 42 nmol/1, range 35 - 48 
nmol /1).
Since the aim of this study was to assess the effects of pulmonary 
hypertension on the right ventricular performance, all of the 
patients had pulmonary hypertension of variable severity (table 13). 
The mean PAP for the group was 29 mmHg, on average, (range 20 - 46 
mmHg) (normal mean PAP < 20 mmHg, table 15). Right ventricular 
systolic pressure (KVSP) was also elevated in all of the patients
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Figure 36 Individual right ventricular e n d - s y s t o l i c  
pressure/volume points (P/V) (©) in 20 patients with 
chronic bronchitis and emphysema and pulmonary 
hypertension.
Most of the right ventricular 
pressure/volume points in the patients lie upwards and 
to the left of the calculated mean right ventricular P/V 
point for normal subjects ( A ).
ventricular end diastolic pressure was 6 1 2 mmHgf and was abnormally 
high in only 3 patients. The average cardiac index was at the lower 
end of the normal range (mean Cl 2.61 t 0.57 ml. min"1. m~2). None 
of the 20 patients had an elevated cardiac index. However, the 
cardiac index was below normal in 8. The total pulmonary vascular 
resistance (PVR) was elevated in every patient (mean PVR 545 t 141 
dynes, s. cm"5). The right ventricular end-diastolic volume 
averaged 68 * 21 ml. m”2 which was lower than the mean estimated for 
normal subjects (79 ml. m"2). The mean right ventricular end 
systolic volume index was 37 1 16 ml. m"2 and was not dissimilar to 
the value calculated for normal subjects (table 14). The mean right 
ventricular ejection fraction in these patients was 0.46 1 0.09, and 
was abnormal (RVEF < 0.40) in only 4 patients. Mean left 
ventricular ejection fraction was 0.57 + 0.09, and was normal (LVEF > 
0.45) in all of the patients.
The mean right ventricular stroke work index (RVSWI) in these 20 
patients with chronic bronchitis and emphysema was 16.3 1 6.2 g.m.m"2 
which was significantly higher than the mean RVSWI for normal 
subjects (12.3 1 3.1, p < 0.01, table 14).
The mean right ventricular end-systolic pressure volume relation, 
indexed to body surface area (P/V) was 1.41 1 0.68, compared with the 
calculated mean for normal subjects of 0.78 (table 14). When 
individual right ventricular end-systolic P/V points for the 20 
patients are plotted on a pressure volume diagram (figure 36) most of 
the points lie above and to the left of the estimated mean end- 
systolic P/V point of normal subjects.
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Sodium nitroprusside displaced the mean right 
ventricular end-systolic pressure/volume point in 10 
patients with chronic bronchitis and emphysema downwards 
and to the left. However, since the right ventricular 
systolic pressure (RVSP)and right ventricular end- 
systolic volume index (PVESVI) were both reduced by 
similar amounts, there was no significant change in the 
right ventricular end-systolic pressure volume index
(PA) •
correlated significantly with the right ventricular end-systolic 
pressure volume index (r = 0.80, p < 0.001). There was no 
correlation between the KVEF and the cardiac index (r = -0.03) but 
there was a significant correlation between the RVEF and the end- 
diastolic volume index (r =-0.61, p < 0.01).
The effect of pulmonary vasodilatation
During infusion with sodium nitroprusside (SNP) in 10 patients (table 
16) heart rate increased significantly, cardiac index was unchanged, 
and therefore stroke volume index fell by a small but significant 
amount. Mean PAP fell from 30 +6 to 22 t 6 mmHg (p < 0.01) as did
RVSP from 45 t 10 to 36 t 8 mmHg (p < 0.01). Pulmonary
vasodilatation occurred since cardiac index was unchanged by SNP and 
the total pulmonary vascular resistance fell from 540 1 126 to 400 1 
140 dynes, s. cm~^ (p < 0.001). This pulmonary vasodilatation 
produced no significant change in arterial oxygen saturation. The 
right ventricular stroke work decreased significantly from 17.2 * 6.2 
to 12.8 t 5.1 g. m. m"^ (p < 0.01). The RVEF increased from 0.46 t 
0.07 to 0.51 1 0.11 during the infusion with SNP (p < 0.05). Both 
the right ventricular end-diastolic and end-systolic volume indexes 
fell from control values of 70 ^  16 to 57 1 1 1  ml. m“2 (p < 0.01) and
from 39 1 12 to 28 1 9 ml.m~^ (p < 0.01) respectively.
Despite the reduction in pulmonary vascular resistance which produced 
an increase in RVEF, the right ventricular end-systolic 
pressure/volume ratio did not change significantly from a control 
value of 1.25 1 0.44 to 1.39 t 0.67 during infusion with SNP (figure 
37). The measurement of the pressure/volume relationship at two 
levels of right ventricular afterload allowed definition of the
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Figure 38 Individual right ventricular end-systolic pressure/volume 
points (P/V) in 10 patients with chronic bronchitis and 
emphysema before (•) and during infusion with sodium 
nitroprusside (o). Although the slopes of individual 
P/V lines joining these points are variable, most of the 
slopes are greater than unity, and sodium nitroprusside 
displaces the P/V points downwards and to the left in all 
cases.
slope of the line (E) joining these two pressure volume points could 
be calculated according to the equation: KVSP = E x KVESVI + B (EVSP
= right ventricular systolic pressuref KVESVI = right ventricular 
systolic volume index, E is the slope describing their relation, B = 
pressure when the end-systolic volume is zero). The individual 
slopes of the pressure volume lines in these 20 patients were very 
variable (figure 38) mean E = 1.73 1 1.81. There was no significant 
correlation between the right ventricular ejection fraction and the 
slope (E) of the pressure volume relation.
DISCUSSION
The traditional view of the consequences of chronic hypoxia in 
patients with chronic bronchitis and emphysema, is the development of 
pulmonary hypertension. This leads to increased right ventricular 
work and hence compensatory right ventricular enlargement and 
eventually 'right ventricular failure* (figure 2) (113, 202).
However, the results I have presented of measurement of RVEF in a 
population of patients with chronic bronchitis and emphysema have 
suggested that right ventricular performance is well preserved in the 
majority of patients, except those who have clinical evidence of 
oedema at the time of study. Moreover the right ventricular 
ejection fraction correlated poorly with the level of the pulmonary 
arterial pressure. These findings led to the study described in 
this chapter in which I have attempted to measure not only the 
'performance* but the 'contractility* of the right ventricle in 
patients with severe chronic bronchitis and emphysema who were 
hypoxic, had pulmonary hypertension, and in the majority had previous 
episodes of oedema. Importantly, however, all of the patients were
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In addition to measurements of pulmonary and right ventricular 
haemodynamicsf simultaneous measurements of RVEF in this study 
enabled calculation of right ventricular volume, which is difficult 
using any other technique. Thus the right ventricular end-systolic 
pressure/volume relation could be calculated and used as a measure of 
right ventricular contractility (289). Although this index of 
ventricular function has been used extensively to study left 
ventricular mechanics (76r 167, 186) its use in the right ventricle 
has been very limited (46, 186). In fact, only one previous study 
has been undertaken to calculate this ratio in patients with chronic 
bronchitis and emphysema (46).
For ethical reasons I have not been able to compare the results of 
measurements of right ventricular mechanics in patients with those of 
normal subjects since.such invasive studies would be unjustified in 
normal subjects. However, right heart catheterisation was performed 
in the patients as part of the routine assessment for long term 
domiciliary oxygen. For comparison, however, I have used the mean 
of measurements of pulmonary and right ventricular haemodynamics from 
20 normal subjects studied by Gurtner et al (133) (table 14). I 
have combined these measurements with the mean RVEF which I have 
measured in 30 normal subjects (chapter 4). Thus I have been able 
to estimate the right ventricular volume, and hence the 
pressure/volume relation in normal subjects. Although not ideal, 
these measurements serve as a useful comparison since values of right 
ventricular volumes, derived from combined haemodynamic and 
radionuclide studies in normal subjects, have not been published 
previously.
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I have used the normal values quoted by Gurtner (133) for several 
reasons. Firstly, the age range of these normal subjects is similar 
to those in whom I have measured RVEF. In addition Gurtner quotes 
complete haemodynamic data, in particular measurements of right 
ventricular systolic pressure (R/SP) and cardiac index which allows 
calculation of the right ventricular pressure/volume relation indexed 
to the body surface area. Moreover, I have not included any 
measurements from patients in Gurtner's study where the quoted 
cardiac index or right ventricular systolic pressure is outwith the 
range of normal values quoted in standard texts (44). Having 
excluded such subjects from the analysis, I have calculated mean 
values of right ventricular systolic and cardiac index data from 20 
normal subjects (table 14).
Although cardiac index and right ventricular ejection fractions were 
lower in the patients with chronic bronchitis and emphysema than in 
normal subjects, both variables were within normal limits in the 
majority of these patients. In previous studies in patients with 
chronic bronchitis and emphysema, the cardiac index has been found to 
be normal (57, 181), although those patients with high pulmonary 
vascular resistance have had either a high normal or low normal 
cardiac index. It has been suggested that the level of the cardiac 
index in patients with chronic bronchitis and emphysema may be 
related to the clinical pattern of the disease (57). Thus those 
with hypoxaemia and hypercapnia and the 'blue and bloated* clinical 
picture tended to have a higher cardiac output at rest than those of 
the 'pink and puffing* clinical type (57). The patients in this 
present study who all had elevated pulmonary vascular resistance were 
in the main of the 'blue and bloated* type. However, in contrast to
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normal range.
In all of the studies in this thesis I have used total pulmonary 
vascular resistance rather than pulmonary vascular or pulmonary 
arteriolar resistance. The reason for this is that the latter 
measurement includes a measurement of pulmonary capillary wedge 
pressure. There is controversy regarding the reliability of the 
measurement of pulmonary capillary wedge pressure in patients with 
severe chronic bronchitis and emphysema. In particular, there is 
debate as to whether this measurement truly reflects the left atrial 
pressure in patients with chronic lung diseases (197, 273). For this 
reason I have calculated the total pulmonary vascular resistance so 
as to avoid introducing a further error in the measurement of 
resistance.
The right ventricular end-diastolic and end-systolic volumes were 
similar in both normal subjects and patients with chronic bronchitis 
and emphysema. At a given level of contractility, if right 
ventricular afterload increases, the ventricle should empty less 
completely and end-systolic volume should increase. Hie fact that 
right ventricular end-systolic volume is relatively normal, despite 
the presence of increased pulmonary vascular resistance in these 
patients, suggests that right ventricular contractility may, in fact, 
be increased in these patients.
The right ventricular stroke work was also higher in the patients 
with chronic bronchitis and emphysema than in the normal subjects. 
The increase in right ventricular stroke work index in the patients 
in this present study was entirely due to the increase in pressure
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5f 13, 14), Khaja et al (181) in a study of patients with chronic 
bronchitis and emphysema with and without 'cor pulmonale*, showed 
that although the relationship between right ventricular end- 
diastolic pressure and stroke index suggested that right ventricular 
function was depressed in those patients with cor pulmonale, when the 
right ventricular stroke work index was plotted against the right 
ventricular end-diastolic pressure, right ventricular function in 
response to exercise appeared normal, Khaja suggested that this 
paradox existed because the increased right ventricular work in these 
patients was as a result of work done against an increased afterload 
or 'pressure work* and this resulted in a lower stroke volume index 
with a consequent reduction in the work expended in producing the 
stroke volume or 'output work*. The findings of this present study 
would support these conclusions.
In this study the mean end-systolic pressure/volume ratios for the 
patients with chronic bronchitis and emphysema was similar to the 
calculated normal value (table 13, 14,) (figure 36). This would 
again indicate that right ventricular function is relatively well 
preserved in these patients despite the presence of pulmonary 
hypertension.
The right ventricular pressure/volume indexes in this study tended to 
be higher than those from the one previous study by Brent et al (45) 
where similar measurements have been made in patients with chronic 
bronchitis and emphysema. This difference can be accounted for by 
the higher right ventricular end-systolic volume in Brent's study 
(Brent et al W ES^j 61 1 22 ml. m“ ;^ this study KVESVI ^7 1 16 ml. m”
O     i
) which resulted from a lower mean RVEF (WEF 0.39 _ 0.07) compared
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particularly in KVEF, are present despite a similar level of 
pulmonary arterial pressure in both studies. These contrasting 
results may be due to methodological differences in the measurement 
of RVEF as discussed previously in this thesis.
Several theoretical limitations must be taken into account when 
considering the use of the right ventricular end-systolic 
pressure/volume relation as a measure of right ventricular 
contractility. Firstly, the theoretical basis for the use of the 
end-systolic pressure/volume relationship as an indicator of 
contractility independent of ventricular loading conditions, comes 
mainly from studies in the left ventricle (38, 129, 226). It is 
possible that the use of this index may not be applicable to the more 
distensible right ventricle. However, Maugham et al, in studies of 
isolated canine ventricles, has suggested that the right ventricular 
end-systolic pressure/volume relation is analogous to that found in 
the left ventricle (224). Konstam et al also demonstrated a linear 
relation between end-systolic pressure and volume in the right 
ventricle in 10 patients with pulmonary hypertension as a result of 
cardiomyopathy or cardiac failure secondary to ischaemic heart 
disease or primary pulmonary hypertension (188).
One further criticism of the results presented here is the use of 
peak right ventricular systolic pressure and not the end-systolic 
pressure in the measurement of the pressure/volume relation. 
However, Marsh et al (215) demonstrated a close correlation between 
the slope of the pressure/volume relation obtained using either the 
peak or the end-systolic pressure from the left ventricle. These 
results have been confirmed by others (167). Thus at least in the
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pressure. Furthermore, the use of the pressure/volume relationship 
may be limited by the fact that the right ventricular systolic 
prssure may not be an accurate measure of right ventricular afterload 
particularly if the dimensions of the right ventricle are altered. 
Afterload is the force which opposes ejection, that is, force = 
pressure x area. When this force is applied to a thick walled 
chamber, as may occur in the presence of right ventricular 
hypertrophy, then the La Place relation is more applicable:
Stress —  P. r/2h 
(P = pressure; r = radius; h = thickness)
Thus the use of ventricular wall stress, which corrects for 
variability in wall thickness and chamber radius, is a more accurate 
reflection of afterload. However, such measurements have not been 
made for the right ventricle.
It is likely, as is the case in the left ventricle, that it is the 
slope of the end-systolic pressure/volume relation, rather than the 
ratio of pressure to volume itself which is the most sensitive 
measure of the inotropic status of the ventricle (290). It was 
Grossman who initially demonstrated the linearity of the end-systolic 
pressure/volume relation in the left ventricle, and its independence 
of the ventricular loading conditions, by measuring the end-systolic 
pressure volume relation at two different levels of left ventricular 
afterload (129). More recently, Mehmel convincingly demonstrated 
the linearity of the left ventricular end-systolic pressure volume 
relation by measuring the pressure volume relation at three different 
levels of right ventricular afterload (226). Hie assessment of this
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therapeutic intervention which may not be indicated or ethical in 
some patients. Thus, as a simplification, in some studies, the 
end-systolic pressure/volume ratio has been used as a measure of 
contractility (167). When the line relating end-systolic 
pressure/volume passes through or near the origin, then any 
individual pressure volume ratio is a measure of the slope of the 
line defining the end-systolic pressure/volume relation, since in 
the equation:
KVSP = E x KVESVI + B, B is zero.
KVSP/KVESVI is therefore a measure of the slope E (KVESVI = right 
ventricular end-systolic volume index). As this is not the case in 
the majority of patients (figure 38) this simplification is often 
unjustified. However, if we assume that at higher right ventricular 
outflow pressure there will be a larger right ventricular volume 
given the same inotropic state, then a smaller ventricular volume for 
a given pressure indicates more complete ventricular contraction, 
suggesting an increase in the inotropic state of the ventricle. As 
FVSP was elevated in the patients in this study and the end-systolic 
and end-diastolic volumes were still relatively normal this suggests 
that right ventricular contractility was normal or even enhanced in 
these patients. Hie fact that KVEF was relatively well preserved 
supports this conclusion.
In order to determine the linearity of the right ventricular end- 
systolic pressure/volume relation and to measure the slope of the 
line describing this relation, 10 patients had measurements made 
before and after RVSP was reduced by an infusion of sodium
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properties, but with no inotropic action. Sodium nitroprusside 
produced both systemic and pulmonary and vasodilatation as shown by 
the fall in systemic and pulmonary vascular resistance (table 13). 
These changes, however, did not produce any significant change in the 
cardiac index despite a small increase in heart rate since there was 
a small fall in stroke volume index. This probably occurred because 
of a reduction in right ventricular pre-load as a result of the 
venodilator properties of sodium nitroprusside. Thus both KVSP and 
WESVI fell during the infusion with sodium nitroprusside producing 
no significant change in the pressure/volume relation. Although the 
slopes of the individual pressure volume lines varied widely (figure
38), there was no significant change in the mean pressure volume 
index for the group during infusion with sodium nitroprusside 
compared with the control value. This data supports the proposition 
that, as in the left ventricle, the right ventricular end-systolic 
pressure/volume relation is linear and relatively independent of the 
loading conditions of the ventricle.
Unfortunately I have no data for comparison of the slope of the 
pressure/volume relation in normal subjects. However, in 60% of 
the patients studied, the slope of the end-systolic pressure/volume 
relation (E) was greater than unity and E was < 0.50 in only 2 
patients. This would suggest normal right ventricular contractility 
in the majority of these patients despite the presence of pulmonary 
hypertension.
The results presented in this study conflict with those of Brent et 
al (46) who found in a group of patients with chronic bronchitis and 
emphysema with a similar degree of pulmonary hypertension that the
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was less than unity in all but one of the cases studied (mean E = 
0.65 1 0.21). Brent also found a poor correlation between the K7EF 
and either the pressure/volume index (P/V) or the slope of the 
pressure volume line at end-systole. This suggested that E7EF was a
poor indicator of right ventricular contractility, again in contrast 
with the findings of the present study, and with results from 
studies of the left ventricle, where both the slope and the P/7 index 
have been shown to correlate with the LVEF (226).
The data presented in this study suggests that the right ventricular 
performance is well maintained against a raised pulmonary arterial 
pressure. This finding is supported by a study by Konstam (188) 
who measured the pressure/volume relation in a population of patients 
with pulmonary hypertension secondary to left ventricular dysfunction 
or with primary pulmonary hypertension. These patients had much 
higher levels of pulmonary arterial pressure (mean PAP 47 1 12 mmHg) 
than the patients with chronic bronchitis and emphysema in the 
present study (mean PAP 29 1 7 mmHg). The slopes of the right 
ventricular pressure/volume relation (E) inKonstam's study, were 
very variable. However, the mean E for these patients was similar 
to that measured by Brent et al (46) who studied patients with much 
lower levels of pulmonary arterial pressure (Brent et al E = 0.65 1
0.25, Konstam et al E = 0.67 t 0.70). Despite these very high 
levels of pulmonary arterial pressure in the patients studied by 
Konstam, (188) (E) was more than unity in many of the patients 
suggesting relatively normal right ventricular contractility.
Previous studies measuring other indices of right ventricular 
performance have also indicated relatively normal right ventricular
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measured the right ventricular maximal isovolumic rate of development 
of ventricular pressure (dP/dt), and found this index of ventricular 
performance to be normal even in those patients with pulmonary 
hypertension and clinical evidence of "right ventricular failure1 
consequent on left ventricular dysfunction. Wroblewski et al (267) 
studied patients with pulmonary hypertension secondary to mitral 
stenosis, and assessed right ventricular performance curves by 
plotting stroke work against end-diastolic pressure , and stroke 
volume against end-diastolic pressure and Khaja et al (181) made a 
similar analysis in bronchitic patients. Both studies concluded that 
right ventricular function remained normal in these patients.
In conclusion:
1. In patients with stable chronic hypoxic bronchitis and 
emphysema, with pulmonary hypertension, the majority had normal 
K7EF and LVEF.
2. RVEF may not be a good indicator of right ventricular 
performance in the face of an increased right ventricular 
afterload.
3. The linearity of the right ventricular end-systolic 
pressure/volume relation has been demonstrated in patients with 
chronic bronchitis and emphysema, at different levels of right 
ventricular afterload.
4. Analysis of both the end-systolic pressure/volume ratio and the 
slope of the line describing this relation, indicates that 
right ventricular contractility is normal, or may even be 
enhanced in such patients despite the presence of chronic 
pulmonary hypertension.
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The effects .QxyggH £n -Eight ventricular performance in patients
The association between the chronic hypoxaemiaf which develops in 
some patients with chronic bronchitis and emphysema, and pulmonary 
hypertension is well known (140). The presence of pulmonary 
hypertension, as discussed previously, is associated with a poor 
prognosis (80, 351). Oxygen, when given acutely to such patients, 
in relatively high inspired concentrations, reduces PAP (3, 105, 159, 
359). Two controlled trials have now shown that long term 
domiciliary oxygen given in inspired concentrations of 24 - 35% can 
prolong survival in patients with hypoxic chronic bronchitis and 
emphysema (225, 251). Neither of these trials, however, showed that 
oxygen therapy given for 15 - 24 hours/day produced a significant 
fall in PAP. However, the slow progression of pulmonary 
hypertension which is seen in such patients (350) was prevented by 
domiciliary oxygen therapy. Oxygen might be expected to improve 
right ventricular function at rest, or during exercise, both when 
given acutely, and over the longer term, and should presumably delay 
the development of 'cor pulmonale*. Detailed studies of the effects 
of oxygen, given in inspired concentrations currently used during 
acute exacerbations of chronic bronchitis and emphysema, or as 
domiciliary oxygen, have not been published.
The aims of the studies in this chapter were to assess the effect of 
'controlled* oxygen on right ventricular performance in patients with 
hypoxic chronic bronchitis and emphysema, when given acutely at 
rest, on exercise, and over a period of 6 months.
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Thirty four patients with chronic bronchitis and emphysema were 
studied (table 17).
The acute effects of oxygen at xest
Eight patients with severe chronic bronchitis and emphysema (table 
17, group I) had simultaneous measurements of left and right 
ventricular ejection fractions, and pulmonary and right ventricular 
haemodynamics made when at rest, breathing air or oxygen, both given 
at a flow rate of 3 litres/minute by nasal prongs in a single blind, 
random order. All of these patients were being assessed for 
domiciliary oxygen therapy. They were current non-smokers, had a 
longstanding history of chronic bronchitis and emphysema, were in a 
stable condition at the time of study, as shown by stable arterial 
blood gas values FEV^ and body weight and had no evidence of 
infective exacerbations over the 3 week period prior to study. All 
had pulmonary arterial hypertension and had previous episodes of 
oedema when a diagnosis of cor pulmonale was made. Patients were 
considered suitable for domiciliary oxygen if their arterial oxygen 
tension when breathing air was less than 8 kPa when their condition 
was stable, with or without carbon dioxide retention and if 
carboxyhaemoglobin measurements indicated that the patient was not 
smoking. One patient had a Pa02 which was greater than 8 kPa 
(group I, patient number 3) and was being assessed for long term 
oxygen therapy since he had had episodes of oedema in the past 
indicative of cor pulmonale.
The preparation for cardiac catheterisation, the methods of 
measurement of the haemodynamic variables and the radionuclide 
techniques are described in Chapter 4. None of the patients had
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medications, which consisted of inhaled bronchodilators and in some 
cases diuretic therapy were given on the night prior to the study so 
as to ensure haemodynamic stability. All of the 8 patients had 
previous episodes of peripheral oedema at which time a diagnosis of 
cor pulmonale was made. None of the patients had oedema at the time 
of study.
The acute effects of oxygen during exercise
The effects of exercise and oxygen on right ventricular performance 
were studied in a further 16 patients with chronic bronchitis and 
emphysema, with less severe disability (Table 17, group II). In 
this study ventricular ejection fractions were measured by 
radionuclide ventriculography together with ear oxygen saturation 
non-invasively, using a Hewlett Packard ear oximeter. All of the 
measurements were made when the patients were upright except as 
described later in 6 patients who performed supine exercise. 
Measurements were made at rest and during upright exercise when 
breathing air or oxygen (both given at a flow rate of 3 litres/minute 
by nasal prongs). The order of the periods of rest or exercise and 
whether oxygen or air was breathed were randomised .
Six of these patients also had, in addition, simultaneous 
measurements of pulmonary arterial pressures after the insertion 
under local anaesthetic of a Swann Ganz catheter as described 
earlier. In these patients arterial blood gas samples were taken 
from an indwelling fine arterial catheter placed in the brachial 
artery. The pulmonary and arterial catheters were inserted under 
local anaesthetic 30 minutes before the measurements were made. In 
these 6 patients measurements of pulmonary arterial pressure were
116
cardiac catheterisation were also being assessed for long term 
domiciliary oxygen but were different patients from those in Group I. 
Measurements of pulmonary arterial pressure were not made in all 16 
patients who exercised since right heart catheterisation was not 
ethically justified in these mildly disabled patients.
Before the exercise study was undertaken each patient performed a 
trial period of exercise to determine if they could complete the 
protocol. In addition, this 'trial run* allowed calculation of the 
patient's maximum voluntary exercise tolerance (MVET). During the 
study the exercise workload was fixed at 50% of MVET, each patient 
exercising at this fixed workload for 5 minutes while measurements 
were made.
Following the injection of technetium^™ h SA. as described previously, 
data was acquired for 4-5 minutes for the measurement of ejection 
fractions when at rest and during exercise. Measurements of ear 
oxygen saturation or arterial blood gas tensions, and in 6 pulmonary 
arterial pressure, were made during the 4th - 5th minute of exercise. 
A fall in oxygen saturation and rise in pulmonary arterial pressure 
occurred during the first 3 minutes of exercise, the levels becoming 
constant between the 3 - 5 minute. A submaximal exercise protocol 
was chosen to ensure relative steady state, and to avoid the 
potential adverse effects on myocardial contractility of lactic 
acidosis due to anaerobic metabolism. I chose not to measure oxygen 
consumption during exercise because this would require the patients 
to breathe from a mouthpiece which could not be tolerated in all of 
the patients.
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arterial blood gas tensions in 8 patients with chronic 
bronchitis and emphysema at rest.
of oxygen or air given in a single blind random fashion by nasal 
prongs at a flow rate of 3 litres/minute for at least 20 minutes or 
until the ear oxygen saturation or the arterial PaC^ was stable for 
at least 5 minutes.
The effect of long term oxygen
Ten patients (Table 17, group III) had measurements of PAP and 
ventricular ejection fractions when at rest, breathing room air, 
before and after 6 months long term domiciliary oxygen was given at a 
flow rate of 1 -3 litres/minute by nasal prongs for 15 - 24 
hours/day. The exact flow rate of oxygen was chosen so as to 
produce an arterial oxygen tension of at least 8 kPa without 
producing a rise in PaQ^ sufficient to change the arterial hydrogen 
ion concentration. Each study was undertaken when the patients 
clinical condition was stable with no change in FEV^, body weight, 
arterial blood gas tensions and no clinical evidence of peripheral 
oedema or infective exacerbations of bronchitis for 3 weeks prior to 
study.
Formulas for derived haemodynamic variables are shown on page (99). 
In addition, the following variables were calculated:
arterial and mixed venous oxygen contents 
(Ca02 and OJO2) (ml/100 ml) = (1.34 x Hb x S02)
+ (0.0031 x P02)
systemic oxygen delivery
(ml/min/m2) = Cl x CaC^
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Results
Acute effects of oxygen at rest 
Arterial blood gas data
Oxygen, when given at rest to 8 patients increased Pa02 from 6.8 1 
SEM 0.4 kPa to 11.6 1 0.8 kPa (p < 0.01) (table). A rise in Pa02 
above 8 kPa occurred in all patients and in Sa02 to a level above 
90%. As is often the case in patients with type II respiratory 
failure breathing oxygen, even at inspired concentrations of between 
24 - 35% can, by the partial removal of the hypoxic ventilatory 
drive, lead to an increase in PaC02 (208, 234). In these patients 
breathing oxygen resulted in a small rise in PaC02 from 6.5 1 0.5 kPa 
to 6.9 1 0.6 kPa (p < 0.05), but this did not produce any significant 
change in the arterial hydrogen ion concentration (table 18, figure
39). Mixed venous oxygen tension (PV02) also increased in every 
patient while breathing oxygen, from a mean of 43 t 0.2 kPa to 5.1 1 
03 kPa (p < 0.05). This resulted in an increase in systemic oxygen 
delivery from 41 t. 4 to 48 t 4 ml/min/m^ (p < 0.01). The increases 
in arterial and venous oxygen contents were similar when breathing 
oxygen, and therefore the arteriovenous oxygen difference was 
unchanged. The increase in arterial oxygen content also resulted in 
an increase in the coefficient of oxygen delivery which occurred in 
every patient while breathing oxygen. There was a signficiant 
correlation between the mixed venous oxygen tension and the 
coefficient of oxygen delivery in these 8 patients when measured at 
rest, breathing air (figure 40) (r = 0.69, p < 0.05).
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Figure 42 Effects of oxygen (3 litres/minute, nasal prongs) on 
right and left ventricular ejection fraction and right 
ventricular stroke work index, when given to 8 patients 
with chronic bronchitis and emphysema at rest.
Heart rate, mean systemic blood pressure, cardiac index and stroke 
volume index were similar whether the patients breathed air or 
oxygen. Thus, in these patients, oxygen did not produce any change in 
the systemic vascular resistance. However, oxygen did produce 
pulmonary vasodilatation since the cardiac index was unchanged and 
mean PAP fell from 30 1 3 to 25 1 2 mmHg (p < 0.05). Thus the total 
pulmonary vascular resistance fell in all 8 patients when breathing 
oxygen from a mean of 570 1 67 to 477 1 51 dynes.s. cm“^ (figure 
41). Those patients with the highest values of PAP or total 
pulmonary vascular resistance when breathing air, tended to have the 
greatest fall in these variables when breathing os^gen. However, 
the correlation between the baseline PAP and change in PAP (r = - 
0.65, NS) or between baseline total pulmonary vascular resistance and 
change in total pulmonary vascular resistance while breathing oxygen 
(r = -0.68 NS) did not quite achieve statistical significance.
Despite these changes in pulmonary vascular resistance the mean right 
ventricular ejection fraction in these 8 patients did not change 
significantly when breathing oxygen compared with the value when 
breathing air (although KVEF did increase in 5 of the 8 patients 
studied) (figure 42). There was also no change in the right 
ventricular stroke work index or the left ventricular ejection 
fraction. There were no significant correlations between the change 
in W E F  when breathing oxygen and the baseline FVEF, or between the 
change in KVEF and the baseline or change in PAP or total pulmonary 
vascular resistance (r = -0. 65 to 0.68). There was a trend for 
oxygen to produce a fall in both right ventricular end-diastolic and 
end-systolic volume indexes, although the change in the mean values 
of these variables did not achieve statistical significance. Thus
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saturation (SaCy when breathing air and the fall in SaC>2 
(ASaO?) during exercise in 16 patients with chronic 
bronchitis and emphysema.
calculated, before and after oxygen, the mean value for the 8 
patients did not change significantly when breathing oxygen (table 
18, 19),
The mean right ventricular end-systolic pressure/volume relation in 
these 8 patients when breathing air at rest was displaced downwards 
and to the left when breathing oxygen (figure 43) in a similar 
fashion to the displacement of the end-systolic pressure/volume 
relation produced by sodium nitroprusside, as described in Chapter 5 
in a similar group of patients. Individual changes in right 
ventricular pressure and volume were too small in some of the 
patients to make any meaningful calculation of the slope of the P/V 
relation, at end-systole, in individual patients.
The. .acute effects oxygen during exercise (Table 20)
The heart rate both at rest and during exercise was not significantly 
different when these patients breathed air or oxygen. The ear 
oxygen saturation (SaC^) fell in all 16 patients while exercising 
breathing air, from a mean of 89 t SEM 1% at rest to 81 1 2% during 
exercise (p < 0.01) (table 20). However, the change in Sa02 during 
exercise was very variable from -1 to -20%. The fall in oxygen 
saturation during exercise correlated with the resting SaC>2 (r = 
0.57, p < 0.05) (figure 44). Breathing oxygen produced an increase 
in the SaC^ when at rest to 95 * 1% (p < 0.01). and although there was 
still a significant fall in Sa02 when exercising breathing oxygen, 
the fall in SaC>2 during exercise was less when breathing oxygen 
(SaC>2 , - 4 1 1%) compared with the fall in SaC>2 when breathing air 
(Sa02, - 8 t 2%, p < 0.001).
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Figure 45A Ear oxygen saturation and right ventricular ejection 
fraction (KVEF) in patients with chronic bronchitis and 
emphysema whose W E F  increased normally (A W E F  > 0.04, 
n = 6) on exercise breathing air. Individual values (•) 
and the means (—o—) are shown at rest and on exercise 
when breathing air or oxygen (3 litres/minute, nasal 
prongs)
Statistical analysis
(1) vs (2) p < 0.05; (3) vs (4) NS.
(1) vs (3) p < 0.05; (2) vs (4) p < 0.05.
(5) vs (6) p < 0.05; (7) vs (8) p < 0.05.
(5) vs (7) NS; (6) vs (8) NS.
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Figure 45B Ear oxygen saturation and right ventricular ejection 
fraction (KVEF) in patients with chronic bronchitis and 
emphysema whose RVEF did not increase normally ( KVEF < 
0.04, n = 10) on exercise breathing air. Individual 
values (•) and the means (-o-) are shown at rest and on 
exercise when breathing air or oxygen (3 litres/minute, 
nasal prongs).
Statistical analysis
(1) vs (2) p < 0.001?
(1) vs (3) p < 0.01?
(5) vs (6) p < 0.02?
(3) vs (4)
(2) vs (4)
p < 0.01. 
p < 0.01.
(7) vs (8) NS. 
(5) vs (7) NS? (6) vs (8) p < 0.01.
when at rest (table 20), ttie mean FVEF did not change significantly 
during exercise when breathing air. These results are similar to 
those in a larger group of 25 patients reported in Chapter 4, which 
included the 16 patients in this study. For the present group of 16 
patients breathing oxygen did not change the FVEF in these patients 
when at rest and again EVEF did not change significantly when 
exercising breathing oxygen (table 20), There was also no 
significant change in mean LVEF during exercise when breathing air 
(table 20), When oxygen was breathed there was also no change in 
LVEF when at rest. However, LVEF increased significantly from 0.54 
t 0.03 at rest to 0.57 t 0.03 (p < 0.01) f during exercise when 
breathing oxygen.
The change in EVEF which occurred during exercise when breathing air 
was very variable from -0.18 to +0.12. As previously described in 
Chapter 4, in order to determine whether the presence or absence of a 
normal right ventricular response to exercise was related to the 
change in SaC^r the 16 patients were divided into 10 patients whose 
EVEF did not rise by 0.05 (figure 45b) and 6 who had a normal 
increase in EVEF of at least 0.05 when exercising breathing air 
(figure 45a). The resting mean FVEF in these 2 groups were similar 
(0.46 t 0*03 vs 0.47 1 0.02 respectively, NS). However, whereas the 
mean EVEF increased from 0.46 1 0.03 to 0.54 * 0.02) in those with a 
normal response to exercise in those with an abnormal response, mean 
EVEF fell from 0.47 t 0.02 to 0.39 t 0.03 (p < 0.02) during exercise 
breathing air. Moreover, this fall in WEF was prevented when these 
patients exercised when breathing oxygen (figure 45b), so that the 
change in EVEF from rest to exercise ( A  EVEF) was significantly 
different when breathing air ( A E\7EFair ~0*01 1 0.01) when compared
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0.01, p < 0.05),
The 6 patients whose EVEF increased normally during exercise, had a 
small but significant fall in mean SaC>2 from 92 t 1 to 90 t 1% (p < 
0.05) when exercising breathing air. However, this fall in Sa02 
was abolished when exercising breathing oxygen (Sa02 at rest 96 1 1%, 
SaC>2 during exercise 95 1 1%, NS) (figure 45a). In contrast those 
patients in whom the EVEF did not increase normally during exercise 
had a fall in SaC^ from 88 1 4% when at rest to 76 t 3% (p < 0.001) 
(figure 45b) during exercise breathing air. Again the fall in Sa02 
was less and the SaC^ was higher when breathing oxygen both at rest 
(Sa02 95 1 1%) and during exercise (Sa02 88 1 2%, p < 0.01). Thus, 
although oxygen breathing did not prevent desaturation during 
exercise in those patients whose EVEF did not increase normally 
during exercise, the fall in oxygen saturation during exercise was 
less and was associated with a higher EVEF. More simply, in the 16 
patients when exercise was performed breathing air there was a 
significant correlation between the change in EVEF and the change in 
Sa02 from rest to exercise (r = 0.55, p < 0.05) (figure 46a). 
Furthermore, a similar significant correlation was obtained between 
the change in EVEF and change in SaC>2 when exercise was performed 
breathing oxygen (r = 0.52, p < 0.05) (figure 46b).
In contrast the changes in LVEF from rest to exercise whether 
breathing air or oxygen were independent of changes in the EVEF. 
Secondly, the degree of desaturation was not significantly different 
in those patients whose LVEF did or did not increase normally during 
exercise.
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Figure 42 Arterial oxygen saturation, mean pulmonary arterial 
pressure and right ventricular ejection fraction in 6 
patients with chronic bronchitis and emphysema, at rest 
or during exercise (EX) when breathing air or oxygen (3 
litres/minute, nasal prongs). Individual values (•) and 
the mean values (-o-) are shown.
-Statistical analysis
(1) vs (2) p < 0.001? (3) vs (4) p < 0.01.
(1) vs (6) p < 0.01; (2) vs (6) p < 0.01.
(5) vs (6) p < 0.01? (7) vs (8) p < 0.01.
(5) vs (7) p < 0.05? (6) vs (9) p < 0.01.
(9) vs (10) p < 0.05? (11) vs (12) NS.
(9) vs (11) NS? (10) vs (12) p < 0.05.
exercise in addition to measurements of KVEF had significant 
desaturation during exercise when breathing air or oxygen. Again 
the Sa02 both at rest and during exercise was higher when breathing 
oxygen (figure 47). The mean PAP during exercise was slightly lower 
when breathing oxygen (PAP 47 1 4 mmHg) compared with the level of 
PAP during exercise when breathing air (PAP 51 1 4 mmHgf p < 0.05). 
However, the increase in PAP from rest to exercise was very similar 
both when breathing air (APAP 22.5 t 5.4 mmHg or when breathing 
oxygen ( A  PAP 22.5 t 6.4 mmHg). As in the 16 patients as a group 
the fall in EVEF on exercise when breathing air in this subgroup of 6 
patients was prevented when exercise was performed when breathing 
oxygen (figure 47).
She effect of long term oxygen (Table 21)
There was no significant change in FEVj g, EVC, heart rate, systemic 
arterial blood pressure, PaC^, PaOC^r hydrogen ion concentration or 
12 minute walking distance in the 10 patients studied before and 
after 6 months domiciliary oxygen. Mean PAP fell significantly from 
32 * 2 to 26 t 2 mmHg (p < 0.01) (table 21) after 6 months oxygen. 
This change in PAP was associated with a small but significant fall 
in right ventricular end-diastolic pressure from 6 1 1 to 4 1 1 mmHg 
(p < 0.02). The fall in pulmonary arterial pressure did not produce 
any significant change in right or left ventricular ejection 
fraction.
BISSISglQN
The purpose of this section of the thesis was to study the effects of 
oxygen on right ventricular performance in patients with hypoxic
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oxygen were similar to those used in the treatment of patients with 
respiratory failure with long term domiciliary oscfgen (225). The 
reason for initiating these studies was that to datef long term 
oxygen therapy is the only treatment which is known to improve 
survival in such patients. However, as discussed earlier, neither 
of the two controlled trials of long term oxygen showed that this 
treatment could reverse the pulmonary arterial hypertension in 
patients with respiratory failure, and in addition, continuous oxygen 
appeared to benefit only those patients with the lowest values of 
pulmonary vascular resistance (251). These findings suggest that we 
should look for reasons other than the reduction of pulmonary 
hypertension and the prevention of cor pulmonale to account for the 
improved survival in patients treated with long term oxygen. Indeed 
the survival data from the MRC trial seems to suggest that, at least 
in some patients, oxygen does not influence the prognosis, since the 
survival for the treated and untreated groups was not significantly 
different until after 500 days of treatment (225). Before 
dismissing the relevance of the cardiovascular effects of oxygen in 
the treatment of patients with hypoxic chronic bronchitis and 
emphysema, I felt it would be worthwhile re-examining the effects of 
'controlled oxygen* on right ventricular mechanics using a 
combination of measurements of EVEF and pulmonary haemodynamics.
The acute effects of oxygen at rest
Recently much attention has been focussed on the factors which 
determine oxygen delivery to the tissues, principally the cardiac 
index and the pulmonary vascular resistance, as distinct from the 
pulmonary arterial pressure, which may not differ markedly from one 
patient with hypoxic chronic bronchitis and emphysema to another (29,
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different processes. Firstly, convectional transport to the tissues 
in the vascular system, which is dependent on both the oxygen 
delivery and the oxygen consumption. The ratio of these two 
variables, the coefficient of oxygen delivery (00D) was introduced by 
Mithoefer (235). Secondly, the mixed venous oxygen tension can be 
considered to be an approximation of the 'mean tissue oxygen tension* 
which cannot be measured, and is a determinant of the diffusional 
transport of oxygen to the tissues, which in turn is dependent on the 
driving pressure head of oxygen.
A recent study in patients with hypoxic chronic bronchitis and 
emphysema has suggested that the variables which were most important 
in distinguishing survivors from non-survivors, were a higher 
arterial oxygen tension and a higher mixed venous oxygen tension, 
rather than the PAP or pulmonary vascular resistance (178). The 
coefficient of oxygen delivery was, however, similar in both 
survivors and non-survivors. By inference, these authors suggested 
that the oxygen supply to the tissues was a critical factor in 
determining survival in such patients, and that the diffusional 
(mixed venous) component of tissue oxygen supply was more important 
than the convectional transport of oxygen in the vascular system as 
measured by the COD. Mixed venous oxygen tension is, of course, 
dependent on the cardiac output and it has been proposed that in 
patients with chronic bronchitis and emphysema who have a decreased 
oxygen carriage, the maintenance of a normal, or indeed high normal 
cardiac output, may be an adaptive mechanism in order to maintain a 
normal tissue oxygen supply. Thus failure to maintain cardiac 
output may worsen survival (177).
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at a flow rate of 3 litres/minute by nasal prongs increased PaC>2 by 
an average of 4,8 kPar but PaCX^ only rose by an average of 0.4 kPaf 
which did not result in any change in arterial hydrogen ion 
concentration. The mean EVO2 in these patients was low (< 4.7 kPa) 
but was increased to a normal level in all but one of the 8 patients 
when breathing oxygen. The lowest coefficient of oxygen delivery 
occurred in the patient with the lowest IVO2 when breathing air, and 
oxygen breathing produced the largest increases in COD in patients 
with low PVO2 «  4.7 kPa) and arterial carbon dioxide retention. 
These effects of oxygen on tissue oxygen delivery have been confirmed 
by others (75, 235). The coefficient of oxygen delivery was low (< 
4) in most of these patients and increased in all patients when 
breathing oxygenf but remained abnormally low in 2 of the 8 patients. 
In these 2 patients cardiac index fell when breathing oxygen in 
contrast to the majority of patients where cardiac index increased 
slightly. Degaute has also shown, in 35 patients who presented with 
acutely decompensated chronic obstructive lung disease, that oxygen 
therapy does not necessarily increase the COD to normal if cardiac 
output decreases (75). Thus at least in some patients the 
beneficial effects of oxygen therapy may be counterbalanced by a fall 
in cardiac output resulting in no significant change in the oxygen 
delivery to the tissues (29, 75, 326). This may be one reason why 
oxygen fails to improve the prognosis in some patients treated with 
long term oxygen therapy.
Of the 8 patients given oxygen in this study, both the PV02 and the 
COD increased to normal in the majority. This improvement in 
tissue oxygenation might have been expected to improve right 
ventricular performance. The results of this study show that the
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but significant fall in pulmonary arterial and systolic right 
ventricular pressure. Heart rate and cardiac index were unchanged 
and hence oxygen produced a small fall in total pulmonary vascular 
resistance without changing the systemic vascular resistance. These 
haemodynamic changes are similar to those previously reported in 
other studies of the effects of oxygen on pulmonary haemodynamics in 
patients with chronic bronchitis and emphysema (3f 66, 157, 159, 243, 
355f 358). However, in most of these studies oxygen was given in 
higher inspired concentrations. I have elected not to study the 
effects of higher inspired concentrations of oxygen since it is 
likely that such concentrations would produce further carbon dioxide 
retention, in these patients with respiratory failure, leading to a 
worsening of the respiratory acidosis which may have adverse effects 
chi cardiac performance. In addition, I was interested in assessing 
the effects of oxygen in inspired concentrations which are used 
therapeutically in such patients.
Despite a significant fall in total pulmonary vascular resistance, 
which occurred in every patient, there was no significant increase in 
RVEF or change in right ventricular stroke work index although the 
right ventricular stroke work index fell in 5 of the 8 patients and 
remained unchanged in 3. Moreover, since the end-systolic 
pressure/volume ratio did not change in these patients, despite a 
reduction in right ventricular systolic pressure, this would suggest 
that in reducing pulmonary vascular resistance and displacing the 
end-systolic P/V point, oxygen acted as a pulmonary vasodilator 
without producing any change in right ventricular contractility.
As I have discussed in the results section some of the changes in
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Figure 48 Mean right ventricular end-systolic pressure/volume 
points before (• ) and during infusion with sodium 
nitroprusside (O) (n = 10) and while breathing air (A) 
or oxygen (A) (n = 8) in patients with chronic 
bronchitis and emphysema. The displacement of the 
pressure volume point is similar in both circumstances.
the pressure volume relation. However, it is interesting to compare 
the changes in the mean pressure volume relations produced by oxygen 
(indexed to body surface area) with those in 10 patients in whom 
pulmonary vasodilatation was produced by intravenous infusion of 
sodium nitroprusside (see Chapter 5). Both groups of patients had 
very similar ventilatory capacity and arterial blood gas values when 
breathing air. The displacement of the mean right ventricular end- 
systolic pressure volume point was also very similar (figure 48). 
Moreover, neither oxygen nor sodium nitroprusside produced any 
significant change in the P/V ratio. Thus although I have 
previously shown a correlation between W E F  and PaC^ in patients with 
chronic bronchitis and emphysema which might have suggested that 
hypoxaemia had a direct cardio-depressive action. The relief of 
hypoxia with oxygen, at least when given acutely in the inspired 
concentrations used in this study, produced pulmonary vasodilatation 
but had no direct effect on right ventricular contractility in these 
patients.
The effects ef long term oxygen
Osqrgen was given in this study for at least 15 hours/day over a 
period of 6 months in a similar way to the MRC trial (225). 
Compliance with the treatment was established since in all cases 
oxygen was supplied by an oxygen concentrator and the hours of usage 
could be calculcated from the meter on the machine. The small fall 
in PAP and right ventricular systolic pressure which oxygen produced 
when given acutely to 8 similar patients, as described above, also 
occurred after 6 months therapy with oxygen. in addition there was 
a small fall in the right ventricular end-diastolic pressure which 
was probably of no clinical significance. Several uncontrolled
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produce a small fall in PAP, which represents a significant reversal 
of the tendency for PAP to rise, albeit slowly, in patients with 
hypoxic pulmonary hypertension (350). However, in the Nott trial 
(251) pulmonary vascular resistance was only slightly reduced after 6 
months therapy with oxygen. In the MRC trial (225) the PAP continued 
to rise at a mean rate of 3 mmHg/year in the control group who did 
not receive oxygen, whereas those given oxygen for 15 hours/day had 
no change in PAP or pulmonary vascular resistance.
In the patients in this study the mean K7EF was normal at rest before 
oxygen and did not change significantly after 6 months treatment 
despite a reduction in PAP. Thus, oxygen both when given acutely 
and over the longer term did not produce any significant change in 
KVEF. Ellis in contrast found, in a preliminary study, that long 
term oxygen did produce a small increase in KVEF (92). In the 
present study the fall in PAP produced by oxygen was small. Indeed 
the level of PAP remained abnormal after 6 months treatment. These 
changes in PAP may have been too small to produce any change in KVEF. 
However, I have previously found no correlation between PAP and KVEF 
in patients with chronic bronchitis and emphysema (Chapter 4). Ihus 
I would not expect that a small change in PAP would influence the 
KVEF. The lack of change of KVEF also suggests that the relief of 
hypoxaemia even over the long term has no direct influence on right 
ventricular performance.
It is interesting that 7 of the 8 patients given oxygen acutely anci 8 
of the 10 patients given oxygen over 6 months had a fall in PAP after 
oxygen. Recent evidence has suggested that the haemodynamic 
response to oxygen therapy both in the short (12) and in tfoe long
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where PAP falls in response to oxygen may have a better prognosis. 
However, the results of this present study indicate that this fall in 
PAP does not produce any significant improvement in right ventricular 
performance, and hence it is unlikely that the effect of oxgyen 
therapy in improving survival in patients with chronic respiratory 
failure, is mediated through a direct effect on the right ventricle.
The effects of oxygen during exercise
As shown in Chapter 4, patients with chronic bronchitis and emphysema 
may have a normal right ventricular ejection fraction at rest, which 
becomes abnormal during exercise. In addition, in these patients, 
it is known that exercise increases PAP, pulmonary wedge and right 
ventricular end-diastolic pressures (55, 159, 170, 297, 356). The 
change in PAP during exercise appears to be related to the severity 
of the disease as shown by recent clinico-pathological studies (362). 
The level of pulmonary arterial pressure during exercise in these 
patients when breathing oxygen is reduced (FIO2 80 - 100%) when 
compared with the value during exercise when breathing air (55, 157, 
159). In this study I have confirmed that when patients with 
chronic bronchitis and emphysema breathe oxygen at inspired 
concentrations of between 30 - 35%, a small fall in the absolute 
level of PAP occurs both at rest and on exercise. However, the 
change in PAP from rest to exercise when breathing air or oxygen is 
not significantly different. It is not certain from previous studies 
(220, 221, 255, 309) if the right ventricular response to exercise is 
related to the degree of resting hypoxaemia or the degree of 
desaturation which occurs in such patients during exercise. Indeed 
the previously reported variability in the response of the right 
ventricle during exercise was unexplained and, in previous studies,
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have also confirmed (chapter 4) a wide individual variation in the 
change in the RVEF during exercise when breathing air. This 
variability seems to be related to the degree of arterial 
desaturation during exercise, those with a greater degree of 
desaturation having an abnormal right ventricular response to 
exercise.
Oxygen desaturation in patients with chronic bronchitis and emphysema 
when measured at rest probably results from impaired ventilation 
perfusion matching and the further desaturation which occurs during 
exercise might imply either worsening of this matching or a reduction 
in oxygen saturation in venous blood returning to the lungs, or a 
combination of both factors. I have found that the fall in SaC>2 
during exercise (when breathing air) correlates with the SaC^ at 
rest. The fall in Sa(>2 during exercise may itself have directly 
impaired ventricular peformance leading to the failure of the KVEF to 
rise on exercise. The lack of change in RVEF in response to acute 
or chronic administation of oxygen, described earlier in this 
chapter, does not support any direct effect of oxygen on the right 
ventricular myocardium. However, the fall in RVEF, during exercise 
when breathing air, was partially reversed when exercise was repeated 
when breathing oxygen. It might be argued that the fall in RVEF 
during exercise was only partially reversed because the inspired 
concentration of oxygen did not completely abolish the desaturation 
which occurred during exercise. Thus, if higher inspired 
concentrations of oxygen had been given the RVEF may have responded 
normally to exercise. I think it is unlikely that the small 
reduction in the level of the exercise PAP which occurred when oxygen 
was breathed had any influence on the improvement in the RVEF. I
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PAP or the right ventricle to account for the results of this study.
There are several possible explanations for the increase in the 
pulmonary arterial pressure which occurs during exercise in patients 
with chronic bronchitis and emphysema (see chapter 1). A recent 
clinicopathological study has shown that the pulmonary haemodynamic 
effects of exercise, performed pre-operatively in patients undergoing 
lung resection, seems to correlate with the extent of the emphysema, 
the airways disease and hypertensive changes in the pulmonary 
arteries found in the resected lung (362). This study showed that 
the greater the extent of the disease in the resected specimen the 
greater was the increase in PAP which occurred during exercise when 
the patient was studied pre-operatively. The authors suggest that 
gas trapping, resulting in increased alveolar and pleural pressures, 
is the major factor which increases PAP during exercise in patients 
with chronic bronchitis and emphysema. They also suggested that the 
small reduction in the level of the exercise PAP which occurred when 
oxygen was breathed, was due to an effect of oxygen in shortening 
time constants in peripheral lung units leading to a fall in the 
intrathoracic pressure. This theory must be confirmed by studies of 
the effects of oxygen on simultaneous measurements of PAP and 
intrathoracic pressure. However, it may be that the changes in lung 
mechanics which occur during exercise, rather than the consequences 
of these changes such as oxygen desaturation or changes in pulmonary 
haemodynamics, have a direct effect on the right ventricular 
peformance during exercise. Thus, changes in intrathoracic pressure 
may be very important in determining the right ventricular response 
to exercise.
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bronchitis and emphysema and found that the mean RVEF did not change 
on exercise when breathing air but, as in this study, individual 
changes in RVEF during exercise were very variable. In contrast to 
this present study, however, Olvey found a significant rise in mean 
RVEF in the same patients when exercise was performed breathing 
oxygen. Individual values of SaC^ or Pa02 are not quoted but the 
mean Pa02 during exercise did not fall when breathing air, suggesting 
that the patients studied by Olvey were similar to the subgroup of 
patients in the present study who had only a trivial fall in Sa02 
during exercise and an increase in RVEF,
Conclusions
1. Despite producing a fall in both pulmonary arterial pressure, 
and pulmonary vascular resistance, and an increase in the 
supply of oxygen to the tissues, oxygen, when given at rest to 
patients with hypoxic chronic bronchitis and emphysema, did not 
produce any significant change in RVEF.
2. In addition, long term oxygen had no significant effect on EVEF 
even in the face of a reduction in pulmonary arterial pressure.
3. Calculation of the end-systolic pressure/volume relation of the 
right ventricle, in patients with hypoxic chronic bronchitis 
and emphysema, showed that the acute administration of oxygen 
resulted in pulmonary vasodilatation, without any direct effect 
on right ventricular contractility.
4. From these results it can be inferred that the effect of long 
term oxygen in improving the prognosis of such patients is not 
through a direct effect on the right ventricle.
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bronchitis and emphysema, both when breathing air or oxygen is 
related to the degree of desaturation which occurs during 
exercise.
6. The fall in EVEF which occurs in some patients when exercising 
breathing air, can be prevented when the exercise is repeated 
when breathing oxygen.
7. The mechanism of the improvement in the right ventricular 
response to exercise when breathing oxygen is unexplained, but 
probably does not result from any direct effect of oxygen on 
either the pulmonary arterial pressure or the right ventricular 
myocardium. It may, be that oxygen produces changes in lung 
mechanics during exercise which may have an indirect effect on 
the right ventricular performance during exercise.
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THE EFFECTS OF A BETA AGONIST ON RIGHT VENTRICULAR PERFORMANCE
The treatment of patients with chronic bronchitis and emphysema and 
'cor pulmonale' is unsatisfactory, and has not advanced over the past 
20 years (102, 103, 104, 115, 161, 202). There are several general 
therapeutic approaches in this condition. The first relates to 
treatment of the underlying respiratory failure (208) with oxygen, 
bronchodilators, and the treatment of respiratory infections. The 
second aims to reverse pulmonary arteriolar vasoconstriction and the 
third, and most controversial, is to improve the cardio-circulatory 
response to the right ventricular pressure overload.
During periods of acute decompensation when oedema develops with or 
without co-existing acute on chronic respiratory failure, treatment 
of the 'right ventricular failure* is non-specific and therapies are 
directed towards the treatment of the underlying respiratory failure. 
Traditional measures aimed at improving cardio-circulatory function 
have not undergone close scrutiny because of the difficulties in 
assessing right ventricular function. Thus relatively few studies 
of patients with decompensated pulmonary heart disease have been 
undertaken. Sane aspects of decompensated pulmonary heart disease 
will be discussed in Chapter 8.
Until recently the treatment of chronic cor pulmonale in patients 
with chronic bronchitis and emphysema has also been neglected. Much 
more attention has been devoted to new therapeutic measures for the 
much rarer condition of primary pulmonary hypertension (116, 117, 
253, 274), where vasodilators have been used with very variable
specific forms of therapy have been employed? long term oxygen (225, 
251), pulmonary vasodilators, and inotropic agents (164, 207, 261, 
296, 316, 323). The use of vasodilators and or inotropes remains 
controversial (161) principally because of the deleterious effects 
which they may have on ventilation/perfusion matching (323, 336), and 
also because the long term efficacy of these drugs in cor pulmonale 
and hence their effect on patient survival has not been documented.
Tliis study in patients with hypoxic chronic bronchitis and emphysema 
and pulmonary hypertension, was conceived to measure the 
cardiovascular effects of pirbuterol, a beta sympathomimetic drug 
structurally similar to salbutamol, with both vasodilator and 
inotropic actions (13, 14, 73). Both the acute effects and those of 
chronic administration of the drug over six weeks were studied. A 
comparison was made of the effects of this drug on right ventricular 
performance with those of sodium nitroprusside in the same patients.
Patients and methods
Twelve patients with chronic bronchitis and emphysema (6 men, 6 
women) were studied (table 22) when in a stable condition. All of 
the patients were hypoxic (mean Pa02 7.3 * 0.8 kPa), most were 
hypercapnic (PaC02 6.4 * 0.7 kPa), and all had pulmonary arterial 
hypertension when breathing room air at rest (mean PAP 30 1 5 mmHg).
Acute studies
As in previous haemodynamic studies each patient's medication (which 
included inhaled bronchodilators and diuretics in most) was given on 
the evening prior to study. No medication was given on the morning of 
the study day. Each patient was studied while semi-supine,
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medication was given. Ten of the 12 patients had taken part in the 
study of the effects of sodium nitroprusside (see Chapter 4). The 
haemodynamic measurements were made with a Swan Ganz flow directed, 
triple lumen catheter, inserted into the pulmonary artery. 
Radionuclide ventriculograms were performed and analysed as described 
in detail in Chapter 4.
Derived haemodynamic and oxygen delivery values were calculated 
according to the equations in Chapters 4 and 5.
In 10 of the patients (Nos 1-10) haemodynamic and radionuclide 
measurements were made after haemodynamic stability had been 
achieved, with the patients at rest and during infusion of sodium 
nitroprusside as described in Chapter 4. When all of the 
haemodynamic parameters had returned to baseline, oral pirbuterol 
was given in a dose of 22.5 mg (patients 1-6) or 15 mg (patients 7- 
12) by mouth. Measurements were repeated at 30 minute intervals for 
2 hours. Two patients (Nos 11, 12) underwent the same study 
protocol but were not given sodium nitroprusside.
.Chronic .study:
Nine of the 12 patients who were studied acutely also received oral 
pirbuterol 15 mg three times/day for 6 weeks in addition to their 
usual therapy. At this time pulmonary arterial pressure, WEF, LVEF, 
arterial blood gas values, and ventilatory capacity were remeasured. 
Three patients did not complete the chronic study; two developed an 
arrhythmia possibly associated with pirbuterol (atrial fibrillation 
in one, multi-focal ventricular and supraventricular ectopic beats in 
another) and one further patient developed an ‘acute infective
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Figure 49A The acute effects of pirbuterol in a single oral dose 
(22,5 mg, n = 6, o— o? 15 mg, n = 6, • - - •) in 
patients with chronic bronchitis and emphysema.
Mean values are shown and the error bars represent 1 
SEM.
Significant differences from the control values:
* p < 0.05? ** p < 0.01.
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Figure 49B The acute effects of pirbuterol in a single oral dose 
(22.5 m g f n = 6, o— o? 15 mg, n = 6, • - - •) in 
patients with chronic bronchitis and emphysema.
Mean values are shown and the error bars represent 1 
SEM.
Significant differences from the control values:
* p < 0.05; ** p < 0.01.
planned. Pirbuterol concentrations were assayed in venous plasma 
(99) in 10 patients one and two hours after the drug was given.
Results
The maximum effects of pirbuterol on pulmonary vascular resistance 
occurred 90 minutes after the drug was given therefore only these 
results are reported (figure 49a and b). The effects of each of 
the dose regimes on pulmonary vascular resistance were similar. 
Although there was no significant change in mean PAP at the lower 
dose, the effects of both dose regimes which occurred 90 minutes 
after each dose have been combined in the analysis.
Acute effects ££ pirbuterol (table 22, 23)
In these 12 patients, there was a small but significant increase in 
heart rate from 87 t 13 to 97 tl5 b/min (p < 0.01) 90 minutes after 
pirbuterol was given. Cardiac index also increased from 2.62 1 0.58 
to 3.15 1 0.62 1/m/m^ (p < 0.01). Although cardiac index increased 
in every patient, the change in stroke volume index was not 
significant. Mean PAP fell from 30 * 5 to 27 t. 5 (p < 0.05) 
resulting in a fall in total pulmonary vascular resistance from 566 * 
149 before to 428 1114 dynes.s.cm“^ after pirbuterol (p < 0.001), a 
fall occurring in every patient (figure 50). Pirbuterol also 
reduced systemic vascular resistance significantly from 1819 1 588 to 
1469 t 525 dynes.s.cm^ (p < 0.001). Although right ventricular 
systolic pressure fell in 7 of the 12 patients studied, pirbuterol 
did not produce any signficant change in right ventricular systolic 
or diastolic pressures. Mean KVEF increased significantly from a 
control value of 0.46 t 0.08 to 0.55 t 0.10 (p < 0.001) after 
pirbuterol, an increase in KVEF occurring in 11 of the 12 patients
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Figure 50 Acute effects of pirbuterol in 12 patients with chronic 
bronchitis and emphysema. Individual values (•) and the 
mean values (-o-) are shown.
Significant differences from control values:
*** p < 0.001.
pirbuterol despite a fall in systemic vascular resistance. Although 
pirbuterol did not change right ventricular end-diastolic volume 
index (table 23), the W  end-systolic volume index fell significantly 
from 38 1 14 to 29 1 1 ml.m-2 (p < 0.05).
Thus the right ventricular end-systolic pressure/volume relation 
increased from an average of 1.40 t 0.74 to 1.77 t 1.02 (p < 0.05). 
The right ventricular stroke work index averaged 16.9 1 6.2 g.m/m2 
and was unchanged by pirbuterol (R7SWI after pirbuterol 17.4 1 6.6 
g.n/m2).
There were no significant correlations between the changes in RVEF 
produced by pirbuterol and the changes in PAPf right ventricular 
systolic pressure, or total pulmonary vascular resistance.
These changes in pulmonary haemodynamics produced by pirbuterol 
resulted in a significant fall in arterial oxygen tension from 13 * 
0.8 to 6.6 1 0.9 kPa (p < 0.05) (table 22) without any significant 
change in PaQC^* was ^ ow t i^ese patients (mean PVO2 4.4 *
0.2 kPa) and did not change significantly after pirbuterol. Despite 
a reduction in PaC>2 after pirbuterol the systemic oxygen delivery 
(SDO2) increased from 44.5 * 6.9 to 51.1 * 7.4 ml/min/m2 (p < 0.01) 
and the coefficient of oxygen delivery (COD) also increased from 3.4 
* 0.5 to 4.1 1 0.9 (p < 0.02). Since there was a small fall in the 
arterial oxygen content after pirbuterol, the increase in systemic 
oxygen delivery was as a result of an increase in cardiac output.
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nitroprusside
In a comparison of the haemodynamic effects of sodium nitroprusside 
and pirbuterol (table 24) in 10 patients with chronic bronchitis and 
emphysema, both drugs produced a significant fall in mean PAP, which 
was more significant after sodium nitroprusside. Both drugs also 
produced a reduction in total pulmonary vascular and systemic 
vascular resistances (table 24). However, whereas cardiac index 
increased in every patient after pirbuterol was given, the change in 
cardiac index was very variable during infusion with sodium 
nitroprusside, so that the mean cardiac index did not change 
significantly in these patients, during infusion with this drug.
The changes in PAP or total pulmonary vascular resistance produced by 
either drug did not show any significant correlation with the 
baseline values of these variables (r = 0.43 - 0.27). There was 
also no significant correlation between the baseline PAP and the 
change in pulmonary vascular resistance produced by either drug. 
Since both drugs produced an acute reduction in pulmonary vascular 
resistance in every patient this variable did not distinguish any 
difference in the action of either drug.
To determine if the changes in systemic and pulmonary vascular 
resistances occurred entirely as a result of changes in cardiac 
output, I have correlated the percentage change in cardiac index with 
the changes in either total pulmonary vascular resistance or systemic 
vascular resistance produced by either drug (figure 51a and b, 52a 
and b). For both drugs there was a good correlation between the 
percentage change in cardiac index and the percentage change in 
systemic vascular resistance. In contrast, although there was a good
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systolic P/V point as shown (o)r whereas pirbuterol 
displaces the P/V point further to the left. The error 
bars represent 1 SEM,
percentage change in pulmonary vascular resistance produced by sodium 
nitroprusside, there was no significant correlation between 
percentage change in cardiac index and the percentage change in 
pulmonary vascular resistance produced by pirbuterol (figure 51a). 
Moreover, during infusion with sodium nitroprusside, the mean percent 
change in the systemic and pulmonary vascular resistances were not 
significantly different. In contrast, however, in all but one patient 
the percentage change in total pulmonary vascular resistance after 
pirbuterol was more than the corresponding change in systemic 
vascular resistance. The only- patient in whom this was not the case 
was, in fact, the only one in whom PAP rose after pirbuterol (table 
24, patient no 5). Thus, the mean percentage change in the total 
pulmonary vascular resistance after pirbuterol was -25.4 1 12.6%, 
which was significantly greater than the mean percentage change in 
systemic vascular resistance which was -18.9 t 9.5% (p < 0.05), 
whereas the corresponding changes in pulmonary and systemic vascular 
resistances produced by sodium nitroprusside were similar (-26.6 1 
15.8 vs 24.0 t 15.3, NS).
The effects of these drugs on the right ventricular end-systolic 
pressure/volume relation were also different (table 24). Sodium 
nitroprusside infusion produced no significant change in the right 
ventricular end-systolic P/V index, whereas this ratio was 
significantly increased by pirbuterol. In the case of pirbuterol 
this had the effect of displacing the right ventricular end-systolic 
P/V point further to the left on the pressure volume diagram (figure 
53).
Plasma pirbuterol concentrations varied (table 25). There were no
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Individual (•) and mean (-o-) values are shown.
pirbuterol and any of the haemodynamic variables.
ghr.Qnic effects g£ pirbuterol (table 26)
In the nine patients who completed 6 weeks' treatment with pirbuterol 
in a dose regime of 15 mg thrice daily, heart rate, arterial blood 
pressure, gas tensions and hydrogen ion concentrations were unchanged 
by the drug. Systolic (but not mean) PAP fell from 43 1 3 before to 
35 1 2 mmHg (p < 0.01) after 6 weeks' treatment (figure 54) and mean 
BVEF rose from 0.45 1 0.04 to 0.52 1 0.03 (p < 0.01), without any 
significant change in LVEF. Oral pirbuterol did not produce any 
changes in ventilatory capacity or in exercise tolerance, as assessed 
by the 12 minute walking distance.
DISCUSSION
The role of vasodilators and inotropic agents in the treatment of 
patients with hypoxic pulmonary hypertension and cor pulmonale 
remains unclear (164). There are several problems in assessing the 
potential benefits of vasodilators on the pulmonary circulation. 
Not least among these is the difficulty which stems from the complex 
relationship of pressure to flow in the pulmonary circulation which 
reflects the resistance. Uiis relationship in the normal lung is 
curvilinear. Thus, as flow increases, vascular resistance decreases 
sharply (140), then more gradually. Thus any assessment of a drug 
on the pressure flow relationship, particularly in a diseased lung, 
based on an assessment of two points on the pressure flow curve, when 
both parameters are changing, is very difficult. In addition, since 
we cannot measure resistance directly, its calculation from 
measurements of flow and pressure may make the interpretation of
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pulmonary blood flow can occur in the pulmonary circulation as a 
result of recruitment of unused vessels, rather than by true 
vasodilatation (274).
The primary aim in this chapter was to measure the cardiovascular 
effects of pirbuterol, a beta-agonist, which has been shown to have 
beneficial cardiovascular effects in congestive cardiac failure, 
secondary to ischaemic heart disease (286, 300). Debate exists over 
whether the mechanism of these haemodynamic effects are due to the 
drug acting as an inotrope, or simply secondary to its vasodilator 
action (14, 73, 247, 286, 300). It was hoped that a comparison of 
the effects of pirbuterol and those of sodium nitroprusside, a 
vasodilator with no inotropic action, would be useful in elucidating 
the mode of action of this drug in patients with chronic bronchitis 
and pulmonary hypertension. Arguably, sodium nitroprusside is not 
the best vasodilator to be contrasted with pirbuterol because of its 
combined arterial and venous effects. However, the comparison may 
be valid, since pirbuterol is also thought to have venodilator 
properties (13).
Pirbuterol produced a small but significant increase in heart rate, 
which may have been due to an effect on cardiac beta-1 receptors. A 
small but significant decrease in PAP occurred 90 minutes after oral 
pirbuterol, which was associated with a consistent rise in cardiac 
index in all patients. Thus, pulmonary vascular resistance fell in 
every patient after pirbuterol. In contrast, sodium nitroprusside 
produced a greater fall in PAP than pirbuterol, without producing a 
significant change in cardiac index, resulting in a similar fall in 
pulmonary vascular resistance. Both drugs produced a similar
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pirbuterol this was as a result of an increase in cardiac output, 
whereas the systemic vascular resistance fell during sodium 
nitroprusside infusion, largely as a result of a fall in systemic BP.
One potential hazard of vasodilators used specifically to promote 
pulmonary vasodilatation in patients with chronic bronchitis and 
emphysema, is that they often produce marked systemic vasodilatation 
without an equal or greater degree of pulmonary vasodilatation, thus 
producing systemic hypotension (135), such as can occur with 
hydrallazine (336). This effect, however, did not appear to occur 
with pirbuterol which produced no significant fall in systemic blood 
pressure. Further evidence of the more specific pulmonary 
vasodilator effect of pirbuterol comes from the correlation between 
the changes in cardiac index and the changes in systemic and 
pulmonary vascular resistance. Although one would expect a 
correlation between these variables for both drugs, since the 
calculation of resistance includes a measure of cardiac index, the 
change in cardiac index correlated more with the change in systemic 
vascular resistance than the change in pulmonary vascular resistance 
after pirbuterol, whereas similar correlations between these 
variables occurred during sodium nitroprusside infusion. Uiis would 
suggest that the change in pulmonary vascular resistance produced by 
pirbuterol was less dependent on an increase in flow which might 
result from recruitment of vessels, and was more likely to be as a 
result of a true change in pulmonary vasomotor tone. Further 
support for a more pronounced specific pulmonary vasodilator action 
for pirbuterol comes from the greater percentage fall in the 
pulmonary vascular compared to. systemic vascular resistance produced 
by this drug. These results contrast with sodium nitroprusside
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resistance. The effects of pirbuterol in producing a greater fall 
in pulmonary, compared with systemic resistance, the fall in PAP 
without significant effect on systemic pressure, together with a rise 
in cardiac output are the factors which Rich et al have identified as 
being those which indicate true pulmonary vasodilatation in patients 
with primary pulmonary hypertension (274). Rich looked 
retrospectively at varioeis previous published reports of the effects 
of vasodilators in primary pulmonary hypertension and found that if a 
pulmonary vasodilator in an individual patient did not reduce PAP, 
then that patient did not have a significantly greater fall in 
pulmonary as compared to> systemic vascular resistance in the face of 
a rise in cardiac output. Of the 12 patients I have studied, only 
two had these haemodyraamic effects after pirbuterol (table 23, 
patients 5 and 12), and iboth had a rise in PAP after this drug.
Great caution should be exercised when comparing concepts developed 
fee vasodilator therapy 3Ln primary pulmonary hypertension with those 
ifl hypoxic pulmonary hypertension (200). However, lessons can be 
learned from a study of ithis condition. It appears, as in primary 
Pulmonary hypertensions that the acute haemodynamic effects of 
vasodilators may be variable in different individuals and are very 
dependent on the homogeneity of the group under study. Moreover, 
t&e acute effects of vasodilators do not necessarily predict their 
lsng term effects (164, 274).
Hsw did the effects of sodium; nitroprusside and pirbuterol on the 
pslmonary and systemic^ vascular resistance affect ventricular 
Performance in these pstients? Sodium nitroprusside produced a 
significant increase i m  LVEP which was not seen after pirbuterol.
than with sodium nitroprusside. This may seem contradictoryr 
particularly as sodium nitroprusside produced a greater fall in PAP. 
How ever, these findings can be explained by the fact that PAP and 
BVEF are not well correlated in patients with chronic bronchitis and 
emphysema, since PAP is not a true reflection of the right 
ventricular afterload (Chapter 4). I have shown that EVEF 
correlated better with total pulmonary vascular resistance which was 
reduced by a similar degree by both drugs in this study. Howeverr 
as discussed abovef the fall in total pulmonary vascular resistance 
produced by pirbuterol was probably due to a true reduction of 
pulmonary vasomotor tone. In addition, the increase in EVEF 
produced by pirbuterol could have been as a result of an increase in 
right ventricular contractility. This concept is supported by the 
significant increase in the right ventricular end-systolic 
pressure/volume relation and the displacement of the pressure volume 
point further to the left after pirbuterol compared to the effects of 
sodium nitroprusside. In order to confirm that pirbuterol had an 
additional inotropic, as well as a vasodilator, action, it would be 
necessary to compare the slope of the pressure volume relation 
obtained at different levels of right ventricular afterload after 
these patients had taken pirbuterol, which was not done in this 
study. However, as discussed previously, the fact that the P/V 
index increased after pirbuterol despite no significant change in 
right ventricular systolic pressure, suggests that this drug produced 
an enhancement of right ventricular contractility.
The effects of pirbuterol on EVEF were sustained after 6 weeks' 
therapy, and although systolic PAP was still reduced when compared 
with control value before the drug was given, the mean PAP was
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This study of the haemodynamic effects of pirbuterol confirms and 
extends studies of the effects of other Beta-agonists in patients 
with chronic bronchitis and emphysema. Terbutaline, has been shown 
to have similar effects on pulmonary vascular resistance and cardiac 
output to those of pirbuterol, at least when given intravenously 
(316) or subcutaneously (47). Terbutaline has also been shown to 
increase EVEF when given subcutaneously (47, 323) and recently oral 
salbutamol has also been shown to increase EVEF (359). However, 
isolated measurements of R7EF (323, 359) are not useful in predicting 
a good clinical response of a drug which may have both inotropic and 
vasodilator properties. Thus, EVEF must be combined with more 
invasive haemodynamic measurements such as in the study by Brent et 
al of the effects of terbutaline on pulmonary haemodynamics (47). I 
would, however, disagree with Brent's conclusions regarding the 
mechanism of the increased EV performance produced by terbutaline, 
which he attributed to a fall in pulmonary vascular resistance due to 
Beta-2 adrenoceptor stimulation. Since Brent and others (47, 323) 
have found that this drug produced a small or insignificant change in 
PAP, I feel it is more likely that the effect of terbutaline in 
increasing right ventricular ejection fraction is as a result of a 
positive inotropic action as with pirbuterol.
One further factor has to be taken into account in assessing the 
effects of a drug on the pulmonary vasculature and that is its effect 
on intrathoracic pressure, which may alter the pulmonary vascular 
resistance. Although it is possible that pirbuterol affected the 
pulmonary mechanics, circumstantial evidence indicates that this was 
not the case. Firstly, over the long term, there was no change in
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irreversible airflow obstruction. However, in addition, re-analysis 
of the pulmonary arterial pressure trace, from the acute study, did 
not show any significant changes in the amplitude of the 
intrathoracic pressure swings in these patients after pirbuterol, 
which indicates indirectly that there was no change in intrathoracic 
pressure.
Data confirming the haemodynamic effects of pirbuterol in this study 
have now been published in a study by Peacock (261),
One concern regarding the use of vasodilators in patients with lung 
disease is the possible aggravation of hypoxaemia as a consequence of 
a loss of the hypoxic regulation in the pulmonary circulation. 
Thus, vasodilatation can occur in underventilated areas of the lungs 
which would worsen the ventilation/perfusion matching. This effect 
has been variably demonstrated with vasodilators such as hydrallazine 
(201, 284, 285) and nifedipine (180, 227, 304, 320). The effect 
appears to depend on the patients studied. In this present study, 
as in the study by Peacock (261) pirbuterol reduced the PaC^. A 
similar fall in PaC^ has not been demonstrated in patients with 
chronic bronchitis and emphysema who were given another Beta-agonist
- terbutaline (47, 323). This potentially delxterious effect of
{
pirbuterol may be offset by the fact that pirbuterol did not alter 
the mixed venous oxygen tension significantly and may, in fact, have 
increased the oxygen delivery to the tissues, since the systemic 
oxygen delivery and the coefficient of oxygen delivery increased as a 
result of an increase in cardiac output. However, this fall in PaC^ 
may have a greater impact during exercise when further desaturation 
may occur. It may be that a combination of long term oxygen and
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over a period of six weeksf pirbuterol produced no significant change 
in arterial blood gas tensions.
Whether any of the haemodynamic effects of a drug which has both 
pulmonary vasodilator and inotropic actions will influence the long 
term prognosis in patients with cor pulmonale remains speculative and 
awaits the outcome of a long term study. Two points, however, are 
worthy of consideration in the design of any long term study of the 
effects of vasodilators. Firstly, the changes in PAP produced by 
all pulmonary vasodilators in previous studies in patients with 
chronic bronchitis and emphysema, including this study, are trivial 
or insignificant (164). If the criteria for an ideal vasodilator 
with which to study the effects on survival was the reduction of 
pulmonary arterial pressure to normal, then none of the vasodilator 
drugs would be suitable. Thus, the search for better drugs which 
have a predominantly pulmonary vasodilator activity, or are 
metabolised in a single pass through the pulmonary circulation, and 
are effective when given by mouth, is urgently needed.
Secondly, if the effects of a drug which has both a vasodilator and 
an inotropic action is to be studied over the long term, it is 
important that its effects are studied in a homogenous group of 
patients with chronic bronchitis and emphysema, particularly in a 
group with the same level of cardiac output. It may be, as 
lyC. / suggested by Bergofsy (29) that those patients with chronic
I bronchitis and emphysema and cor pulmonale who fail to maintain a
, /
£ /  high normal cardiac output, and hence fail to maintain adguate oxygen
//
delivery to the tissues, have a worse prognosis. Such' patients may 
benefit from the effects of a drug with vasodilator and inotropic
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inotropic therapy in the majority of patients studied in this thesis 
with chronic stable cor pulmonale, in whom I have found a normal or 
enhanced inotropic state. Consideration of the right ventricular 
end-systolic pressure/volume relation is therefore useful as an 
indicator of the baseline ventricular contractility in such patients, 
and may shed some light on the longstanding controversy over the 
conflicting effects of digoxin in patients with cor pulmonale (26, 
51, 102, 128, 223).
jXM JJSIQMS
1. The Beta-agonist pirbuterol, when given acutely by mouth, 
produced significant pulmonary vasodilatation in patients with 
hypoxic chronic bronchitis and emphysema and pulmonary 
hypertension.
2. Pirbuterol also produced a fall in systemic vascular 
resistance, largely as a result of an increase in cardiac 
output, since systemic blood pressure remained unchanged.
3. An analysis of the pressure flow changes produced by pirbuterol 
in the pulmonary circulation, together with the relatively 
greater fall in pulmonary vascular resistance produced by the 
drug, compared with its effects on systemic vascular 
resistance, suggested that pirbuterol had an effect in 
decreasing pulmonary vascular tone.
4. Both sodium nitroprusside and pirbuterol produced increases in 
right ventricular ejection fraction in these patients.
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5. The increase in right ventricular ejection fraction may have 
been partially due to pulmonary vasodilatation. However, an 
analysis of the right ventricular end-systolic pressure/volume 
relation suggested that pirbuterol had, in addition, a positive 
inotropic action, in contrast to sodium nitroprusside which was 
shown to be a vasodilator with no inotropic action.
6. Hiese haemodynamic effects of pirbuterol were associated with a 
fall in Pa02 but this did not have a detrimental effect on 
tissue oxygen delivery.
7. Hie acute effects of pirbuterol on systolic PAP and KVEF were 
sustained over a period of 6 weeks' therapy with the drug, 
without producing any change in arterial blood gas tensions, 
ventilatory capacity or exercise tolerance.
/
/
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RIGHT VENTRICULAR FUNCTION IN DECOMPENSATED PULMONARY HEART DISEASE
Although the dire consequences of a sudden increase in right 
ventricular afterload, such as occurs in massive pulmonary embolism, 
are well known (134, 202, 212, 313), the effects on right ventricular 
function of progressive increases in pulmonary arterial pressure, 
with or without intravascular volume loading, have received less 
attention. In primary pulmonary hypertension (116, 117) it is easy 
to imagine that the high levels of pulmonary arterial pressure found 
in this condition would lead to afterload dependent right ventricular 
hypertrophy, and eventually right ventricular 'pump* failure, 
analogous to the situation in the left ventricle, when faced with 
systemic arterial hypertension. However, the effects of severe 
chronic bronchitis and emphysema on right ventriclar performance are 
much more complicated. Firstly, the levels of the pulmonary 
arterial hypertension in this condition are seldom as high as those 
found in primary pulmonary hypertension, which often approach 
systemic values (116). In my experience the mean pulmonary arterial 
pressure in most patients with chronic respiratory failure as a 
result of chronic bronchitis and emphysema, is between 20-35 mmHg. 
However, most studies suggest that during acute exacerbations of 
respiratory failure the pulmonary arterial pressure rises further 
(152, 366) probably as a result of several mechanisms which include 
worsening hypoxaemia, acidosis, and changes in pulmonary mechanics 
(197, 198). Acute changes in pulmonary arterial pressure also 
occur, to a variable degree, during exercise (197) on a background of 
mild pulmonary hypertension which is present even when the patient's 
condition is stable. This varying pulmonary hypertension leads to a
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addition, chronic hypoxia may itself have a direct effect on the 
right ventricular myocardium.
Not every patient who develops pulmonary hypertension as a result of 
hypoxic chronic bronchitis and emphysema, who presents with acute on 
chronic respiratory failure, develops clinical signs of heart 
failure. The sequence events which result in the development of 
oedema in this syndrome are unknown and depend on these adaptive 
mechanisms. There is, as discussed previously, controversy as to 
whether the clinical syndrome of acute decompensated cor pulmonale or 
pulmonary heart disease, with its associated oedema and a raised 
jugular venous pressure is indeed really due to 'heart failure* (60, 
276). It is still true to say that the cause of the oedema in 
decompensated pulmonary heart disease is unknown.
The data presented earlier in this thesis indicates that the right 
ventricular ejection fraction remains relatively normal in most 
patients with chronic bronchitis and emphysema, except in those who 
are oedematous at the time of study. Moreover analysis of the right 
ventricular end-systolic pressure/volume relation suggests that right 
ventricular contractility is normal, in patients with chronic 
bronchitis and emphysema, who have pulmonary hypertension and 
previous episodes of right ventricular failure, but whose condition 
is stable. I felt it would be important to extend the measurements 
of right ventricular mechanics to patients who presented acutely, 
with oedema and the clinical syndrome of right 'heart failure*.
The aim of the study in this chapter was to assess the right 
ventricular pressure/volume relation in such patients using a
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radionuclide ventriculography. Moreover, the acute effects of 
oxygen were also studied, and compared with data obtained in patients 
with pulmonary hypertension who were studied when their clinical 
condition was stable.
Patients and methods
Six patients with chronic bronchitis and emphysema were studied 
(table 27). All of these patients had presented acutely, and were 
admitted to hospital in respiratory failure, with gross peripheral 
oedema, when a diagnosis of pulmonary heart disease was made. The 
patients were selected if there was no other obvious acute 
precipitating cause for their 'heart failure* such as acute pulmonary 
embolus (although it was impossible to completely exclude this 
diagnosis). Four of the 6 patients were presenting with oedema for 
the first time having had chronic bronchitis and emphysema for at 
least 10 years. Ohe patients were studied within 48 hours of their 
admission after the purpose of the study and its research nature had 
been explained to them, and their written informed consent had been 
obtained. Initial emergency treatment was undertaken as appropriate 
before each study, which included nebulised bronchodilators and 
oxygen in every case, and intravenous diuretics and antibiotics if 
these were considered necessary. None of the patients were 
receiving theophyllines or digoxin. Patients were excluded from the 
study if they required treatment for acute on chronic respiratory 
failure in the form of respiratory stimulants. If a patient had a 
respiratory acidosis on admission, the study was delayed until this 
was controlled so as to avoid any potential depressant effect which 
acidosis might have on the myocardium. Ohe timing of the study was 
also delayed until the patient's clinical condition permitted the
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particularly no diuretic therapyf for at least 12 hours prior to 
study. None of the patients were known to have previous evidence of 
hypertensive, valvular or ischaemic heart disease.
If any patient's condition was such that these entry criteria could 
not be met within 48 hours of admission, he was excluded from the 
study. The aim was therefore to study patients who were considered 
to have 'acute right heart failure* secondary to chronic bronchitis 
and emphysema and respiratory failure and not those who were in the 
convalescent phase or who did not present acutely but who had 
worsening oedema perhaps as a result of a recent change in diuretic 
therapy. The study was approved by the hospital's Ethical 
Committee.
The patients were studied semi-supine. A Swan Ganz catheter was 
inserted under local anaesthetic using a Seldinger technique into the 
femoral vein and hence to the pulmonary artery. Pressures were 
recorded from the fluid filled catheter in the right atrium, right 
ventricle pulmonary artery and pulmonary capillary wedge positions. 
As -described previously, pressures were averaged over at least three 
respiratory cycles. Mean pressures were derived by electrical 
integration. Cardiac output was recorded in triplicate and an 
average of three values with a variability of < 5% was used in the 
analysis.
A fine arterial line (Vigon gauge 18) was inserted into the non­
dominant brachial artery under local anaesthetic to facilitate 
withdrawal of arterial blood gas samples. Systemic arterial 
pressures were recorded using a sphygmomanometer.
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750 mBq of technetium^labelled human serum albumin was injected 
into a peripheral vein and allowed to equilibrate in the blood pool. 
The patient was then placed under the gamma camera for the 
measurement of ejection fractions by gated equilibrium radionuclide 
ventriculograhy as previously described (chapter 3),
Measurements were made with the patients breathing room air or oxygen 
given at 1-3 litres/minute by nasal prongs, Hie exact flow rate of 
oxygen was determined so as to obtain an adequate arterial oxygen 
tension but not to increase arterial carbon dioxide tension such that 
the hydrogen ion concentration rose to > 50 nmol/1, Air or oxygen 
was breathed by the patient in a random single blind fashion. If 
air was the first gas to be breathed then the patient would not have 
breathed oxygen for at least one hour before measurements were made. 
Oxygen was breathed for at least 30 minutes before any measurements 
were made.
At least 20 minutes were allowed for haemodynamic stability, after 
all of the intravascular lines were in place, before any measurements 
were made. Derived haemodynamic and oxygen delivery values were 
calculated from the equations described in Chapters 5 and 6.
Results (table 28, 29, 30)
_L.
All of the patients were hypoxic when breathing air (mean Pa02 5.2 _ 
(SD) 1.2 kPa) and hypercapnic (mean PaC02 8.0 t. 1«2 kPa) but with a 
normal arterial hydrogen ion concentration (mean [H*] 43 t 3 nmol/1), 
except one patient whose hydrogen ion concentration was minimally 
elevated at 46 nmol/1 (table 28).
157
RI
GH
T 
VE
NT
RI
CU
LA
R 
PE
AK
 
SY
ST
OL
IC
 
PR
ES
SU
RE
 
(m
mH
g)
80r
70-
60-
50-
40-
30-
20 -
1 0 -
0-
Fjgure £5
Nor
Pa1
Mean P/V ratio 
'mal subjects 078 
ients with CP
Wi
Wr
iout oedema T6y±UVb p<0 02 
i oedema 0 41±0*27
•o
A
a mean for normal subjects
Patients with cor pulmonale 
•-without oedema,n=8 
o-with oedema, n=6
0 20 30 40 50 ~60~ 70 80 90 100
RIGHT VENTRICULAR VOLUME INDEX (ml.m’2)
Individual right ventricular end-systolic pressure/volume 
points in 8 patients with cor pulmonale studied when 
their clinical condition was stable (•), and in 6 
patients with cor pulmonale presenting acutely with 
oedema (o). "The calculated mean right ventricular end- 
systolic pressure/volume point for normal subjects ( A  ) 
is also shown.
3.9 1 0.4 kBa) while breathing room air. The coefficient of oxygen 
delivery was quite variable in these patients, and was low in 3 of 
the 6 patients studied.
All of the patients had an elevated mean PAP (range 25 - 40 mmHg) 
and an elevated right ventricular systolic pressure (range 42 - 62 
mmHg). The right ventricular end-diastolic pressure was elevated in 
the majority (mean 12 t 8 mmHg). Pulmonary capillary wedge pressure 
was normal (mean 8 1 4 mmHg) in all but one patient (table 29).
Mean cardiac index was also normal for the group (mean 3.65 1 1.00) 
and was above normal in one patient and below normal in one other 
patient. Total pulmonary vascular resistance was high in every 
patient (mean 453 t 106 dynes, s. cm^). EVEF was also low in every 
patient (mean EVEF 0.23 1 0.11) and was very low, ie < 0.30 in 3 of 
the 6 patients. LVEF was more variable (mean 0.42 * 0.12) and was 
abnormal in 3 of the 6 patients studied. The right ventricular 
stroke work index was well maintained (mean 18.8 1 6.6 g.m.m.” )^ •
Calculated right ventricular end-diastolic volume index was high in 
the majority of patients (table 30). The mean right ventricular 
end-systolic pressure/volume index was also low (mean P/V index 0.41 
* 0.27). When plotted on a pressure volume diagram, the individual 
P/V points lay above and to the right of the calculated mean right 
ventricular pressure/volume point for normal subjects (figure 55).
Oxygen (1-3 1/min), when breathed by these patients for a period of 
30 minutes, increased Pa02 to a mean of 9.0 t 2.6 (p < 0.01). One 
patient (no 5) did not achieve a very satisfactory level of Pa02 when
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in this patient led to rapid CO2 retention and acidosis, therefore 
the relatively low level of Pa02 when breathing oxygen was accepted. 
PaC(>2 also rose significantly to 8.6 t 1.3 kPa (p <0.01) when 
breathing oxygenf which produced a significant increase in the 
hydrogen ion concentration (table 28), 3 of the 6 patients becoming 
significantly acidotic. The IVC^ also increased significantly when 
breathing oxygen, to a mean of 5.3 t 0.7 kPa (p < 0.01) and was 
within the normal range in all but one patient when breathing oxygen.
The arterial oxygen content increased significantly while breathing 
oxygen when compared with the value when breathing airr as did the 
systemic oxygen delivery. However, there was no significant change 
in the coefficient of oxygen delivery which increased in 4 patients 
and fell in 2 while breathing oxygen (table 28).
Oxygen breathing did not change the mean heart rate or the mean 
systemic blood pressure significantly. However, there was a small 
but significant increase in systemic vascular resistance from 1197 1 
624 to 1292 1 653 dynes, s. citT^ ( p < 0.02) (table 30). An 
increase in systemic vascular resistance occurred in every patient 
when breathing oxygen, as a result of a fall in the cardiac index 
from an average of 3.65 ^ 1.00 to 3.42 1 1.04 1/min/m^ ( p < 0.01).
Mean PAP and right ventricular systolic pressure both fell 
significantly when breathing oxygen by an average of 15% and 8% 
respectively, a fall in both variables occurring in every patient 
(table 30). However, there was no significant change in right 
ventricular end-diastolic, right atrial, or pulmonary capillary wedge 
pressure while breathing oxygen. Despite this fall in pulmonary
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the total pulmonary vascular resistance although a fall in pulmonary 
vascular resistance occurred in 5 of the 6 patients studied, an 
increase occurring in one patient as a result of a marked fall in 
cardiac index (patient no 2). Moreover, oxygen in these 6 patients 
did not produce any significant change in the right ventricular 
stroke work index, which was 18.0 t 7 gm.m.~2 while breathing air, 
and 16.7 1 7 g m . r n . ~ 2  while breathing oxygen.
Calculated right ventricular end-diastolic and end-systolic volume 
indices did not change significantly on average while oxygen was 
breathed. However, individual falls in these volume indices were 
very variable from 0 to 74% (table 26). Moreover oxygen breathing 
did not produce any significant change in the mean right ventricular 
end-systolic pressure/volume index.
The effects of acute administration of oxygen in these 6 patients 
with acute decompensation of their pulmonary heart disease were 
compared with those in 8 patients, also with pulmonary hypertension 
and previous episodes of oedema but who were studied when their 
clinical condition was stable. The results of breathing oxygen in 
these patients has been discussed previously in chapter 6 (table 17, 
group I, table 18, table 19). The age and ventilatory capacity in 
both groups of patients was not significantly different (table 27). 
As expected the PaC^ was lower and the PaCC>2 was higher in those 
patients studied in the decompensated state (table 27). 
Interestingly, the right ventricular systolic, mean pulmonary 
arterial pressure, and right ventricular end-diastolic pressure 
together with total pulmonary vascular resistance were not 
significantly different in either group of patients but the cardiac
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was stable (mean cardiac index 2.58 t 0.6 l/min/m^) compared with 
those who were studied when acutely decompensated (mean cardiac index 
3.65 1 1.0 l/min/m^, p < 0.05).
The stroke volume index was also similar in both groups of patients 
as was the LVEF. However, the mean KVEF was only 0.24 t 0.11 in 
those with oedema compared with an average of 0.47 t 0.10 (p < 0.01) 
in those who were studied when stable. The right ventricular end- 
diastolic volume index was also significantly higher (mean KVED7I 218 
1 116 vs 69l 26 m l . m “ 2 ,  p < 0.05) and the right ventricular end- 
systolic P/V index was lower in those with oedema (P/V 0.41 1 0.27) 
compared with those patients who were studied when stable (P/V 1.61 1
0.41, p < 0.02). The right ventricular stroke work index was 
similar in both groups (table 27).
When breathing oxygen both groups tended to have similar changes in 
arterial blood gas tensions. However, the effect on PaCX^ was more 
pronounced in those who had presented acutely (table 20). Although 
PVC>2 and systemic oxygen delivery increased when breathing oxygen in 
both groups of patients, the coefficient of oxygen delivery was not 
changed significantly by oxygen in either group.
Similar reductions in PAP and right ventricular systolic pressure 
occurred while either group breathed oxygen. However, in contrast 
to those who were studied when stable, where oxygen produced no 
change in cardiac index, those who were studied when acutely 
decompensated had a significant fall in cardiac index and thus no 
significant fall in total pulmonary vascular resistance. In neither 
group was the right ventricular stroke work index or the right
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significantly by breathing oxygen.
mscu.ssiQN
The prime aim of this section of the dissertation was to determine 
whether patients with chronic respiratory failure who present acutely 
with oedema could truly be considered to have 'heart failure1. 
Previous reviews of the literature on this topic have been based on 
relatively few studies and have been somewhat contradictory (60, 104, 
113, 202, 276). Most take the classical view that whatever changes 
may take place in renal blood flow, or in renal hormone levels to 
account for the oedema of cor pulmonale, during periods of acute 
decompensation, the right ventricle 'fails* in the clinical sense as 
a pump due principally to an augmented right ventricular afterload.
Let us put this theory to the test by considering the data presented 
in this chapter. In interpreting the results, it must borne in mind 
that these patients were a highly selected group who presented 
acutely with decompensation of their pulmonary heart disease and in 
whom gross oedema was the main reason for their presentation.
Firstly, the ability of these 6 patients to maintain their cardiac 
output was preserved, and was normal in all but 2 patients. Of 
these 2 patients one had a cardiac index which was only minimally 
reduced and the other had a slightly increased cardiac index. 
Indeed, for the group as a whole, the cardiac index was significantly 
higher, (although still within the normal range) than that of a 
comparable group of patients who had pulmonary hypertension and cor 
pulmonale but did not have oedema when studied (chapter 6). Cardiac
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with decompensated pulmonary heart disease (4, 6, 152f 170, 197). 
This confirms the findings of a review of the earlier literature by 
Wade and Bishop (338) which concluded that there was no evidence to 
support the earlier contention that acutely decompensated pulmonary 
heart disease is a form of 'high output* cardiac failure (102). 
Neither is this a condition of 'low output* failure, such as occurs 
with the left ventricle as a result of hypertensive, ischaemic or 
rheumatic heart disease. Indeed, the right ventricular stroke work 
in this study was similar in those patients with and without oedema 
and was well maintained or even increased as compared with the values 
found in normal subjects (133, 181).
As discussed in Chapter 5, the data from a study by Khaja (181) in 
patients with cor pulmonale (admittedly defined as 'cardiac 
enlargement s*L failure* associated with lung disease, ie not 
necessarily patients presenting acutely with oedema) has shown that 
during the stress of exercise, although the stroke index may be 
compromised and the right ventricular end-diastolic pressure rises 
during exercise suggesting depressed right ventricular function, when 
the right ventricular end-diastolic pressure is plotted against the 
right ventricular stroke work index, these patients appear to have a 
normal right ventricular response to exercise. Similar findings 
have been presented in a study by Jezek (170) and in a single patient 
study by Berglund (26)
The traditional view is that as cor pulmonale progresses abnormally 
high filling pressures occur in the right ventricle to maintain 
cardiac output, particularly during exercise, and that eventually 
this results in an abnormal right ventricular end-diastolic pressure
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The right ventricular end-diastolic pressure was higher than normal 
in 4 of the 6 patients in this study (and would be expected to be 
even higher during exercise). However, this does not necessarily 
indicate that the right ventricle is failing. Indeed despite gross 
oedema, 2 patients had normal right ventricular end-diastolic 
pressure , which has to be explained. Several other factors can 
influence the right ventricular end-diastolic pressure such as 
intrathoracic pressure and increased blood volume. Indeed fluid 
retention alone can increase ventricular end-diastolic pressure in 
the absence of cardiac failure (90). Moreover, right ventricular 
hypertrophy can decrease right ventricular compliance and lead to an 
increased right ventricular end-diastolic pressure in non-failing 
hearts (170).
The range of right ventricular end-diastolic pressure in the patients 
in this study was very wide, from 3 to 27 mmHg in a population of 
patients with acutely decompensated pulmonary heart disease. I have 
also found elevations in right ventricular end-diastolic pressure in 
a population of patients with chronic bronchitis and emphysema 
without oedema (see chapter 5, table 13). Unexplained elevations in 
end-diastolic pressures in the right ventricle have also been found 
in normal subjects (133). I have no data on the effects of exercise 
on the right ventricular end-diastolic pressure in these patients but 
it has been suggested that although right ventricular end-diastolic 
pressure rises in patients with pulmonary heart disease during 
exercise, it is those patients who in addition have no corresponding 
increase in stroke volume who have truly depressed right ventricular 
function (170). The right ventricular end-diastolic pressure may 
therefore be a relatively poor indicator of right ventricular
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In this study I have been able to measure the increase in right 
ventricular end-diastolic volume which takes place in order to 
maintain a normal cardiac output in these patients. In some cases 
the increase in right ventricular end-diastolic volume was up to five 
times the calculated normal value (see chapter 5), Ihis increase in 
right ventricular end-diastolic volume was reflected in the large 
increase in cardiac size seen clinically in such patients (260). 
Ihe increase in right ventricular end-diastolic volume at least in 
some patients (eg numbers 5 and 6) in this study occurred at the 
expense of an increase in end-diastolic pressure as predicted by 
Starling's Law.
In addition to the haemodynamic measurements discussed above, I have 
extended this study to an analysis of right ventricular mechanics 
which has not been considered in previous studies because of the 
difficulty in assessing right ventricular volumes. Moreover, 
although there have been previous studies of patients with chronic 
bronchitis and oedema (4f 6, 152, 170, 197), in only one study are 
details given so as to determine whether patients were studied when 
they presented acutely with decompensated pulmonary heart disease 
(6). In this important study by Abraham and colleagues, which is 
the most comparable with this present study, 8 patients with chronic 
bronchitis and emphysema were studied who presented with acute 
respiratory failure (although the mean pH was normal in these 
patients). Only 6 of these patients, in fact, had oedema. 
Haemodynamic parameters were studied on the day of admission and 
thereafter, daily for 5 days, and again on recovery. As in this 
present study, these patients were treated as necessary prior to
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Abraham (6) that the most convincing evidence comes to suggest a rise 
in pulmonary arterial pressure and pulmonary vascular resistance 
during an acute exacerbation of chronic bronchitis which subsequently 
falls during recovery. I have not, as yetr studied the patients in 
this present study when they have recovered. However, it is 
interesting that the mean PAP and pulmonary vascular resistance in 
these patients who presented acutely with oedema was not 
significantly different from a similar group of patients studied when 
stable (table 29). It is surprising that those patients with oedema 
had both an increase in the right ventricular end-diastolic volume 
index and a reduction in the right ventricular end-systolic 
pressure/volume relation when compared to those patients without 
oedemaf since this suggests depressed right ventricular 
contractility despite the presence of similar levels of right 
ventricular systolic pressure. This is illustrated by the 
displacement of the right ventricular end-systolic pressure/volume 
points further to the right in the pressure volume diagramf in those 
patients presenting acutely with oedema, when compared with those who 
were studied when stable (figure 55).
Although oxygen reduced pulmonary arterial and right ventricular 
systolic pressures in the 6 patients in this study, it did not change 
total pulmonary vascular resistance significantly and the cardiac 
index fell on average while breathing oxygen. Similar results were 
also described fcy Abraham in patients with acute respiratory failure 
(6). Thus although on average the right ventricular end-systolic 
P/V relation did not change when breathing oxygen which might 
indicate that oxygen acted primarily as a vasodilator and had no 
direct effect on right ventricular contractility, individual changes
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slope of the end-systolic P/V relation in the right ventricle, using 
the two end-systolic pressure/volume points while breathing air or 
breathing oxygen, was not justified. In fact, in some of the 
patients the P/V index increased considerably due to a decrease in 
right ventricular end-diastolic volume, suggesting that in at least 
some of these patients, oxygen may have had an effect on right 
ventricular contractility. Further studies are in progress to 
calculate the slope of the right ventricular end-systolic 
pressure/volume relation in patients with acutely decompensated 
pulmonary heart disease during infusion with sodium nitroprusside. 
One of the problems, however, in interpreting data obtained from this 
study is that no data is available of the slope of the right 
ventricular end-systolic pressure/volume relation in normal subjects.
In these patients with oedema, the reduction in the mean right 
ventricular end-systolic P/V ratio was as a result of an increase in 
the right ventricular end-diastolic volume. These increases were 
very variable in this small group of patients. This variability 
probably reflects the degree of adaptation required by the right 
ventricle in patients who present acutely with oedema in order to 
maintain cardiac output. Thus, the results of this study suggest 
diminished right ventricular contractility in patients with chronic 
bronchitis and emphysema and respiratory failure who present acutely 
with oedema, since both the end-systolic P/V ratio and the FVEF are
"7 low in such patients. The fact that at least in t^of adaptation
1/"
required by the right ventricle in patients who present acutely with 
oedema in order to maintain cardiac output. Thus, the results of 
this study suggest diminished right ventricular contractility in 
patients with chronic bronchitis and emphysema and respiratory
167
P/V ratio and the KVEF are low in such patients. The fact that at
■ / 7
/ least in/ttration of oxygen to these patients did not appear to 
normalise the right ventricular end-systolic pressure/volume 
relation, (although the effect was variable), suggesting that oxygen 
did not have any consistent effect on right ventricular 
contractility.
I would , however, tend to agree with Harris and Heath (140) who, in 
describing patients with acute decompensated pulmonary heart disease, 
state that "although these patients are oedematous and have a raised 
systemic venous pressure and increased cardiac size, the term 
'cardiac failure1 seems hardly appropriate to describe a condition in 
which the cardiac output is normal. The term seems even less apt in 
the light of the normal response of the cardiac output to exercise.
The fall in cardiac index seen in this study when these patients 
breathe oxygen has been reported in other studies (3, 358). Thus, 
although the arterial oxygen tension, the PVO2 and the systemic 
oxygen delivery increased when oxygen was breathed, the coefficient 
of oxygen delivery did not increase. Since the arterial oxygen 
content rose when these patients breathed oxygen, the coefficient of 
oxygen delivery fell because of an increase in the arterial venous 
oxygen content difference, which resulted from a fall in cardiac 
output. Thus, as suggested by Bergofsky (29), and in two other 
previous studies (178, 326), any beneficial effects of oxygen on 
pulmonary arterial pressure and arterial oxygen tension may be offset 
in some cases by an alteration of the adaptive mechanisms which have 
developed to maintain cardiac output. ttius, in this present study, 
oxygen produced a dramatic fall in right ventricular end-diastolic
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maintain a normal cardiac output, The result was an acute fall in 
cardiac output and on average no significant rise in the coefficient 
of oxygen delivery.
Whether or not these variables, which measure tissue oxygen delivery, 
change when oxygen is breathed depends on the balance between the 
rise in arterial oxygen tension (more particularly the oxygen 
saturation) and the fall in the cardiac index produced by oxygen. 
It is possible that the addition of an inotropic agent to oxygen in 
the treatment of these patients could counterbalance this effect, 
although whether this would be important clinically is not clear.
The fall in cardiac output when breathing oxygen, which I have shown 
in these patients, may also have implications for the unrestricted 
use of loop diuretics (150, 249) which may further lower the cardiac 
index.
Finally, although I have previously shown a reduction in the LVEF in 
patients with chronic bronchitis and emphysema who have oedema, the 
range of values of LVEF in the patients in this present study was 
very wide from 0.29 to 0.52. The mean pulmonary capillary wedge 
pressure in these patients was 8 ^ 4  mmHg and there was no evidence, 
at least in the patients I have studied, of grossly elevated 
pulmonary capillary wedge pressures as reported in some studies (150, 
197). Thus, the relatively normal pulmonary capillary wedge 
pressures in these patients does not suggest that the reduction in 
LVEF which occurred in some patients was as a result of left 
ventricular failure. However, I have expressed doubts as to the 
accuracy of pulmonary capillary wedge pressures as a true reflection
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LEFT VENTRICULAR EJECTION FRACTION
Figure 56 Relationship between left ventricular ejection fraction 
and right ventricular end-diastolic volume index in 26 
patients with chronic bronchitis and emphysema.
emphysema and these views are supported by others (31f 256, 273). I 
would suggest that the large increases in right ventricular end- 
diastolic volume which occur in these patients produces a degree of 
impairment of left ventricular function. Although in the 6 patients 
in this study there was no significant correlation between the LVEF 
and the right ventricular end-diastolic volume index, there was a 
significant correlation between these two variables when a similar 
analysis was made in 26 patients pooled from the various studies in 
this thesis (figure 56).
flmflSSHS
1. In 6 patients presenting acutely with oedema as a result of 
decompensated respiratory failure, the right ventricular 
ejection fraction and the right ventricular end-systolic 
pressure/volume relation suggested that right ventricular 
contractility was depressed in these patients.
2. However, cardiac output and right ventricular stroke work index 
. were well maintained by an adaptive mechanism involving large
increases in the right ventricular end-diastolic volume index, 
much as Starling's Law would predict.
3. Isolated measurements of right ventricular ejection fractions in 
such patients are not helpful in understanding the complex 
haemodynamic changes which occur, but when combined with 
measurements of cardiac output and right ventricular pressure, 
can improve our understanding of cardiac performance in 
pulmonary heart disease.
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4. In a comparison of two groups of patients with chronic 
bronchitis and emphysema and cor pulmonale with and without 
oedema, those who presented acutely with oedema had a reduction 
in right ventricular performance when compared with those 
studied when stable, which did not appear to be as a result of 
an acute increase in the pulmonary arterial pressure.
5. The relief of hypoxaemia in both groups of patients did not have 
any significant effect on the right ventricular end-systolic 
pressure/volume relation, nor on the right ventricular ejection 
fraction despite producing a fall in pulmonary arterial 
pressure. These results suggest that oxygen in both groups of 
patients had no consistent effect on right ventricular 
contractility.
6. In those patients who presented acutely with oedema, oxygen 
produced a reduction in cardiac output which could theoretically 
have deleterious effects on tissue oxygenation.
7.. The range of values of left ventricular ejection fraction in 
these patients was very wide but even in those with diminished 
left ventricular ejection fraction, there was little evidence to 
support the presence of left ventricular failure.
8. The reduction in left ventricular ejection fraction in patients 
with chronic bronchitis and emphysema may result from an 
increase in the right ventricular end-diastolic volume.
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General discussion and future directions
In this thesis I have endeavoured to measure the haemodynamic changes 
which occur in patients with chronic bronchitis and emphysema. In 
particularf I have used the relatively new technique of radionuclide 
ventriculography to measure the right ventricular ejection fraction, 
in an assessment of right ventricular function in such patients.
Simultaneous measurements of right ventricular ejection fraction and 
conventional pressure and flow measurements obtained at right heart 
catheterisation, allowed a more detailed analysis of right 
ventricular mechanics, particularly in those patients with pulmonary 
hypertension and 'cor pulmonale*. The data obtained from the 
studies in this thesis has raised many questions. A detailed 
discussion and summary of the conclusions drawn from the various 
studies in this thesis is given at the end of each chapter. 
However, it may be useful to attempt to answer the questions which I 
posed previously (page 14-15) and also to discuss possible future 
studies which might follow from the present work.
1. Js right jql lsft ventricular function impaired in patients w ith 
ghconic bronohitis sd& .emphy.ss.nia2
The results in Chapter 4 indicate that in patients with chronic 
bronchitis and emphysema, right ventricular ejection fraction is, on 
average, lower than in normal subjects. Although this difference is 
significant, the vast majority of patients with chronic bronchitis 
and emphysema have a relatively normal right ventricular ejection 
fraction. Moreover, the left ventricular ejection fraction is 
normal in the majority of such patients.
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It is of interest to determine the significance of a single 
measurement of right ventricular ejection fraction in a patient with 
chronic bronchitis and emphysema. Left ventricular ejection 
fraction is of considerable prognostic significance in patients after 
myocardial infarction where there is permanent myocardial damage 
(77). However, in a small number of patients in whom I have 
repeated measurements of right ventricular ejection fraction over the 
course of three years, I have found little change in the right 
ventricular ejection fraction when the patients are studied in a 
stable condition (unpublished observations). In addition 
preliminary data on the variability of T O  in individual patients, 
comparing measurements which are made when the patients are stable 
and in the decompensated state indicates, as might be expected, 
that right ventricular ejection fraction does appear to vary in an 
individual patient depending on the influence of changes in pulmonary 
arterial pressure, right ventricular pre-load and contractility. 
Moreover, right ventricular ejection fraction may be abnormal during 
(and probably for a period after) an acute exacerbation of chronic 
bronchitis and emphysema and return to relative normality during the 
recovery period (unpublished observations). Thus, a single 
measurement of right ventricular ejection fraction in a patient with 
chronic bronchitis and emphysema is unlikely to be a good predictor 
of survival particularly as I have shown that right ventricular 
ejection fraction does not correlate with pulmonary arterial 
pressure, which itself predicts survival. Preliminary data in 45 
patients with chronic bronchitis and emphysema who were followed up 
for a period of 2 years after an initial measurement of right 
ventricular ejection fraction, seems to indicate that right 
ventricular ejection fraction is not a good predictor of survival
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in this thesis after the initial measurement of right ventricular 
ejection fraction is in progress.
Although it may not be an indicator of survival, an isolated 
measurement of right ventricular ejection fraction does give a 
general indication of right ventricular performance in patients with 
chronic bronchitis and emphysema. It is also possible that a low 
value of right ventricular ejection fraction in a patient with 
chronic bronchitis and emphysema, who does not have oedema at the 
time of study, may foretell the development of cor pulmonale. Thus 
right ventricular ejection fraction may be useful as a general, non- 
invasive assessment of cardiac function in patients with chronic 
bronchitis and emphysema who have developed respiratory failure and 
who are in danger of developing pulmonary heart disease. Studies 
are in progress to answer this question.
2. E m  sLqss. xighfc y^ nfcEiculai: functionr .asgassed by the right 
yentriculai: .ejection fraction * .relate to the clinical parameters cf 
disease in patients with .chronic bronchitis and einphyseinaZ 
The results described in Chapter 4 indicate that the right 
ventricular ejection fraction correlates with indices of the severity 
of the disease, such as the arterial blood gas tensions. Although 
these correlations were significant, they were not strong. An 
important finding in this study was that right ventricular ejection 
fraction is reduced in the vast majority of patients who have oedema.
The lack of correlation which I have found between right ventricular 
ejection fraction and pulmonary arterial pressure is disappointing, 
but not surprising, as discussed in Chapter 4. This finding
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Figure 52 The static image from an NMR scan of a patient with 
decompensated pulmonary heart disease shows a dilated 
right ventricle (RV) and a relatively normal left 
ventricle (LV).
is fundamental to an understanding of the limits of the ejection 
fraction as a measure of ventricular performance, to realise that it 
is dependent on three variables, pre-load, contractility and
afterload* A further fundamental premis is that the pulmonary 
arterial pressure is not a true reflection of the right ventricular 
afterload which is best measured by the right ventricular wall 
stress* Thus, a good correlation between pulmonary arterial 
pressure and right ventricular ejection fraction should not be 
expected. Right ventricular ejection fraction is not a non-invasive 
measure of pulmonary arterial pressure and the search for a technique 
which accurately, and non-invasively, measures pulmonary arterial 
pressure must continue (352).
In order to relate right ventricular ejection fraction to right 
ventricular afterload, right ventricular wall stress must be 
measured. This requires an estimation of right ventricular wall 
thickness and volume. As discussed previously, this is difficult to 
measure in the right ventricle because of its complex geometry. 
However, cardiac scanning using nuclear magnetic resonance may allow 
such measurements to be made in the future in the right ventricle 
(figure 57). Gating techniques can now produce NMR movie images and 
may enable the measurements necessary for the calculation of the 
right ventricular wall stress to be made and correlated with the 
right ventricular ejection fraction.
3. How .do.es the presence ef pulmonary hypertension affect right 
ventricular function In patients ffith chronic bronchitis and
emphysema?
The combination of simultaneous measurements of right ventricular
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ventricular volume. The right ventricular end-systolic 
pressure/volume relation can therefore be calculated producing new, 
and more detailed, information on right ventricular function. The 
data in this study indicates that even in the face of an increased 
pulmonary arterial pressure, right ventricular contractility is 
normal in patients with chronic bronchitis and emphysema, or may even 
be enhanced.
The results of this study could be extended in several ways. 
Firstly, in order to prove the linearity of the right ventricular 
end-systolic pressure/volume relation, three measurements of this 
variable should be made at different levels of right ventricular 
afterload, using increasing doses of sodium nitroprusside. To 
determine the change in the slope of the end-systolic pressure/volume 
relation under conditions of increased contractility, measurements of 
the end-systolic pressure/volume ratio are necessary, during infusion 
of an inotrope such as dobutamine with simultaneous reduction of 
right ventricular afterload by sodium nitroprusside. Such studies 
would determine whether the right ventricular end-systolic pressure 
volume relation (as in the left ventricle) is independent of loading 
conditions but sensitive to changes in contractility, which the 
results of this study seem to suggest.
In this thesis I have not been able to make measurements of the right 
ventricular end-systolic pressure/volume relation in normal subjects 
but have derived this value from normal data in the literature. In 
order to conclusively confirm normal right ventricular contractility 
in patients with pulmonary hypertension, it would be necessary to 
compare measurements of the end-systolic pressure/volume in patients
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Studies are also in progress to derive continuous right ventricular 
pressure/volume loops in the right ventricle, in a more detailed 
analysis of right ventricular mechanics. These studies involve 
continuous recording of right ventricular pressure recorded by right 
heart catheter, together with continuous estimation of ventricular 
volumes, derived from the time activity curves of the right 
ventricular radio nuclide ventriculogram. Analysis of this data by 
digital computer should allow derivation of a continuous 
pressure/volume loop. These measurements would allow analysis of 
the adaption of the right ventricle to increasing pulmonary arterial 
pressure.
4. what £££ ±h£ .effects sm .right .ventricular function M  reducing 
pulmonary arterial pressure?
As expected, reduction of right ventricular pressure by sodium 
nitroprusside did not change the right ventricular end-systolic 
pressure/volume relation and hence the right ventricular 
contractility. Similarly, oxygen produced only trivial pulmonary 
vasodilatation without change in the right ventricular ejection 
fraction or the pressure/volume relation in patients with chronic 
bronchitis and emphysema and pulmonary hypertension. Hius, there 
was no evidence from the results presented in Chapter 5 to indicate 
that either acute or long term oxygen had any direct effect on right 
ventricular function. Thus, the effect of oxygen in improving 
survival in patients with hypoxic chronic bronchitis and emphysema is 
not the result of a direct effect on right ventricular function. 
Further research is needed to predict which patients benefit from 
long term oxygen and also to determine the mode of action of oxygen
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systolic pressure/volume relation may be an important advance in
assessing the mode of action of drugs used in the treatment of
pulmonary heart disease.
5. Hqw does ±he right ventricle function in patients .with .pulmonary 
hypertension and clinical signs of right ventricular failure? 
Measurement of right ventricular volumes in patients with chronic 
bronchitis and emphysema and oedema has shown that right ventricular 
ejection fraction is reduced as a result of an increase in right 
ventricular end-diastolic volume. This increase in right 
ventricular end-diastolic volume appears to be an adaptive mechanism 
allowing the right ventricle to maintain stroke volume, just as 
Starling's law would predict (250). Studies in patients with 
pulmonary heart disease and oedema are being extended at present by 
re-studying these patients when oedema free during recovery, to 
determine if the reduction in right ventricular ejection fraction and 
the change in the end-systolic pressure/volume relation is 
reversible.
From the data presented in this thesis, the alteration in right 
ventricular end-diastolic volume which occurs in patients with 
pulmonary heart disease and oedema does not appear to be as a direct 
result of an increase in pulmonary arterial pressure. The mechanism 
of the oedema in 'cor pulmonale1 remains unexplained (276). 
However, several studies seem to indicate that changes in renal 
hormones and renal blood flow in chronic hypoxic bronchitis and 
emphysema may play a central role in the development of the oedema of 
pulmonary heart disease. The most consistent observation, in the 
relatively few studies of renal function in patients with 'cor
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oedema (2, 264f 318). In addition there is a variable fall in 
glomerular filtration rate. Although the changes in renal blood 
flow are not closely related to the changes in arterial blood gas 
tensions which occur during recovery, it seems likely that hypoxia, 
and possibly hypercapnia, may have a role in producing local renal 
vasoconstriction (2).
Reduced renal blood flow stimulates release of renin which occurs in 
the majority of patients with chronic bronchitis and emphysema and 
oedema (337). Renin stimulates angiotensin production and hence 
aldosterone and retention of salt and water. The conversion of 
angiotensin I to angiotensin II requires angiotensin converting 
enzyme which is abundant in the pulmonary vascular endothelium. 
Recently, it has been shown that hypoxia tends to reduce the activity 
of this enzyme in peripheral blood (230). It has also been shown in 
normal subjects that in response to hypoxia there is a variability in 
the fall in angiotensin converting enzyme (231). It is likely that 
a similar variability exists in patients with chronic bronchitis and 
emphysema, some of whom may fail to reduce angiotensin converting 
enzyme when hypoxic leading to the conversion of more angiotensin I 
to angiotensin II and hence to aldosterone, resulting in salt and 
water retention. These interesting hypotheses require further 
study.
Thus, it can be seen that several mechanisms may produce the oedema 
of 'cor pulmonale*. Further research during the acute and recovery 
phase of patients with acute decompensated pulmonary heart disease 
are needed to determine the sequence of events producing this 
syndrome and to relate the changes in renal haemodynamics to the
179
180
AEPENDJX 1
The work for this thesis was carried out entirely in the Departments 
of Medicine, Royal Infirmary, Edinburgh and Respiratory Medicine, 
Rayne Laboratory, City Hospital, Edinburgh, under the supervision of 
Dr A L Muir, Reader, Department of Medicine, and Professor D C 
Flenley, Department of Respiratory Medicine, University of Edinburgh. 
The practical work was carried out entirely by myself. In the 
assessment of the reproducibility of the measurement of ejection 
fractions, I was assisted by Dr Q F Xue. During some of the 
catheter studies I was helped by Dr A D Morgan, Dr C G Wathen, Dr K 
Prince and Dr K W  Whyte. My appointments during the preparation of 
this thesis have been MRC Research Fellow/Lecturer, Department of 
Respiratory Medicine, University of Edinburgh and, more recently, 
Senior Registrar in Respiratory Medicine, Lothian Health Board.
All of the studies in this thesis were approved by the hospital's 
Ethical Committee.
Part of the work in this thesis has appeared in published form or has 
been presented at scientific societies:
1. MacNee W, Xue Q F, Hannan W J, Flenley D C, Adie C J, Muir A L. 
Assessment by radionuclide angiography of right and left 
ventricular function in chronic bronchitis and emphysema.
181
2. Xue Q F, MacNee W, Flenley D C, Hannan W Jf Adie C Jf Muir AL. 
Can right ventricular performance be assessed by equilibrium 
radionuclide ventriculography? Thorax 1983; 38: 486-93.
3. MacNee W f Wathen C G, Hannan W  Jf Flenley D C, Muir A L. 
Effects of pirbuterol and sodium nitroprusside on pulmonary 
haemodynamics in hypoxic cor pulmonale. Br Med J 1983; 287: 
1169-72.
4. MacNee W f Prince K, Flenley D C, Muir A L. The effects of 
pulmonary hypertension on right ventricular performance. 
Progress in Respiratory Research 1985 (in press).
5. MacNee W, Morgan A Df Wathen C G, Muir A Lf Flenley D C. 
Right ventricular performance during exercise in OOPD - the 
effects of oxygen. Respiration 1985 (in press).
182
FACTORS CONTRIBUTING TO THE DEVELOPMENT OF PULMONARY HYPERTENSION
Increased pulmonary vascular resistance resulting from:
Loss of capillaries due to disease processes, eg emphysema, pulmonary 
embolism.
Changes in respiratory gases.
Alterations in pulmonary mechanics.
Increased cardiac output.
Increased pulmonary blood volume.
Increased viscosity of blood.
Raised pulmonary venous pressure.
TABLE 2
RIGHT AND LEFT VENTRICULAR FUNCTION IN 
30 NORMAL SUBJECTS
SUBJECT AGE SEX RVEF LVEF
No ( y r s )  REST EXERCISE REST EXERCISE
1- 32 M 0.59  0.71 0 .67  0 .80
2 34 M 0 .59 0 .65  0 .60  0 .73
3 27 M 0.49  0 .54  0 .50  0 .56
4 27 M 0 .48  0 .56  0 .55  0.71
5 24 M 0.47  0 .66  0 .54  0 .63
6 28 M 0 .57 0 .66  0 .54  0 .59
7 33 M 0 .48  0 .53  0 .52  0 .64
8 26 M 0.59  0 .63  0 .56  0 .66
9 41 M 0 .50 0 .58  0 .74  0 .79
10 50 M 0 .60 0.65 0 .55  0 .75
11 28 M 0 .48  — 0 .60  —
12 32 M 0 .50 — 0.51
13 21 M 0.83 — 0 .62  '
14 49 F 0.62 - -  0 .54
15 50 F 0.64 - -  0 .70
TABLE 2 (cont'd)
RIGHT AND LEFT VENTRICULAR FUNCTION IN 
30 NORMAL SUBJECTS
SUBJECT AGE SEX RVEF LVEF
No ( y r s )  REST EXERCISE REST EXERCISE
16 61 M 0.66 - -  0.69
17 31 F . 0 .66  —  0.75
18 58 M . 0 .69 — 0 .70  - -
19 34 M 0.75 —  0.64
20 63 M 0.55 - -  0 .70
21 46 F 0 .58  - -  0.51
22 60 M 0.51 - -  0.65
23 45 M 0.52 - -  0.57
24 36 M 0 .60 - -  0 .59
25 30 M 0.55 - -  0.65
26 37 M 0 .53 - -  0.52
27 42 M 0 .50 - -  0.61
28 52 M 0.61 - -  0 .58
29 28 M 0 .68  - -  0.84
30 58 M 0 .67  - -  0.63
Mean 39.4 0 .58  0.62 0.61 0.69
SD 12.5 0 .09  0.06 0 .08  0 .08
OF 100 PATIENTS WITH CHROMIC BRONCHITIS AND EMPHYSEMA
IT I ENT 
No
SEX AGE
( y r s )
PaO£
(!<Pa)
PaCOp 
( kPa)
FEV1.0
( D
FVC
(1)
RVEF LVEF RV 
F a i 1ure
1 F 60 5.5 7.6 0 .4 1.7 0.31 0 .37 Present
2 M 53 5 .9 7.5 0 .8 2 .4 0 .32 0 .49 No
3 M 63 7.6 5.9 1.1 3.7 0.45 0 .49 Past
• 4 F 64 7.2 6 .3 1.2 1.5 0 .58 0 .67 Past
5 M 52 7.2 5.4 1.2 2 .8 0 .49 0 .54 No
6 M 57 7.2 7.7 0 .5 1.2 0 .43 0 .46 Presen t
7 M 48 7.3 6 .5 0 .7 2.1 0 .40 0 .40 Presen t
8 F 67 7.1 7.7 0 .6 1.6 0 .43 0 .54 Past
9 M 50 8 .7 5.7 0 .7 1.8 0 .44 0.62 No
10 M 57 5.1 8.2 0 .6 2 .9 0 .37 0 .30 Presen t
11 F 59 5.7 6.5 0 .8 2 .2 0.54 0 .56 Past
12 M 68 8 .7 6 .8 0.5 1 .8 0.51 0 .62 No
13 M 49 8 .3 6 .0 0 .9 2.3 0 .40 0 .49 No
14 M 80 7.6 5 .8 0 .4 0 .7 0 .64 0 .62 No
15 M 78 7.4 7.9 0 .7 2 .2 0 .43 0 .39 Past
16 M y 68 4 .8 8.3 0.5 1.7 0.35 0 .34 Presen t
17 : yF,:-;^ 67 6 .9 7.1 0 .6 1.2 0.41 0 .49 Past
18 M 63 6,1 7.1 0 .6 3.7 0 .53 0.51 Past
19 M 55 6 .8 6.7 0.6 2 .0 0.41 0.44 P resen t
20 M 50 5.3 7.3 0.6 1.1 0.30 0.61 Past
21 F 70 6 .9 6.7 0.7 1.7 0 .38 0 .36 P resen t
22 F 60 9.5 4 .9 0 .6 1.5 0.55 0.57 Past
23 F 67 5 .0 10.8 0 .4 0 .9 0.35 0 .30 Past
24 F 64 7.1 7.1 0 .4 1.0 0 .38 0 .40 P resen t
25 M 66 8.4 6 .7 0.6 2.3 0.62 0.66 No
OF 100 PATIENTS WITH CHRONIC BRONCHITIS AND EMPHYSEMA
ITIENT
No
SEX AGE
( y r s )
PaO^
( kPa)
PaCO^ 
( kPa)
FEV1.0
(1)
FVC
(1)
RVEF LVEF RV 
F a i 1ure
26 M 58 6 .3 5.2 1.4 2.5 0.33 0 .29 Presen t
27 M 60 4 .7 9.2 0.5 2.4 0.32 0.32 Presen t
28 M 71 7.0 6.7 0.6 1.6 0 .38 0 .44 Presen t
29 M 59 9.2 6 .5 0 .8 1.5 0.33 0 .60 No
30 F 57 6.5 9.3 0 .3 1.2 0.62 0.72 Past
31 M 58 8 .0 4 .5 0 .8 1.8 0.43 0.46 Past
32 M 45 5.6 8.5 0 .2 0.5 0.24 0 .50 Present
33 M 67 9.5 4 .9 1.4 3.6 0.65 0 .67 No
34 M 71 7.3 6 .8 1.2 2 .9 0.42 0 .64 No
35 M 52 9.2 5.5 1.7 2.7 0.54 0 .74 No
36 M 61 9.5 5.3 1.2 2.2 0 .58 0 .57 No
37 M 67 5.5 8.1 0.6 3.3 0.41 0 .50 Past
38 F 70 8 .6 5.4 0.6 1.2 0.56 0 .49 No
39 F 65 6 .0 7.1 0.5 1.6 0.41 0 .79 Past
40 M 71 6 .9 7.1 0.7 1.8 0.32 0 .40 Presen t
41 F 70 7.1 7.3 0.6 1.6 0.44 0 .47 Past
42 M 58 6 .3 6 .7 0.5 1.5 0.44 0 .63 Past
43 M 70 6 .5 6 .4 0.5 1.4 0.47 0.51 Past
44 M 58 8 .3 6 .3 1.3 3.3 0.46 0 .64 No
45 M 55 8 .3 5.7 0.7 1.6 0.54 0 .64 No
46 F 71 7.2 6.1 1.0 2 .3 0 .50 0 .62 No
47 M 44 7.6 7.5 0.5 1.4 0 .37 0 .52 Presen t
48 F 41 6 .7 5.2 0 .7 1.2 0 .60 0 .52 No
49 M 55 8 .0 7.1 0 .7 2.2 0.37 0.61 Past
50 F 58 8 .3 6 .4 0 .7 1.4 0.42 0.52 No
OF 100 PATIENTS WITH CHRONIC BRONCHITIS AND EMPHYSEMA
(TIENT SEX AGE PaO^ PaCO^ FEV1.0 FVC RVEF LVEF RV
No ( y r s ) ( kPa) (kPa) (1) (1) F a i 1ure
51 F 66 7.1 8 .0 0 .5 1.7 0.57 0 .52 No
52 M 67 5.2 8.4 0.5 1.0 0.42 0.51 Past
53 F 69 6 .0 7.6 0.5 2 .0 0.54 0 .5 0 Past
54 M 67 8 .8 6 .2 0 .7 1.5 0 .38 0.61 No
55 M 42 7.5 5.6 1.0 2 .8 0.43 0 .48 Past
56 F 70 7.8 5.5 0 .4 0 .8 0 .58 0 .56 Past
57 F 70 7.4 5.4 0 .9 1.8 0 .28 0 .47 Presen t
58 M 65 7.2 4 .4 1.1 3 .7 0.55 0 .46 No
59 F 60 8.1 5.2 0 .9 3.0 0.49 0 .53 No
60 F 58 8 .0 6 .0 0 .7 1.4 0.41 0 .52 No
61 M 65 8.1 6.1 1.3 3.6 0.44 0 .48 Past
62 M 62 7.6 5.2 0 .9 2.5 0.52 0 .68 No
63 M 57 9.4 5 .8 0.7 2.1 0.43 0.71 No
64 M 65 7.2 4 .4 1.4 2.1 0.55 0 .67 No
65 M 62 6 .8 5.9 0.5 1.6 0.41 0.51 Past
66 M 65 6 .8 6 .0 0.5 1.1 0.37 0 .55 Presen t
67 M 58 8.6 6.1 0 .8 2 .0 0.42 0.71 No
68 F 56 9.5 5 .8 0 .8 2.3 0.56 0 .5 8 No
69 F 65 9 .8 6.1 1.0 2.2 0 .50 0 .64 No
70 M 52 11.3 4.2 2.9 4 .7 0.55 0.51 No
71 . F 62 7.6 6.7 0.3 0 .9 0.55 0 .59 Past
72 F 55 7.4 5.6 1.7 2.4 0 .43 0 .46 No
73 F 65 8 .0 6.3 1.0 2.3 0.42 0 .34 Presen t
74 F 50 4.6 7.8 0.4 0 .7 0.35 0 .3 8 Presen t
75 F 70 6 .0 6 .7 0.3 1.5 0.33 0 .49 Present
OF 100 PATIENTS WITH CHRONIC BRONCHITIS AND EMPHYSEMA
PATIENT
No
SEX AGE
( y r s )
Pa02 
( k P a )
PaC02 
( k Pa)
FEV1.0
(1)
FVC
(1)
RVEF LVEF RV
F a i l u r e
76 F 64 6.4 5.6 0 .3 1.2 0 .38 0 .44 P resen t
77 M 66 7.0 6.2 0.5 2.6 0 .34 0.61 Past
78 M 64 7.5 5.3 0.5 l . i 0 .57 0 .55 Past
79 F 62 6 .0 6 .3 0.5 0 .46 0 .67 Past
80 F 58 6.7 5.7 0 .3 1.4 0 .38 0.41 P resen t
81 M 65 7.1 4 .8 0 .9 2 .2 0 .24 0 .4 0 P resen t
82 F 66 8.2 5 .9 0 .4 0 .7 0.55 0 .70 No
83 F 70 6 .6 8.1 0.5 1.7 0.36 0.41 P resen t
84 M 70 8 .9 5.7 0 .9 1.3 0 .43 0 .57 Past
85 M 65 7.6 6.2 0.5 1.6 0.51 0 .68 Past
86 F 62 7.3 5 .8 0 .5 1.0 0 .42 0 .50 Past
87 M 68 5 .3 7.5 1.0 2 .3 0 .34 0 .39 Presen t
88 M 50 8 .7 5 .5 0 .7 2 .6 0 .39 0 .45 No
89 M 65 7.5 5.4 1.1 2 .6 0 .42 0.41 Past
90 M 56 8.2 5.9 0.5 3.1 0 .48 0 .5 7 No
91 M 70 6.2 7.4 0.4 2 .0 0 .34 0 .5 8 P re sen t
92 M 65 8.5 5.3 0 .9 4 .3 0 .45 0 .47 Past
93 M 56 7.0 7.0 0.7 2.6 0 .47 0 .52 Past
94 M 62 8.4 5 .8 0.6 1.7 0 .33 0 .46 Past
95 M 42 8 .0 6 .0 0 .8 1.9 0 .39 0.61 Past
96 F 62 7.0 6.4 0 .8 2.3 0.17 0 .24 Presen t
97 F 64 7.1 6.1 1.0 1.4 0.35 0 .56 Past
98 F 70 5.3 6 .9 0.7 1.6 0 .30 0 .52 Present
99 M 65 7.2 7.4 1.2 2.3 0 .26 0.31 Present
100 M 79 6.3 4.9 1.0 2.2 0.58 0 .58 Past
Mean 62 7.3 6.4 0.75 1.98 0.44 0.52
SO 8 1.3 1.2 0.38 0.80 0.10 0.11
1
2
3
4
' 5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
PATIENTS WITH CHRONIC BRONCHITIS AND EMPHYSEMA AND
NO HISTORY OF OEDEMA
AGE
( y r s )
FEV.
1
FVC
1
PaO?
kPa
PaCO?
kPa
RVEF LVEF
53 0 .8 2.4 5 .9 7.5 0.32 0 .49
52 1.2 2 .8 7.2 5.4 0 .49 0.54
50 0.7 1.8 8.7 5.7 0 .44 0.62
68 0.5 1.8 8 .7 6 .8 0.51 0.62
49 0 .9 2.3 8.3 6 .0 0 .40 0 .49
80 0 .4 0 .7 7.6 5 .8 0.64 0.62
66 0.6 2.3 8 .4 6 .7 0.62 0 .66
59 0 .8 1.5 9.2 6 .5 0.33 0 .60
67 1.4 3.6 9.5 4 .9 0.65 0 .67
71 1.2 2 .9 7.3 6 .8 0.42 0.64
52 1.7 2.7 9.2 5.5 0.54 0 .74
61 1-2 2.2 9.5 5 .3 0 .58 0.57
70 0.6 1.2 8.6 5.4 0.56 0 .49
58 1.3 3.3 8.3 6 .3 0.46 0 .64
55 0 .7 1.6 8 .3 5 .7 0.54 0.64
71 1.0 2 .3 7.2 6.1 0 .50 0.62
41 0.7 1.2 6 .7 5.2 0 .60 0.52
58 0.7 1.4 8 .3 6 .4 0.42 0.52
66 0.5 1.7 7.1 8 .0 0 .57 0.57
67 0.7 1.5 8 .8 6.2 0 .38 0.61
65 1.1 3.7 7.2 4 .4 0.55 0.46
60 0 .9 3 .0 8.1 5.2 0 .49 0.53
58 0.2 1.4 8 .0 6 .0 0.41 0.52
62 0.9 2.5 7.6 5.2 0.52 0 .68
57 0 .7 2.1 9.4 5 .8 0.43 0.71
65 1.4 2.1 7.2 4 .4 0.55 0.67
58 0 .8 2 .0 8 .6 6.1 0.42 0.71
56 0 .8 2.3 9.5 5 .8 0.56 0 .58
65 1.0 2.2 9 .8 6.1 0.50 0.64
52 2.9 4.7 11.3 4.2 0.55 0.51
55 1.7 2.4 7.4 5 .6 0 .43 0.46
66 0.4 0 .7 8.2 5 .9 0.55 0 .70
50 0.7 2.6 8 .7 5.5 0 .39 0.45
56 0.5 3.1 8 .2 5 .9 0 .48 0.57
60 0.93 .2 .24  : 8.3 5 .8 0.49 0 .59
8 0.50 0.86 1.1 0 .8 0.09 0 .08
PATIENTS WITH CHRONIC BRONCHITIS AND EMPHYSEMA AND
A PAST HISTORY OF OEDEMA
'ATI ENT 
No
AGE
( y r s )
FEV, 
1 1
FVC
1
PaOp
kPa
PaCo« 
kPa c
RVEF LVEF
1 63 1.1 3.7 7.6 5 .9 0.45 0.49
2 64 1.2 1.5 7.2 6.3 0 .58 0.67
3 67 0.6 1.6 7.1 7.7 0.43 0.54
4 59 0 .8 2.2 5.7 6 .5 0.54 0.56
5 78 0 .7 2.2 7.4 7.9 0.43 0 .39
6 67 0.6 1.2 6 .9 7.1 0.41 0 .49
7 63 0.6 3.7 6.1 7.1 0.53 0.51
8 50 0.6 1.1 5.3 7.3 0.30 0.61
9 60 0 .6 1.5 9.5 4 .9 0.55 0.57
10 67 0 .4 0 .9 5 .0 10.8 0.35 0 .30
11 57 0 .3 1.2 6.5 9.3 0.62 0.72
12 58 0 .8 1.8 8 .0 4.5 0 .43 0.46
13 67 0.6 3.3 5.5 8.1 0.41 0 .50
14 65 0.5 1.6 6 .0 7.1 0.41 0.79
15 70 0 .6 1.6 7.1 7.3 0.44 0.47
16 58 0.5 1.5 6 .3 6.7 0 .44 0.63
17 70 0.5 1.4 6 .5 6 .4 0 .47 0.51
18 55 0.7 2.2 8 .0 7.1 0 .37  - 0.61
19 67 0.5 1.0 5.2 8.4 0.42 0.51
20 69 0.5 2.0 6 .0 7.6 0.54 0 .50
PATIENTS WITH CHRONIC BRONCHITIS AND EMPHYSEMA AND
A PAST HISTORY OF OEDEMA
PATIENT
No
AGE
( y r s )
FEV.
1
FVC
1
Pa02
kPa
PaCO~
kPa
RVEF LVEF
21 42 1.0 2 .8 7.5 5.6 0.43 0 .48
22 70 0.4 0 .8 7 .8 5.5 0 .58 0.56
23 65 1.3 3.6 8.1 6.1 0.44 0 .48
24 62 0.5 1.6 6 .8 5 .9 0.41 0.51
25 62 0.3 0 .9 7.6 6 .7 0.55 0 .59
26 66 0.5 2 .6 7.0 6.2 0 .34 0.61
27 64 0.5 1.1 7.5 5 .3 0.57 0.55
28 62 0.5 1.9 6 .0 6 .3 0.46 0 .67
29 70 0 .9 1.3 8 .9 5.7 0.43 0 .57
30 65 0.5 1.6 7.6 6 .2 0.51 0 .68
31 62 0.5 1.0 7.3 5 .8 0.42 0 .50
32 65 1.1 2.6 7.5 5 .4 0.42 0.41
33 65 0 .9 4 .3 8.5 5.3 0.45 0 .47
34 56 0.7 2 .6 7.0 7.0 0.47 0.52
35 62 0.6 1.7 8 .4 5 .8 0.33 0.46
36 42 0 .8 1.9 8 .0 6 .0 0 .39 0.61
37 64 1.0 1.4 7.1 6.1 0.35 0 .56
38 79 1.0 2.2 6 .3 4 .9 0 .58 0 .5 8
Mean 63 0.68 1.92 7.1 6 .6 0.45 0.54
SD 8 0.25 0.88 1.0 1.3 0.08 0.09
PATIENTS WITH CHRONIC BRONCHITIS AND EMPHYSEMA
WITH OEDEMA WHEN STUDIED
PATIENT
No
AGE
( y r s )
FVC
1
Pa02
kPa
PaCX^
kPa
RVEF LVEF
1 60 0 .4 1.65 5.5 7.6 0.31 0.37
2 57 0.45 1.2 7.2 7.7 0 .43 0.46
3 68 0.7 2.1 7.3 6.5 0 .40 0 .40
4 57 0.6 2 .9 5.1 8.2 0.37 0 .30
5 68 0.5 1.7 4 .8 8 .3 0.35 0 .34
6 55 0 .6 2 .0 6 .8 6 .7 0.41 0.44
7 70 0 .7 1.7 6 .9 6 .7 0 .38 0.36
8 64 0 .4 1.0 7.1 7.1 0 .38 0 .40
9 58 1.4 2.5 6 .3 5.2 0 .33 0 .29
10 60 0.5 2.4 4 .7 9.2 0.32 0.32
11 71 0.6 1.6 7.0 6 .7 0 .38 0 .44
12 45 0.2 0.5 5.6 8.5 0.24 0 .50
13 71 0 .7 1.8 6 .9 7.1 0.32 0 .40
14 44 0.5 1.4 7.6 7.5 0.37 0.52
15 70 0 .9 1.8 7.4 5.4 0 .28 0.47
16 65 0.5 1.1 6 .8 6 .0 0.37 0.55
17 65 1.0 2 .3 8 .0 6 .3 0.42 0.34
18 50 0 .4 0 .7 4 .6 7.8 0.35 0 .38
19 70 0 .3 1.5 6 .0 6 .7 0 .33 0 .49
20 64 0.3 1.2 6 .4 5.6 0 .38 0 .44
21 58 0 .3 1.4 6 .7 5.7 0 .38 0.41
22 65 0 .9 2.2 7.1 4 .8 0.24 0 .40
23 70 0.5 1.7 6 .6 8.1 0 .36 0.41
24 68 1.0 2.3 5.3 7.5 0.34 0 .39
25 70 0.4 2.0 6.2 7.4 0.34 0 .58
26 62 0 .8 2.3 7.0 6.4 0.17 0.24
27 70 0.7 1.6 5.3 6 .9 0.30 0.52
28 65 1.2 2.3 7.2 7.4 0.26 0.31
Mean
SD
63
8
0.62
0.29
1.74
0.56
6.4
1.0
7.0
1.1
0.34
0.06
0.41
0 .08
Kllani ftNU LCr I V c m  I\i uu i_nr\ i uit^ i iun ni i\i_o i n u u  v>n i_/\l.i\w ~»i_
IN PATIENTS WITH CHRONIC BRONCHITIS AND EMPHYSEMA
PATIENT
No
FEVi
(1)
FVC
(1)
Pa02
(kPa)
PaCO^
(kPa)
H+ ion 
( n m o l / I )
1 0 .9 3 .0 8.1 5.2 41
2 0.7 1.4 8 .0 6 .0 45
3 1.3 3.6 8.1 6.1 40
4 0 .9 2.5 7.6 5.2 36
5 0 .7 2.1 9.4 5 .8 42
6 1.4 2.1 7.2 4 .4 39
7 0.5 1.6 6 .8 5.9 41
8 0.5 1.1 6 .8 6 .0 39
9 0 .8 2 .0 8.6 6.1 44
10 0 .8 2.3 9.4 5 .8 44
11 1.0 2.2 9.8 6.1 44
12 2 .9 4.7 11.3 4.2 39
13 0 .3 0 .9 7.6 6.7 43
14 1.3 2.4 7.4 5.6 43
15 1.0 2.3 8 .0 6 .3 41
16 0.3 1.5 6 .0 6.7 39
17 0 .5 1.1 7.5 5.3 38
18 0.5 1.9 6 .0 6 .3 45
19 0 .4 0.9 8.2 5 .9 40
20 0.5 1.6 7.6 6.2 45
21 0.7 2.6 8.7 5.5 42
22 0.7 2.6 7.0 7 .0 44
23 1.0 1.4 7.1 6.1 45
24 0.6 2 .0 8.4 5 .8 40
25 0.4 2 .0 6.2 7.4 45
Mean
SD
0.82
0.53
2.07
0.85
7.9
1.2
5.9
0 .7
42
3
12
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
an
RIGHT AND LEFT VENTRICULAR FUNCTION AT REST AND ON EXERCISE
IN PATIENTS WITH CHRONIC BRONCHltlS AND EMPHYSEMA
AGE SEX Sa02 (%) RVEF LVEF
( y r s )  REST EXERCISE REST EXERCISE REST EXERCISE
60 F 90 87 0 .49 0.65 0 .53 0.49
58 F 91 85 0.41 0.47 0.52 0.53
65 M 93 92 0.44 0.50 0.48 0.60
54 M 91 83 0.52 0.41 0.68 0 .68
57 M 92 89 0.43 0.51 0.71 0.69
60 M 88 77 0.55 0 .49 0.67 0.67
62 M 87 67 0.41 0.42 0.51 0.63
65 M 85 66 0.37 0.32 0.55 0.56
58 F 90 84 0.42 0.43 0.71 0 .70
68 M 95 89 0.56 0 .49 0 .58 0 .66
65 F 95 94 0.50 0.54 0.64 0 .64
52 M 93 91 0.51 0.57 0.55 0 .58
66 F 86 68 0.55 0 .37 0 .59 0 .58
55 F 88 85 0.43 0.37 0.46 0 .54
65 F 90 76 0.42 0 .43 0 .34 0.31
68 F 79 69 0.33 0 .19 0 .49 0.42
64 M 88 86 0.55 0.61 0.57 0.55
62 F 83 77 0.46 0.37 0.67 0 .68
66 F 89 80 0.55 0.44 0 .70 0.69
62 M 88 84 0.46 0.46 0.63 ^ 0.63
50 M 93 87 0.39 0.38 0.45 0 .50
56 M 82 74 0.47 0.39 0.52 0.54
55 F 86 79 0.35 0.34 0.56 0.55
62 M 91 82 0.33 0.33 0.46 0.52
70 M 78 75 0.34 0.31 0.58 0.56
61 88 81 0.45 0.43 0.57 0.58
5 5 8 0.07 0.10 0.09 0 .09
< 0.05 > 0.05 > 0.05
•SIMULTANEOUS MEASUREMENTS OF PAP AND RVEF IN PATIENTS
WITH CHRONIC BRONCHITIS AND EMPHYSEMA
>ATIENT PaO^ PaCX^
S y s t o l i c  
PAP
Mean
PAP RVEF
No (kPa) (kPa) mmHg mmHg
1 6 .0 7.1 59 38 0.41
2 7.1 7.3 52 32 0.42
3 6 .3 6.7 46 33 0.42
4 6.5 6.4 39 26 0.47
5 8.3 6 .3 54 30 0.46
6 8.3 5.7 36 26 0.54
7 7.2 6.1 38 21 0 .50
8 7.6 7.5 53 30 0.37
9 6.7 5.2 65 38 0 .60
10 8 .0 7.1 37 22 0.37
11 8 .3 6.4 49 30 0.42
12 7.0 8 .0 32 22 0.57
13 5.2 8.4 55 34 0.42
14 6 .0 7.6 46 32 0 .54
15 8 .8 6.2 31 20 . 0 .38
16 7.5 5.6 40 23 0.43
17 4.5 8.6 73 46 0.54
18 7.8 5.5 50 30 ' 0 .58
19 7.4 5.4 48 24 0 .28
20 7.2 4.4 53 28 0.55
21 6 .9 7.1 34 24 0.32
22 6 .8 5 .9 38 24 0.41
23 6 .8 6 .0 41 32 0.37
24 7.6 6.7 46 32 0.55
25 7.4 5.6 27 21 0.43
SIMULTANEOUS MEASUREMENTS OF PAP AND RVEF IN PATIENTS
WITH CHRONIC BRONCHITIS AND EMPHYSEMA
\TIENT PaO^ PaCO^
S y s t o l i c  
PAP
Mean
PAP RVEF
No (kPa) (kPa) mmHg mmHg
26 8 .0 6 .3 32 26 0.42
27 6 .0 6 .7 49 38 0.33
28 8.7 5 .5 15 12 0 .39
29 7.5 5 .4 16 12 0.42
30 8.2 5 .9 25 11 0 .48
31 6.2 7 .4 47 26 0 .34
32 8.5 5 .3 19 12 0.45
33 8 .4 5 .8 32 18 0.33
34 8 .0 6 .0 40 25 0 .39
35 7.0 6.4- 74 47 0.17
36 6.3 7.7 40 22 0.35
37 5.5 7.6 46 34 0.34
38 7.6 5 .9 39 27 0.45
39 5.4 8.1 96 58 0.37
40 6.1 7.1 45 36 0.51
41 5.3 7.3 40 26 0.61
42 6.3 7.7 40 24 0.55
43 6.5 7.3 27 16 0 .38
44 5.1 8.2 95 60 0.32
45 5.6 8 .5 58 32 0.24
46 6.5 7.2 70 44 0.45
47 6.1 6 .8 28 10 0 .43
48 7.0 6.2 54 50 0.34
49 6.4 5.6 42 29 0 .38
50 6.3 6 .8 38 32 0.45
RIGHT VENTRICULAR EJECTION FRACTION IN NORMAL 
SUBJECTS -  A REVIEW OF THE LITERATURE
AUTHORS No o f  RVEF AT RVEF ON
SUBJECTS REST EXERCISE
FIRST PASS METHOD
STEELE (1976, 312) 14 0.57
+ 0.03
BERGER (1978, 23) 50 0.55 + 0.05
TOBINICK (1978, 333 ) 22 0.52 + 0.04
JOHNSON (1979, 171 ) 11 0.47 + 0.04 0 .57 + 0.06
BERGER (1979, 24) 14 0 .54 + 0.03 0 .68 + 0.02
WALTON (1979, 341 ) 17 0.65 + 0 .08
SLUTSKY (1980, 307 ) 10 0.53 + 0.03
OLVEY (1980, 255 ) 10 0.53 + 0.02 0 .63 + 0.02
MATTHAY (1980, 221 ) 25 0.54 + 0.03 0 .67 + 0.03
WINZELBERG (1981, 360 ) 13 0.60 + 0.07
PETER (1983, 262 ) 10 0.44 + 0.06 0.55 + 0.07
KAUL (1984, 176 ) 18 0.46 + 0 .08
EQUILIBRIUM METHOD
MADDAHI (1979, 209 ) 15 0 .48
+ 0.05 0 .60 + 0 .0 7 *
MADDAHI (1979, 209 ) 10 0.49
+ 0 .04 0.67 + 0 . 0 8 * *
SLUTSKY (1980, 306 ' 20 0.49
+ 0 .10 0.64 + 0 .08
SORENSEN (1980, 310 ) 10 0.51
+ 0.07
SLUTSKY (1981, 308 ) 10 0.50
+ 0.06
HOLMAN (1981, 156 ) 11 0.59
+ 0 .08
MORRISON (1982, 240 ) 9 0.53
+ 0.05 0 .69
+ 0.06
KORR (1982, 189 ) 20 0.53
+ 0.06
SLUTSKY (1982, 309 ) 15 0.50
+ 0.06 0'.61
+ 0.04
HENZE (1982, 151 ) 9 0.52
+ 0.06
XUE (1983, 364 ) 18 0.62
+ 0.09
KONSTAM (1983, 187 ) 16 0.47 + 0.11
ERICKSON (1983, 95 ) 20 0.48 + 0.04
LEGRAND (1983, 193 ) 10 0 .58 + 0 .08
KAUL (1984, 176 j 18 0.43 + 0.06
* Submaximal e x e r c i s e
* *  Maximal e x e r c i s e
RIGHT VENTRICULAR EJECTION FRACTION IN
PATIENTS WITH CHRONIC BRONCHITIS AND
EMPHYSEMA - A REVIEW OF THE LITERATURE
AUTHORS No OF RVEF AT RVEF ON
PATIENTS REST EXERCISE
E l l i s  e t  al 39 0 .47 - 0.02
1977 ( 92)
Olvey e t  al 18 0 .43 - 0 .02 0 .44  - 0 .03
1978 (255)
Berger e t  al 36 0.47  -  0 .12
1978 (23 )
Mat thay e t  al 30 0 .49 -  0.01 0 .47  -  0 .02
1980 (222)
S lu t s k y  e t  al 20 0 .46 -  0 .09
1980 (307)
Mathur e t  al 15 0 .34 -  0 .08
1981 (223)
Hooper e t  al \  14 0 .37  -  0 .14  -
1982 (158)
Dah ls t rom e t  al 10 0 .43 -  0 .14 0 .39  -  0 .14
1983 (72)
E r ickson  i
1983 (95)
Brown e t
1984 (51)
Tuxen e t  
1984 (336)
B ren t  e t  
1984 (48)
e t  al 10 0 .38  -  0.11
 al 12 0.41 -  0 .04  0 .44  -  0 .03
al 9 0 .33  -  0 .08
al 30 0.41 -  0.07
LEFT VENTRICULAR EJECTION FRACTION IN
PATIENTS WITH CHRONIC BRONCHITIS AND
EMPHYSEMA - A REVIEW OF THE LITERATURE
AUTHORS No OF LVEF AT LVEF ON
PATIENTS REST EXERCISE
Stee le  e t  al 28 0.52 - 0 . 0 2
1975 (311)
K l i n e  e t  al 18 0 .64  - 0 .13
1977 (184)
Olvey e t  al 18 0.65  “  0 .71  —
1978 (255)
Berger e t  al 35 0 .58  -  0.15
1978 (2 3 )
Mat thay e t  al  30 0 .62 -  0 .02 0 .71  -  0 .02
1980 (221)
S lu t s k y  e t  al  2 0  0 .58  - 0 .09
1980 ( 307)
S lu t s k y  e t  al 12  0 .60  ± 0 . 1 2  0 . 6 2 - 0 . 1 1
1981 ( 308)
B ren t  e t  al  20 0.61 -  0.11
1982 ( 46)
E r ickson  e t  al 10  0 .59  -  0.11
1983 ( 95)
Brown e t  al 12 0 .59  - 0 .03  0 .6 3  - 0 .04
1984 ( 51)
CORRELATION BETWEEN PAP AND RVEF 
- A REVIEW OF THE LITERATURE
AUTHOR No OF PATIENTS
PATIENTS/SUBJECTS STUDIED
CORRELATION
COEFFICIENT
El 1 i s  e t  al 
1977 (92)
Winze lberg  e t  al 
1979 (360)
K o r r  e t  al 
1982 (189)
Friedman e t  al 
1982 (123)
M o r r i so n  e t  al 
1983 (241)
M o r r i son  e t  al
1982 (240)
Dahls t rom e t  al
1983 (72)
B ren t  e t  al
1984 (46)
Mahler  e t  al 
1984 (210)
Burghuber e t  al 
1984 (53)
35
56
37
49
39
9
10
30
12
14
COPD
A o r t i c  and m i t r a l  
va lve  d isease
Normal s u b je c t s  
v a l v u l a r  and 
ischaemic  h e a r t  
d isease
Cardiomyopathy 
ischaemic  and 
v a l v u l a r  h e a r t  
d isease
Cardiomyopathy 
v a l v u l a r  and 
ischaemic  h e a r t  
d i  sease
Chronic lung 
d iseases
COPD
COPD
COPD
- 0 .3 2  (NS)
0 .23  (NS)
- 0 .8 2  (p < 0 . 0 0 1 )
- 0 .5 6  (p < 0 .0 5 )  
- 0 . 5 7  (p < 0 .05 )
Normal s u b je c t s  ( r  n o t  quo ted )  (NS)
- 0 .7 5  (p < 0 .05 )  
- 0 .7 4  (p < 0 .0 1 )  
- 0 . 4 8  (NS)
- 0 .7 5  (p < 0 .01 )
TABLE 11
DETERMINANTS OF RIGHT VENTRICULAR SYSTOLIC FUNCTION
A f t e r ! o a d  -  w a l l  s t r e s s  (62)
Approx im a t ions
Pulmonary a r t e r i a l  p ressure  (353)
To ta l  pulmonary v a s c u la r  r e s i s t a n c e  (354)
A d d i t i o n a l  c o n s i d e r a t i o n s
V e n t r i c u l a r  volume -  volume o ve r lo a d  (61)
Wall t h i c k n e s s  (62)
T r i c u s p i d  r e g u r g i t a t i o n  (196)
I n t r a - t h o r a c i c  p ressure  v a r i a t i o n s  (302)
C o n t r a c t i l e  f u n c t i o n
Free w a l l  ( p o s s ib l e  co nco m i ta n t  r i g h t  v e n t r i c u l a r  i n f a r c t )  
Approx im at ions
Proximal  h igh grade r i g h t  co rona ry  a r t e r y  l e s i o n s  (100) 
I n f e r i o r  l e f t  v e n t r i c u l a r  w a l l  mot ion  a b n o rm a l i t y  (267) 
Septum
Approx im at ions
Global RVEF (101)
A d d i t i o n a l  c o n s i d e r a t i o n s
V e n t r i c u l a r  i n t e r a c t i o n  (344)
P a t te rn  o f  r i g h t  v e n t r i c u l a r  c o n t r a c t i o n  (11) 
E n d - s y s t o l i c  p ressure  volume r e l a t i o n  (291)
TABLE 11 (cont'd)
Pre-1oad -  e n d - d i a s t o l i c  volume (62)
Approx im a t ions
Transmural f i l l i n g  p ressures  (302) 
I n t r a - c a v i t y  f i l l i n g  p ressures  
A d d i t i o n a l  c o n s i d e r a t i o n s
V e n t r i c u l a r  i n t e r a c t i o n  (344) 
I n t r a - t h o r a c i c  p ressure  v a r i a t i o n s  (302) 
P e r i c a r d i a l  f u n c t i o n  (283)
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RIGHT VENTRICULAR HAEMODYNAMICS IN 20 NORMAL SUBJECTS 
- G ur tne r  e t  al 1975 (133)
Sub je c t
No
Sex RVSP
mmHg
r vedp
mmHg
Cl
l . m i r T  .m
SVI
~ 2 ml.m" 2
RVSWI
-2g.m.m
1 M 15 3 3.01 40 6 .5
2 M 22 4 4.20 71 17.4
3 M 27 5 3.07 43 12.9
' 4 M 24 4 3.13 43 11.7
5 M 23 6 4.05 55 12.7
6 M 27 4 4.13 50 15.6
7 M 30 7 4.20 51 16.0
8 M 30 8 2 . 8 6 39 11.7
9 M 28 7 2.99 51 14.6
10 M 28 6 2.76 48 14.4
11 M 28 9 3.63 52 14.9
12 M 24 4 3.04 38 10.3
13 M 24 5 3.21 46 11.9
14 F 26 7 3.72 45 1 1 . 6
15 F 27 6 3.47 37 1 0 . 6
16 M 30 8 3.86 57 17.1
17 F 25 9 3.61 39 8 .5
18 M 28 7 3.45 39 1 1 . 1
19 M 22 4 3.64 36 ' 8 . 8
20 F 26 9 3.27 40 8 . 2
MEAN 26 6.1 3.47 46 12.3
SD 4 1.9 0.46 9 3.1
ESTIMATION OF MEAN RV VOLUMES FOR NORMAL SUBJECTS
RVSP SVI RVEF RVEDVI RVESVI P/V
MEAN 26 46 0.58 79 33 0 .78
RANGE OF NORMAL RESTING HAEMODYNAMIC VALUES
Pressures (mmHg) S y s t o l i c E n d -d ia s to l  i c Mean
R ig h t  a t r iu m
R ig h t  v e n t r i c l e
Pulmonary a r t e r y
Pulmonary a r t e r y  wedge
15-30
15-30
0-8
3-12
0-8
9-20
1-12
Card iac index
-1 -2 (m l .m in  .m )
2 . 5 - 4 . 2
_5
Res is tances  (dynes s. cm )
Pulmonary v a s c u la r  20-120
Systemic v a s c u la r  770-1500
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The effects of controlled oxygen on right ventricular function
P a t i e n t
No
Age
y r s
Sex FEVi
1
FVC
1
FEV^FVC
%
PaO^
kPa
PaCO^
kPa
H+
nm o l / I
Group I
1 67 M 0.5 1.1 50 5.2 8 .4 47
2 69 F 0.5 2 . 0 25 6 . 0 7.6 45
3 67 M 0.7 1.5 47 8 . 8 6 . 2 39
4 40 M 1.0 2 . 8 36 7.5 5.6 38
5 6 8 F 0 . 6 1.1 61 4 .5 8 . 6 42
6 70 F 0 .4 1.0 40 7 .8 5.5 45
7 70 M 0.9 1 . 8 50 7.4 5 .4 38
8 65 M 1.1 3.7 30 7.2 4 .4 39
Mean 64.5 0 .7 1.9 42 6 .9 6 .5 42
SD 10 0 .3 1 . 0 12 1.5 1.6 4
Group I I
1 60 • F 0 .9 3 .0 30 8.1 5.2 41
2 58 F 0.7 1.4 50 8 . 0 6 . 0 46
3 65 M 1.3 3.6 36 8.1 6.1 40
4 58 M 0.9 2.5 36 7.6 5.2 36
5 57 M 0.7 2.1 33 9.4 5 .8 42
6 65 M 1.4 2 . 1 67 7.2 4 .4 39
7 58 M 0 . 8 2 . 0 40 8 . 6 6 .1 44
8 6 8 M 0 . 8 2.3 35 9.4 5 .8 44
9 65 F 1.0 2.2 46 9 .8 6 .1 44
10 52 M 2.7 4 .7 45 11.3 4.2 39
11 62 M 0.5 1.6 32 6 . 8 5,. 9 41
12 65 M 0.5 1.1 46 6 . 8 6 . 0 39
13 62 F 0.3 0 .9 33 7.6 6 .7 43
14 55 F 1.7 2 . 6 65 7.4 5.6 43
15 65 F 1.0 2.3 44 8 . 0 6 .3 41
16 68 F 0 .3 1.5 2 0 6 . 0 6 .7 39
Mean 61.5 1.0 2.2 41 8.1 5 .8 41
SD 5 0 . 6 1.0 12 1.3 0.7 3
TABLE 17 (cont'd)
The effects of controlled oxygen on right ventricular function
P a t i e n t
No
Age
y r s
Sex
F E V 1
1
FVC
1
FEV^FVC
%
PaO^
kPa
PaCO^
kPa
H+
nm o l / I
Group I I I
1 66 M 0.5 1.5 33 6.3 6 .7 41
2 65 M 0.7 2.2 32 8 . 0 771 45
3 70 F 0 . 6 1.6 38 7.1 7.3 42
4 64 F 0.5 1.7 29 7.1 8 . 0 46
5 69 F 0.5 1.6 31 6 . 0 7.1 35
6 69 F 0 . 8 3.0 27 6.5 7.2 40
7 64 F 0.4 1.7 24 5.5 7.6 39
8 42 - F 0.7 1.2 58 6.7 5 .2 39
9 62 M 0.5 1 .0 31 6 . 8 5 .9 41
10 70 F 0 .4 1.0 40 7.8 5 .5 45
Mean 64 0 . 6 1.7 34 6 . 8 6 . 8 41
SD 8 0.1 0 . 6 10 0 . 8 0 .9 3
GROUP I -  ACUTE EFFECTS OF OXYGEN AT REST
GROUP I I  -  ACUTE EFFECTS OF OXYGEN DURING EXERCISE
GROUP I I I  -  EFFECTS OF LONG TERM OXYGEN
A r t e r i a l  and mixed venous b lood  gas and haemodynamic data 
in  8  p a t i e n t s  w i t h  c h r o n ic  b r o n c h i t i s  and emphysema a t  r e s t + 
w h i l e  b re a th in g  a i r  o r  oxygen 3 l i t r e s / m i n  by nasal prongs (Mean -  SEM)
AIR OXYGEN
Pa0 2  kPa 6 . 8
PaC0 2  kPa 6.5
Sa02 % 84
[H+] nmo l / I  42
PV02 kPa 4 .3
Ca02 m l/ 1 0 0  ml 16.2
CvO m l / 1 0 0 ml 11.4
C (a -v ) 0 2 m l/ 1 0 0  ml 4 7
COD 3.5
HR b/min 88
Mean sys tem ic  BP mmHg 97
Cl 1/min/m^ 2.58
Mean PAP mmHg 30
SVI ml /m2 30
TPVR dynes .s .cm "^  570
RVSP mmHg 47
RVEDP mmHg 7
RVEF 0.47
RVESVI m l .  m” 2 39
RVEDVI m l .  m' 2 69
RVSWI g .m /bea t /m 2 15.8
End s y s t o l i c  P/V r a t i o  1.69
LVEF 0.54
SVR dynes,  s. cm~^ 1915
Systemic oxygen ? 41
d e l i v e r y  m l /m in /m
+ 0.4 11 . 6 + 0 . 8 < 0 . 0 1
+ 0.5 6 .9 + 0 . 6 < 0.05
+ 4 95 + 2 < 0 . 0 2
+
1 43 + 2 NS
+
0.2 5.1 + 0 . 2 < 0.05
+
1 .0 18.2 + 0 . 7 < 0 . 0 1
4-
1 .0 13.8 + 0 . 7 < 0 . 0 1
+ 0.03 4 .4 + 0 . 2 NS
+ 0.3 4.2 + 0 . 3 < 0 . 0 1
+ 3 8 8 + 5 NS
+ 3 95 + 5 NS
+
0. 2 1 2.61 + 0 . 22 NS
+ 3 25 + 2 < 0.05
+ 3 31 + 4 NS
+ 67 477 + 51 < 0 . 0 1
+ 4 41 + 4 < 0 . 0 1
+
1 6
+
1 NS
+ 0.04 0.51 + 0 . 04 NS
+ 7 33 + 7 NS
+ 9 ’ 64 + 10 NS
+ 2.4 13.5 + 2 . 4 NS
+ 0.35 1.74 + 0 . 42 NS
+ 0.03 0.55 + 0 . 04 NS
+ 233 1864 + 2 2 0 NS
+ 4 48 + 4 < 0 . 0 1
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The e f f e c t  o f  oxygen on r i g h t  and l e f t  v e n t r i c u l a r  e j e c t i o n  f r a c t i o n s  
i n  16 p a t i e n t s  w i t h  c h r o n ic  b r o n c h i t i s  an<ji emphysema, a t  r e s t  and 
d u r in g  e x e r c i s e  (Means -  SEM)
(1 )  Res ta i r  (2)  E x e r c i s e a i r  (3 )  Res tQxygen (4 )  e x e r c i s e oxygen
IR (b /m in ) 90 + 4 111 + 4 90 + 5 111 + 4
;ao2 (%) 89 + 1 81 + 2 95 + 1 91 + 1
[VEF • 0.46 + 0 . 0 2 0.45 + 0.03 0.45 + 0 . 0 2 0.45 + 0 . 0 2
.VEF 0.56 + 0.03 0.58 + 0.03 0.54 + 0.03 0 .57 + 0.03
iTATISTICAL ANALYSIS
IR: (1 ) VS ( 2 ) P < 0 . 0 0 1 ; (3) VS (4) P < 0 . 0 0 1 ;
(1 ) VS (3) NS; ( 2 ) VS (4) NS
ia0 9 : (1 ) vs ( 2 ) P < 0 . 0 0 1 ; (3) VS (4) P < 0 . 0 1 ;( 1 ) VS (3) P < 0 . 0 0 1 ; ( 2 ) VS (4) P < 0 . 001
1VEF: (1 ) vs ( 2 ) (3 ) VS (4) ; ( 1) VS ( 3 ) ; ( 2 ) VS (4)  a l l  NS
.VEF: (1 ) vs ( 2 ) NS; (3)  VS (4) p < 0 . 01
(1 ) vs (3) NS; (2 )  VS (4) NS
Table 21
A r t e r i a l  b lo od  gas and haemodynamic da ta  b e fo re  and a f t e r  6 months 
oxygen (1 -3  1 /m in '  by nasal  p rongs) g ive n  to  10 p a t i e n t s  
(Means -  SEM) w i t h  c h r o n i c  b r o n c h i t i s  and emphysema f o r  
a t  l e a s t  15 h rs /2 4  h rs .  A l l  measurements were made
w h i l e  the  p a t i e n t s  b rea thed  room a i r .
Before  A f t e r  6 months p
oxygen oxygen
PaO^ kPa 6 . 8 + 0.3 7.0 + 0 .3 NS
PaCO^ kPa 6 . 8
+ 0 .3 6.5 + 0 .3 NS
[H+]  nm o l / I 41 + 1 41 + 1 NS
SaO^ % 85
+
1 84 + 1 NS
HR b/min 90 + 4 93 + 3 NS
Mean s y s t o l i c  BP mmHg 91 + 3 90 + 3 NS
Mean PAP mmHg 32 + 2 26 + 2 < 0 . 01
RVSP mmHg 47 + 4 35 + 2 < 0 . 01
RVEDP mmHg 6 + 1 4 + 1 < 0 . 02
RVEF 0.44 + 0.03 0 .48 + 0 . 0 2 NS
LVEF 0.54 + 0.04 0 .59 + 0.04 NS
12MD m 404 + 85 423 + 61 NS
FEV1 . 0  1 0 . 6
+ 0.04 0.5 + 0 .04 NS
FVC 1 1.7 + 0.19 1.61 + 0 . 2 NS
Weight  Kg 64.5 + 4 .3 64.0 + 4 .5 NS
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Table 25
Plasma p i r b u t e r o l  c o n c e n t r a t i o n s  i n  10 p a t i e n t s  60 and 120 
minutes a f t e r  a d m i n i s t r a t i o n  o f  the  drug
P a t i e n t  Dose o f  p i r b u t e r o l  Plasma p i r b u t e r o l
No (mg) (g/1 )
60 min 1 2 0  min
3 22.5 45.1 34.6
4 22.5 9.6 35.2
5 22.5 4 .2 45.0
6 22.5 43.7 24 .8
7 15 8 .1 1 0 . 0
8 15 5 .3 9.7
9 15 26.1 36.2
10 15 19.4 36.8
11 15 6 .9 3 .7
12 15 34.9 33.9
Haemodynamic v a r i a b l e s  (Mean -  SEM) and a r t e r i a l  b lood  gas te n s io n s  
be fo re  and a f t e r  6 weeks'  t re a tm e n t  w i t h  o r a l  p i r b u t e r o l  15 mg t h r i c e  d a i l y  
i n  9 p a t i e n t s  w i t h  c h r o n i c  b r o n c h i t i s  and emphysema
C on t ro l  A f t e r  6 weeks p 
p i r b u t e r o l
Heart  r a t e  ( b e a ts /m in ) 86 + 5 92 + 5 NS
A r t e r i a l  b lood  p ressure  (mmHg):
S y s t o l i c 124 + 5 121 + 5 NS
D i a s t o l i c 73 + 4 74 + 3 NS
A r t e r i a l  b lood  gas te n s io n s  (kPa):
Oxygen 7.2 + 0 .3 6 .9 + 0 . 2 NS
Carbon d io x i d e 6 . 8 + 0 . 2 7.2 + 0 .3 NS
Oxygen s a t u r a t i o n  (%) 86 + 2 84 + 2 NS
Hydrogen ion  c o n c e n t r a t i o n  (n m o l /1 ) 43 + 1 44 + 1 NS
Pulmonary a r t e r i a l  p ressure  (mmHg):
S y s t o l i c 43 + 3 35 + 2 < 0 . 0 1
Mean 28 + 2 26 + 2 NS
R ig h t  v e n t r i c u l a r  e j e c t i o n  f r a c t i o n 0.45 + 0.04 0.52 + 0.03 < 0 . 0 1
L e f t  v e n t r i c u l a r  e j e c t i o n  f r a c t i o n 0 .60 + 0.03 0.61 + 0.03 NS
FEV1 . 0 (1 ) 0 .58
+ 0.06 0 .60 + 0.05 NS
FVC (1) 1 . 6 6 + 0 . 1 0 1 . 6 6 + 0 . 1 0 NS
12  m inu te  w a lk in g  d i s t a n c e  (m) 424 + 1 0 0 439 + i0 4 NS
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